id	sid	tid	token	lemma	pos
iajs-3351	1	1	287	287	NUM
iajs-3351	1	2	©	©	NOUN
iajs-3351	1	3	published	publish	VERB
iajs-3351	1	4	by	by	ADP
iajs-3351	1	5	college	college	NOUN
iajs-3351	1	6	of	of	ADP
iajs-3351	1	7	education	education	NOUN
iajs-3351	1	8	for	for	ADP
iajs-3351	1	9	pure	pure	ADJ
iajs-3351	1	10	science	science	NOUN
iajs-3351	1	11	(	(	PUNCT
iajs-3351	1	12	ibn	ibn	PROPN
iajs-3351	1	13	al	al	PROPN
iajs-3351	1	14	-	-	PUNCT
iajs-3351	1	15	haitham	haitham	PROPN
iajs-3351	1	16	)	)	PUNCT
iajs-3351	1	17	,	,	PUNCT
iajs-3351	1	18	university	university	NOUN
iajs-3351	1	19	of	of	ADP
iajs-3351	1	20	baghdad	baghdad	PROPN
iajs-3351	1	21	.	.	PUNCT
iajs-3351	2	1	this	this	PRON
iajs-3351	2	2	is	be	AUX
iajs-3351	2	3	an	an	DET
iajs-3351	2	4	open	open	ADJ
iajs-3351	2	5	-	-	PUNCT
iajs-3351	2	6	access	access	NOUN
iajs-3351	2	7	article	article	NOUN
iajs-3351	2	8	distributed	distribute	VERB
iajs-3351	2	9	under	under	ADP
iajs-3351	2	10	the	the	DET
iajs-3351	2	11	terms	term	NOUN
iajs-3351	2	12	of	of	ADP
iajs-3351	2	13	the	the	DET
iajs-3351	2	14	creative	creative	ADJ
iajs-3351	2	15	commons	common	NOUN
iajs-3351	2	16	attribution	attribution	NOUN
iajs-3351	2	17	4.0	4.0	NUM
iajs-3351	2	18	international	international	ADJ
iajs-3351	2	19	license	license	NOUN
iajs-3351	2	20	ihjpas	ihjpa	NOUN
iajs-3351	2	21	.	.	PUNCT
iajs-3351	3	1	37	37	NUM
iajs-3351	3	2	(	(	PUNCT
iajs-3351	3	3	3	3	NUM
iajs-3351	3	4	)	)	PUNCT
iajs-3351	3	5	2024	2024	NUM
iajs-3351	3	6	ibn	ibn	PROPN
iajs-3351	3	7	al	al	PROPN
iajs-3351	3	8	-	-	PUNCT
iajs-3351	3	9	haitham	haitham	PROPN
iajs-3351	3	10	journal	journal	PROPN
iajs-3351	3	11	for	for	ADP
iajs-3351	3	12	pure	pure	ADJ
iajs-3351	3	13	and	and	CCONJ
iajs-3351	3	14	applied	applied	ADJ
iajs-3351	3	15	sciences	sciences	PROPN
iajs-3351	3	16	journal	journal	PROPN
iajs-3351	3	17	homepage	homepage	NOUN
iajs-3351	3	18	:	:	PUNCT
iajs-3351	3	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3351	3	20	pissn	pissn	ADJ
iajs-3351	3	21	:	:	PUNCT
iajs-3351	3	22	1609	1609	NUM
iajs-3351	3	23	-	-	SYM
iajs-3351	3	24	4042	4042	NUM
iajs-3351	3	25	,	,	PUNCT
iajs-3351	3	26	eissn	eissn	NOUN
iajs-3351	3	27	:	:	PUNCT
iajs-3351	3	28	2521	2521	NUM
iajs-3351	3	29	-	-	SYM
iajs-3351	3	30	3407	3407	NUM
iajs-3351	3	31	association	association	NOUN
iajs-3351	3	32	of	of	ADP
iajs-3351	3	33	ace2	ace2	PROPN
iajs-3351	3	34	,	,	PUNCT
iajs-3351	3	35	insulin	insulin	NOUN
iajs-3351	3	36	resistance	resistance	NOUN
iajs-3351	3	37	,	,	PUNCT
iajs-3351	3	38	and	and	CCONJ
iajs-3351	3	39	other	other	ADJ
iajs-3351	3	40	parameters	parameter	NOUN
iajs-3351	3	41	in	in	ADP
iajs-3351	3	42	obese	obese	ADJ
iajs-3351	3	43	polycystic	polycystic	ADJ
iajs-3351	3	44	ovary	ovary	ADJ
iajs-3351	3	45	syndrome	syndrome	NOUN
iajs-3351	3	46	patients	patient	NOUN
iajs-3351	3	47	infected	infect	VERB
iajs-3351	3	48	with	with	ADP
iajs-3351	3	49	covid-19	covid-19	PROPN
iajs-3351	3	50	shaimaa	shaimaa	ADJ
iajs-3351	3	51	imad	imad	PROPN
iajs-3351	3	52	ali	ali	PROPN
iajs-3351	3	53	1,2	1,2	NUM
iajs-3351	3	54	,	,	PUNCT
iajs-3351	3	55	*	*	PUNCT
iajs-3351	3	56	,	,	PUNCT
iajs-3351	3	57	fayhaa	fayhaa	PROPN
iajs-3351	3	58	m.	m.	NOUN
iajs-3351	3	59	khaleel	khaleel	PROPN
iajs-3351	3	60	2	2	NUM
iajs-3351	3	61	and	and	CCONJ
iajs-3351	3	62	ali	ali	PROPN
iajs-3351	3	63	majeed	majeed	PROPN
iajs-3351	3	64	ali	ali	PROPN
iajs-3351	3	65	almukram	almukram	PROPN
iajs-3351	3	66	3	3	NUM
iajs-3351	3	67	1	1	NUM
iajs-3351	3	68	*	*	PROPN
iajs-3351	3	69	department	department	NOUN
iajs-3351	3	70	of	of	ADP
iajs-3351	3	71	chemistry	chemistry	NOUN
iajs-3351	3	72	,	,	PUNCT
iajs-3351	3	73	college	college	NOUN
iajs-3351	3	74	of	of	ADP
iajs-3351	3	75	sciences	science	NOUN
iajs-3351	3	76	,	,	PUNCT
iajs-3351	3	77	alnahrain	alnahrain	NOUN
iajs-3351	3	78	university	university	NOUN
iajs-3351	3	79	,	,	PUNCT
iajs-3351	3	80	baghdad	baghdad	PROPN
iajs-3351	3	81	,	,	PUNCT
iajs-3351	3	82	iraq	iraq	PROPN
iajs-3351	3	83	.	.	PUNCT
iajs-3351	4	1	2	2	NUM
iajs-3351	4	2	department	department	NOUN
iajs-3351	4	3	of	of	ADP
iajs-3351	4	4	chemistry	chemistry	NOUN
iajs-3351	4	5	,	,	PUNCT
iajs-3351	4	6	college	college	NOUN
iajs-3351	4	7	of	of	ADP
iajs-3351	4	8	sciences	science	NOUN
iajs-3351	4	9	for	for	ADP
iajs-3351	4	10	women	woman	NOUN
iajs-3351	4	11	,	,	PUNCT
iajs-3351	4	12	university	university	NOUN
iajs-3351	4	13	of	of	ADP
iajs-3351	4	14	baghdad	baghdad	PROPN
iajs-3351	4	15	,	,	PUNCT
iajs-3351	4	16	baghdad	baghdad	PROPN
iajs-3351	4	17	,	,	PUNCT
iajs-3351	4	18	iraq	iraq	PROPN
iajs-3351	4	19	.	.	PUNCT
iajs-3351	5	1	3	3	NUM
iajs-3351	5	2	school	school	NOUN
iajs-3351	5	3	of	of	ADP
iajs-3351	5	4	pharmacy	pharmacy	NOUN
iajs-3351	5	5	,	,	PUNCT
iajs-3351	5	6	university	university	NOUN
iajs-3351	5	7	of	of	ADP
iajs-3351	5	8	maryland	maryland	PROPN
iajs-3351	5	9	,	,	PUNCT
iajs-3351	5	10	baltimore	baltimore	PROPN
iajs-3351	5	11	,	,	PUNCT
iajs-3351	5	12	us	we	PRON
iajs-3351	5	13	.	.	PUNCT
iajs-3351	6	1	*	*	PUNCT
iajs-3351	6	2	corresponding	correspond	VERB
iajs-3351	6	3	author	author	NOUN
iajs-3351	6	4	.	.	PUNCT
iajs-3351	7	1	received:19	received:19	PROPN
iajs-3351	7	2	march	march	PROPN
iajs-3351	7	3	2023	2023	NUM
iajs-3351	7	4	accepted	accept	VERB
iajs-3351	7	5	:	:	PUNCT
iajs-3351	7	6	3	3	NUM
iajs-3351	7	7	may	may	PROPN
iajs-3351	7	8	2023	2023	NUM
iajs-3351	7	9	published	publish	VERB
iajs-3351	7	10	:	:	PUNCT
iajs-3351	7	11	20	20	NUM
iajs-3351	7	12	july	july	PROPN
iajs-3351	7	13	2024	2024	NUM
iajs-3351	7	14	doi.org/10.30526/37.3.3351	doi.org/10.30526/37.3.3351	NOUN
iajs-3351	7	15	abstract	abstract	ADJ
iajs-3351	7	16	polycystic	polycystic	ADJ
iajs-3351	7	17	ovary	ovary	ADJ
iajs-3351	7	18	syndrome	syndrome	NOUN
iajs-3351	7	19	(	(	PUNCT
iajs-3351	7	20	pcos	pcos	PROPN
iajs-3351	7	21	)	)	PUNCT
iajs-3351	7	22	has	have	VERB
iajs-3351	7	23	a	a	DET
iajs-3351	7	24	high	high	ADJ
iajs-3351	7	25	predisposition	predisposition	NOUN
iajs-3351	7	26	to	to	ADP
iajs-3351	7	27	many	many	ADJ
iajs-3351	7	28	cardiometabolic	cardiometabolic	ADJ
iajs-3351	7	29	risk	risk	NOUN
iajs-3351	7	30	factors	factor	NOUN
iajs-3351	7	31	that	that	PRON
iajs-3351	7	32	increase	increase	VERB
iajs-3351	7	33	susceptibility	susceptibility	NOUN
iajs-3351	7	34	to	to	ADP
iajs-3351	7	35	severe	severe	ADJ
iajs-3351	7	36	complications	complication	NOUN
iajs-3351	7	37	of	of	ADP
iajs-3351	7	38	covid-19	covid-19	PROPN
iajs-3351	7	39	and	and	CCONJ
iajs-3351	7	40	also	also	ADV
iajs-3351	7	41	exhibit	exhibit	VERB
iajs-3351	7	42	an	an	DET
iajs-3351	7	43	increased	increase	VERB
iajs-3351	7	44	likelihood	likelihood	NOUN
iajs-3351	7	45	of	of	ADP
iajs-3351	7	46	subfertility	subfertility	NOUN
iajs-3351	7	47	.	.	PUNCT
iajs-3351	8	1	therefore	therefore	ADV
iajs-3351	8	2	,	,	PUNCT
iajs-3351	8	3	women	woman	NOUN
iajs-3351	8	4	with	with	ADP
iajs-3351	8	5	polycystic	polycystic	ADJ
iajs-3351	8	6	ovary	ovary	ADJ
iajs-3351	8	7	syndrome	syndrome	NOUN
iajs-3351	8	8	may	may	AUX
iajs-3351	8	9	be	be	AUX
iajs-3351	8	10	disproportionately	disproportionately	ADV
iajs-3351	8	11	affected	affect	VERB
iajs-3351	8	12	by	by	ADP
iajs-3351	8	13	this	this	DET
iajs-3351	8	14	epidemic	epidemic	NOUN
iajs-3351	8	15	and	and	CCONJ
iajs-3351	8	16	its	its	PRON
iajs-3351	8	17	related	related	ADJ
iajs-3351	8	18	consequences	consequence	NOUN
iajs-3351	8	19	.	.	PUNCT
iajs-3351	9	1	the	the	DET
iajs-3351	9	2	accumulation	accumulation	NOUN
iajs-3351	9	3	of	of	ADP
iajs-3351	9	4	extra	extra	ADJ
iajs-3351	9	5	body	body	NOUN
iajs-3351	9	6	fat	fat	NOUN
iajs-3351	9	7	that	that	PRON
iajs-3351	9	8	has	have	VERB
iajs-3351	9	9	the	the	DET
iajs-3351	9	10	possibility	possibility	NOUN
iajs-3351	9	11	of	of	ADP
iajs-3351	9	12	affecting	affect	VERB
iajs-3351	9	13	health	health	NOUN
iajs-3351	9	14	is	be	AUX
iajs-3351	9	15	referred	refer	VERB
iajs-3351	9	16	to	to	ADP
iajs-3351	9	17	as	as	ADP
iajs-3351	9	18	obesity	obesity	NOUN
iajs-3351	9	19	,	,	PUNCT
iajs-3351	9	20	which	which	PRON
iajs-3351	9	21	is	be	AUX
iajs-3351	9	22	the	the	DET
iajs-3351	9	23	outcome	outcome	NOUN
iajs-3351	9	24	of	of	ADP
iajs-3351	9	25	an	an	DET
iajs-3351	9	26	imbalance	imbalance	NOUN
iajs-3351	9	27	between	between	ADP
iajs-3351	9	28	energy	energy	NOUN
iajs-3351	9	29	intake	intake	NOUN
iajs-3351	9	30	and	and	CCONJ
iajs-3351	9	31	expenditure	expenditure	NOUN
iajs-3351	9	32	,	,	PUNCT
iajs-3351	9	33	whereby	whereby	SCONJ
iajs-3351	9	34	more	more	ADJ
iajs-3351	9	35	calories	calorie	NOUN
iajs-3351	9	36	are	be	AUX
iajs-3351	9	37	consumed	consume	VERB
iajs-3351	9	38	than	than	SCONJ
iajs-3351	9	39	are	be	AUX
iajs-3351	9	40	expended	expend	VERB
iajs-3351	9	41	through	through	ADP
iajs-3351	9	42	exercise	exercise	NOUN
iajs-3351	9	43	.	.	PUNCT
iajs-3351	10	1	this	this	DET
iajs-3351	10	2	study	study	NOUN
iajs-3351	10	3	investigated	investigate	VERB
iajs-3351	10	4	the	the	DET
iajs-3351	10	5	relationship	relationship	NOUN
iajs-3351	10	6	between	between	ADP
iajs-3351	10	7	angiotensin	angiotensin	NOUN
iajs-3351	10	8	-	-	PUNCT
iajs-3351	10	9	converting	convert	VERB
iajs-3351	10	10	enzyme	enzyme	NOUN
iajs-3351	10	11	2	2	NUM
iajs-3351	10	12	and	and	CCONJ
iajs-3351	10	13	insulin	insulin	NOUN
iajs-3351	10	14	resistance	resistance	NOUN
iajs-3351	10	15	and	and	CCONJ
iajs-3351	10	16	other	other	ADJ
iajs-3351	10	17	parameters	parameter	NOUN
iajs-3351	10	18	in	in	ADP
iajs-3351	10	19	pcos	pcos	PROPN
iajs-3351	10	20	patients	patient	NOUN
iajs-3351	10	21	with	with	ADP
iajs-3351	10	22	covid-19	covid-19	PROPN
iajs-3351	10	23	infection	infection	NOUN
iajs-3351	10	24	.	.	PUNCT
iajs-3351	11	1	the	the	DET
iajs-3351	11	2	study	study	NOUN
iajs-3351	11	3	groups	group	NOUN
iajs-3351	11	4	comprised	comprise	VERB
iajs-3351	11	5	120	120	NUM
iajs-3351	11	6	sample	sample	NOUN
iajs-3351	11	7	ladies	lady	NOUN
iajs-3351	11	8	,	,	PUNCT
iajs-3351	11	9	involving	involve	VERB
iajs-3351	11	10	80	80	NUM
iajs-3351	11	11	pcos	pcos	NOUN
iajs-3351	11	12	patients	patient	NOUN
iajs-3351	11	13	with	with	ADP
iajs-3351	11	14	and	and	CCONJ
iajs-3351	11	15	without	without	ADP
iajs-3351	11	16	covid-19	covid-19	PROPN
iajs-3351	11	17	and	and	CCONJ
iajs-3351	11	18	40	40	NUM
iajs-3351	11	19	control	control	NOUN
iajs-3351	11	20	ladies	lady	NOUN
iajs-3351	11	21	.	.	PUNCT
iajs-3351	12	1	the	the	DET
iajs-3351	12	2	leading	lead	VERB
iajs-3351	12	3	group	group	NOUN
iajs-3351	12	4	of	of	ADP
iajs-3351	12	5	patients	patient	NOUN
iajs-3351	12	6	was	be	AUX
iajs-3351	12	7	divided	divide	VERB
iajs-3351	12	8	into	into	ADP
iajs-3351	12	9	subgroups	subgroup	NOUN
iajs-3351	12	10	based	base	VERB
iajs-3351	12	11	on	on	ADP
iajs-3351	12	12	bmi	bmi	PROPN
iajs-3351	12	13	.	.	PUNCT
iajs-3351	13	1	blood	blood	NOUN
iajs-3351	13	2	samples	sample	NOUN
iajs-3351	13	3	were	be	AUX
iajs-3351	13	4	taken	take	VERB
iajs-3351	13	5	from	from	ADP
iajs-3351	13	6	kamal	kamal	PROPN
iajs-3351	13	7	-	-	PUNCT
iajs-3351	13	8	al	al	PROPN
iajs-3351	13	9	-	-	PUNCT
iajs-3351	13	10	samarai	samarai	NOUN
iajs-3351	13	11	hospital	hospital	NOUN
iajs-3351	13	12	between	between	ADP
iajs-3351	13	13	december	december	PROPN
iajs-3351	13	14	2021	2021	NUM
iajs-3351	13	15	and	and	CCONJ
iajs-3351	13	16	june	june	PROPN
iajs-3351	13	17	2022	2022	NUM
iajs-3351	13	18	.	.	PUNCT
iajs-3351	14	1	some	some	DET
iajs-3351	14	2	biochemical	biochemical	ADJ
iajs-3351	14	3	parameters	parameter	NOUN
iajs-3351	14	4	were	be	AUX
iajs-3351	14	5	measured	measure	VERB
iajs-3351	14	6	for	for	ADP
iajs-3351	14	7	all	all	DET
iajs-3351	14	8	study	study	NOUN
iajs-3351	14	9	groups	group	NOUN
iajs-3351	14	10	,	,	PUNCT
iajs-3351	14	11	which	which	PRON
iajs-3351	14	12	included	include	VERB
iajs-3351	14	13	serum	serum	NOUN
iajs-3351	14	14	ace2	ace2	PROPN
iajs-3351	14	15	,	,	PUNCT
iajs-3351	14	16	d	d	NOUN
iajs-3351	14	17	-	-	PUNCT
iajs-3351	14	18	dimer	dimer	ADJ
iajs-3351	14	19	,	,	PUNCT
iajs-3351	14	20	lipid	lipid	NOUN
iajs-3351	14	21	profile	profile	NOUN
iajs-3351	14	22	,	,	PUNCT
iajs-3351	14	23	gst	gst	NOUN
iajs-3351	14	24	activity	activity	NOUN
iajs-3351	14	25	,	,	PUNCT
iajs-3351	14	26	fbs	fbs	PROPN
iajs-3351	14	27	,	,	PUNCT
iajs-3351	14	28	and	and	CCONJ
iajs-3351	14	29	hormones	hormone	NOUN
iajs-3351	14	30	.	.	PUNCT
iajs-3351	15	1	pcos	pcos	PROPN
iajs-3351	15	2	women	woman	NOUN
iajs-3351	15	3	had	have	VERB
iajs-3351	15	4	a	a	DET
iajs-3351	15	5	higher	high	ADJ
iajs-3351	15	6	bmi	bmi	NOUN
iajs-3351	15	7	,	,	PUNCT
iajs-3351	15	8	fbs	fbs	PROPN
iajs-3351	15	9	,	,	PUNCT
iajs-3351	15	10	lipid	lipid	NOUN
iajs-3351	15	11	profile	profile	NOUN
iajs-3351	15	12	(	(	PUNCT
iajs-3351	15	13	except	except	SCONJ
iajs-3351	15	14	high	high	ADJ
iajs-3351	15	15	-	-	PUNCT
iajs-3351	15	16	density	density	NOUN
iajs-3351	15	17	lipoprotein	lipoprotein	NOUN
iajs-3351	15	18	)	)	PUNCT
iajs-3351	15	19	,	,	PUNCT
iajs-3351	15	20	d	d	X
iajs-3351	15	21	-	-	PUNCT
iajs-3351	15	22	dimer	dimer	ADJ
iajs-3351	15	23	,	,	PUNCT
iajs-3351	15	24	waist	waist	NOUN
iajs-3351	15	25	/	/	SYM
iajs-3351	15	26	hip	hip	NOUN
iajs-3351	15	27	ratio	ratio	NOUN
iajs-3351	15	28	,	,	PUNCT
iajs-3351	15	29	testosterone	testosterone	NOUN
iajs-3351	15	30	,	,	PUNCT
iajs-3351	15	31	insulin	insulin	NOUN
iajs-3351	15	32	,	,	PUNCT
iajs-3351	15	33	and	and	CCONJ
iajs-3351	15	34	homa	homa	PROPN
iajs-3351	15	35	-	-	PUNCT
iajs-3351	15	36	ir	ir	PROPN
iajs-3351	15	37	(	(	PUNCT
iajs-3351	15	38	p	p	X
iajs-3351	15	39	<	<	X
iajs-3351	15	40	0.0001	0.0001	NUM
iajs-3351	15	41	)	)	PUNCT
iajs-3351	15	42	.	.	PUNCT
iajs-3351	16	1	while	while	SCONJ
iajs-3351	16	2	gst	gst	NOUN
iajs-3351	16	3	-	-	PUNCT
iajs-3351	16	4	activity	activity	NOUN
iajs-3351	16	5	and	and	CCONJ
iajs-3351	16	6	ace2	ace2	NOUN
iajs-3351	16	7	levels	level	NOUN
iajs-3351	16	8	were	be	AUX
iajs-3351	16	9	lower	low	ADJ
iajs-3351	16	10	in	in	ADP
iajs-3351	16	11	pcos	pcos	PROPN
iajs-3351	16	12	(	(	PUNCT
iajs-3351	16	13	p	p	X
iajs-3351	16	14	<	<	X
iajs-3351	16	15	0.001	0.001	NUM
iajs-3351	16	16	)	)	PUNCT
iajs-3351	16	17	,	,	PUNCT
iajs-3351	16	18	suggesting	suggest	VERB
iajs-3351	16	19	that	that	SCONJ
iajs-3351	16	20	pcos	pcos	PROPN
iajs-3351	16	21	women	woman	NOUN
iajs-3351	16	22	are	be	AUX
iajs-3351	16	23	at	at	ADP
iajs-3351	16	24	risk	risk	NOUN
iajs-3351	16	25	for	for	ADP
iajs-3351	16	26	cardiovascular	cardiovascular	ADJ
iajs-3351	16	27	diseases	disease	NOUN
iajs-3351	16	28	,	,	PUNCT
iajs-3351	16	29	in	in	ADP
iajs-3351	16	30	the	the	DET
iajs-3351	16	31	current	current	ADJ
iajs-3351	16	32	research	research	NOUN
iajs-3351	16	33	,	,	PUNCT
iajs-3351	16	34	we	we	PRON
iajs-3351	16	35	found	find	VERB
iajs-3351	16	36	there	there	PRON
iajs-3351	16	37	is	be	VERB
iajs-3351	16	38	a	a	DET
iajs-3351	16	39	probable	probable	ADJ
iajs-3351	16	40	relationship	relationship	NOUN
iajs-3351	16	41	between	between	ADP
iajs-3351	16	42	ace2	ace2	PROPN
iajs-3351	16	43	and	and	CCONJ
iajs-3351	16	44	homa	homa	PROPN
iajs-3351	16	45	ir	ir	PROPN
iajs-3351	16	46	in	in	ADP
iajs-3351	16	47	pcos	pcos	PROPN
iajs-3351	16	48	patients	patient	NOUN
iajs-3351	16	49	who	who	PRON
iajs-3351	16	50	have	have	VERB
iajs-3351	16	51	a	a	DET
iajs-3351	16	52	coronavirus	coronavirus	NOUN
iajs-3351	16	53	infection	infection	NOUN
iajs-3351	16	54	.	.	PUNCT
iajs-3351	17	1	keywords	keyword	NOUN
iajs-3351	17	2	:	:	PUNCT
iajs-3351	17	3	angiotensin	angiotensin	NOUN
iajs-3351	17	4	-	-	PUNCT
iajs-3351	17	5	converting	convert	VERB
iajs-3351	17	6	enzyme	enzyme	NOUN
iajs-3351	17	7	2	2	NUM
iajs-3351	17	8	,	,	PUNCT
iajs-3351	17	9	covid-19	covid-19	PROPN
iajs-3351	17	10	,	,	PUNCT
iajs-3351	17	11	d	d	NOUN
iajs-3351	17	12	-	-	PUNCT
iajs-3351	17	13	dimer	dimer	ADJ
iajs-3351	17	14	,	,	PUNCT
iajs-3351	17	15	insulin	insulin	NOUN
iajs-3351	17	16	resistance	resistance	NOUN
iajs-3351	17	17	,	,	PUNCT
iajs-3351	17	18	polycystic	polycystic	ADJ
iajs-3351	17	19	ovary	ovary	ADJ
iajs-3351	17	20	syndrome	syndrome	NOUN
iajs-3351	17	21	.	.	PUNCT
iajs-3351	18	1	1	1	X
iajs-3351	18	2	.	.	X
iajs-3351	18	3	introduction	introduction	NOUN
iajs-3351	18	4	polycystic	polycystic	ADJ
iajs-3351	18	5	ovary	ovary	ADJ
iajs-3351	18	6	syndrome	syndrome	NOUN
iajs-3351	18	7	(	(	PUNCT
iajs-3351	18	8	pcos	pcos	PROPN
iajs-3351	18	9	)	)	PUNCT
iajs-3351	18	10	is	be	AUX
iajs-3351	18	11	a	a	DET
iajs-3351	18	12	heterogeneous	heterogeneous	ADJ
iajs-3351	18	13	condition	condition	NOUN
iajs-3351	18	14	described	describe	VERB
iajs-3351	18	15	as	as	ADP
iajs-3351	18	16	an	an	DET
iajs-3351	18	17	ovulatory	ovulatory	NOUN
iajs-3351	18	18	,	,	PUNCT
iajs-3351	18	19	hyperandrogenism	hyperandrogenism	NOUN
iajs-3351	18	20	,	,	PUNCT
iajs-3351	18	21	or	or	CCONJ
iajs-3351	18	22	polycystic	polycystic	ADJ
iajs-3351	18	23	appearance	appearance	NOUN
iajs-3351	18	24	of	of	ADP
iajs-3351	18	25	the	the	DET
iajs-3351	18	26	ovaries	ovary	NOUN
iajs-3351	18	27	.	.	PUNCT
iajs-3351	19	1	the	the	DET
iajs-3351	19	2	detection	detection	NOUN
iajs-3351	19	3	of	of	ADP
iajs-3351	19	4	pcos	pcos	PROPN
iajs-3351	19	5	has	have	AUX
iajs-3351	19	6	extremely	extremely	ADV
iajs-3351	19	7	established	establish	VERB
iajs-3351	19	8	recommendations	recommendation	NOUN
iajs-3351	19	9	with	with	ADP
iajs-3351	19	10	increased	increase	VERB
iajs-3351	19	11	risk	risk	NOUN
iajs-3351	19	12	for	for	ADP
iajs-3351	19	13	metabolic	metabolic	NOUN
iajs-3351	19	14	disorders	disorder	NOUN
iajs-3351	19	15	,	,	PUNCT
iajs-3351	19	16	type	type	NOUN
iajs-3351	19	17	2	2	NUM
iajs-3351	19	18	diabetes	diabetes	NOUN
iajs-3351	19	19	mellitus	mellitus	NOUN
iajs-3351	19	20	(	(	PUNCT
iajs-3351	19	21	t2	t2	NOUN
iajs-3351	19	22	dm	dm	PROPN
iajs-3351	19	23	)	)	PUNCT
iajs-3351	19	24	,	,	PUNCT
iajs-3351	19	25	cardiovascular	cardiovascular	ADJ
iajs-3351	19	26	diseases	disease	NOUN
iajs-3351	19	27	(	(	PUNCT
iajs-3351	19	28	cvd	cvd	NOUN
iajs-3351	19	29	)	)	PUNCT
iajs-3351	19	30	,	,	PUNCT
iajs-3351	19	31	and	and	CCONJ
iajs-3351	19	32	endometrial	endometrial	ADJ
iajs-3351	19	33	carcinoma	carcinoma	NOUN
iajs-3351	19	34	.	.	PUNCT
iajs-3351	20	1	pcos	pcos	PROPN
iajs-3351	20	2	should	should	AUX
iajs-3351	20	3	be	be	AUX
iajs-3351	20	4	considered	consider	VERB
iajs-3351	20	5	in	in	ADP
iajs-3351	20	6	any	any	DET
iajs-3351	20	7	adolescent	adolescent	ADJ
iajs-3351	20	8	female	female	NOUN
iajs-3351	20	9	with	with	ADP
iajs-3351	20	10	a	a	DET
iajs-3351	20	11	primary	primary	ADJ
iajs-3351	20	12	complaint	complaint	NOUN
iajs-3351	20	13	of	of	ADP
iajs-3351	20	14	hirsutism	hirsutism	NOUN
iajs-3351	20	15	,	,	PUNCT
iajs-3351	20	16	acne	acne	NOUN
iajs-3351	20	17	,	,	PUNCT
iajs-3351	20	18	skin	skin	NOUN
iajs-3351	20	19	inflammation	inflammation	NOUN
iajs-3351	20	20	,	,	PUNCT
iajs-3351	20	21	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	22	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	23	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	24	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	25	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	26	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	27	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	28	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	29	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	30	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	31	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	32	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	33	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	34	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	35	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	36	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	37	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	38	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	NOUN
iajs-3351	20	39	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3351	20	40	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	PROPN
iajs-3351	20	41	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	42	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	43	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	44	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	45	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	46	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	47	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	48	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	49	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	50	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	51	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	52	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	53	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	54	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	55	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	56	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	57	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	58	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	59	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	60	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	61	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	62	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	63	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	64	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	65	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	66	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	67	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	68	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	69	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	70	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	71	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	72	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	73	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	74	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	75	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	76	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	77	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	78	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	79	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	80	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	81	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	82	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	83	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	84	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	85	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	86	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	87	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	ADP
iajs-3351	20	88	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	PROPN
iajs-3351	20	89	https://orcid.org/0000-0001-6799-8053	https://orcid.org/0000-0001-6799-8053	PROPN
iajs-3351	20	90	mailto:moonlight9478@yahoo.com	mailto:moonlight9478@yahoo.com	PROPN
iajs-3351	20	91	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3351	20	92	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3351	20	93	https://orcid.org/0009-0009-3140-6197	https://orcid.org/0009-0009-3140-6197	AUX
iajs-3351	20	94	mailto:alialmukram@umaryland.edu	mailto:alialmukram@umaryland.edu	NOUN
iajs-3351	20	95	ihjpas	ihjpa	NOUN
iajs-3351	20	96	.	.	PUNCT
iajs-3351	21	1	37	37	NUM
iajs-3351	21	2	(	(	PUNCT
iajs-3351	21	3	3	3	NUM
iajs-3351	21	4	)	)	PUNCT
iajs-3351	21	5	2024	2024	NUM
iajs-3351	21	6	288	288	NUM
iajs-3351	21	7	menstrual	menstrual	ADJ
iajs-3351	21	8	anomaly	anomaly	NOUN
iajs-3351	21	9	,	,	PUNCT
iajs-3351	21	10	or	or	CCONJ
iajs-3351	21	11	a	a	DET
iajs-3351	21	12	rise	rise	NOUN
iajs-3351	21	13	in	in	ADP
iajs-3351	21	14	body	body	NOUN
iajs-3351	21	15	mass	mass	NOUN
iajs-3351	22	1	[	[	X
iajs-3351	22	2	1,2	1,2	NUM
iajs-3351	22	3	]	]	PUNCT
iajs-3351	22	4	.	.	PUNCT
iajs-3351	23	1	insulin	insulin	NOUN
iajs-3351	23	2	resistance	resistance	NOUN
iajs-3351	23	3	(	(	PUNCT
iajs-3351	23	4	ir	ir	NOUN
iajs-3351	23	5	)	)	PUNCT
iajs-3351	23	6	is	be	AUX
iajs-3351	23	7	viewed	view	VERB
iajs-3351	23	8	as	as	ADP
iajs-3351	23	9	the	the	DET
iajs-3351	23	10	primary	primary	ADJ
iajs-3351	23	11	pathological	pathological	ADJ
iajs-3351	23	12	agent	agent	NOUN
iajs-3351	23	13	out	out	ADP
iajs-3351	23	14	of	of	ADP
iajs-3351	23	15	sight	sight	NOUN
iajs-3351	23	16	of	of	ADP
iajs-3351	23	17	expanded	expand	VERB
iajs-3351	23	18	metabolic	metabolic	NOUN
iajs-3351	23	19	unsettling	unsettling	ADJ
iajs-3351	23	20	influences	influence	NOUN
iajs-3351	23	21	in	in	ADP
iajs-3351	23	22	pcos	pcos	PROPN
iajs-3351	23	23	patients	patient	NOUN
iajs-3351	23	24	'	'	PART
iajs-3351	23	25	irregular	irregular	ADJ
iajs-3351	23	26	menstrual	menstrual	NOUN
iajs-3351	23	27	and	and	CCONJ
iajs-3351	23	28	appearances	appearance	NOUN
iajs-3351	23	29	of	of	ADP
iajs-3351	23	30	other	other	ADJ
iajs-3351	23	31	metabolic	metabolic	NOUN
iajs-3351	23	32	disorders	disorder	NOUN
iajs-3351	23	33	found	find	VERB
iajs-3351	23	34	in	in	ADP
iajs-3351	23	35	this	this	DET
iajs-3351	23	36	disease	disease	NOUN
iajs-3351	23	37	[	[	X
iajs-3351	23	38	3	3	NUM
iajs-3351	23	39	]	]	PUNCT
iajs-3351	23	40	.	.	PUNCT
iajs-3351	24	1	abnormal	abnormal	ADJ
iajs-3351	24	2	growth	growth	NOUN
iajs-3351	24	3	of	of	ADP
iajs-3351	24	4	hair	hair	NOUN
iajs-3351	24	5	in	in	ADP
iajs-3351	24	6	pcos	pcos	PROPN
iajs-3351	24	7	patients	patient	NOUN
iajs-3351	24	8	is	be	AUX
iajs-3351	24	9	associated	associate	VERB
iajs-3351	24	10	with	with	ADP
iajs-3351	24	11	elevated	elevated	ADJ
iajs-3351	24	12	values	value	NOUN
iajs-3351	24	13	of	of	ADP
iajs-3351	24	14	androgen	androgen	NOUN
iajs-3351	24	15	,	,	PUNCT
iajs-3351	24	16	which	which	PRON
iajs-3351	24	17	is	be	AUX
iajs-3351	24	18	commonly	commonly	ADV
iajs-3351	24	19	produced	produce	VERB
iajs-3351	24	20	from	from	ADP
iajs-3351	24	21	the	the	DET
iajs-3351	24	22	ovaries	ovary	NOUN
iajs-3351	24	23	,	,	PUNCT
iajs-3351	24	24	and	and	CCONJ
iajs-3351	24	25	a	a	DET
iajs-3351	24	26	higher	high	ADJ
iajs-3351	24	27	sensitivity	sensitivity	NOUN
iajs-3351	24	28	of	of	ADP
iajs-3351	24	29	the	the	DET
iajs-3351	24	30	pilosebaceous	pilosebaceous	ADJ
iajs-3351	24	31	part	part	NOUN
iajs-3351	24	32	to	to	ADP
iajs-3351	24	33	androgen	androgen	NOUN
iajs-3351	24	34	.	.	PUNCT
iajs-3351	25	1	higher	high	ADJ
iajs-3351	25	2	secretion	secretion	NOUN
iajs-3351	25	3	of	of	ADP
iajs-3351	25	4	insulin	insulin	NOUN
iajs-3351	25	5	in	in	ADP
iajs-3351	25	6	the	the	DET
iajs-3351	25	7	blood	blood	NOUN
iajs-3351	25	8	causes	cause	VERB
iajs-3351	25	9	adipocyte	adipocyte	ADJ
iajs-3351	25	10	dysfunction	dysfunction	NOUN
iajs-3351	25	11	and	and	CCONJ
iajs-3351	25	12	hypertrophy	hypertrophy	NOUN
iajs-3351	25	13	,	,	PUNCT
iajs-3351	25	14	which	which	PRON
iajs-3351	25	15	leads	lead	VERB
iajs-3351	25	16	to	to	ADP
iajs-3351	25	17	an	an	DET
iajs-3351	25	18	increased	increase	VERB
iajs-3351	25	19	secretion	secretion	NOUN
iajs-3351	25	20	of	of	ADP
iajs-3351	25	21	proinflammatory	proinflammatory	ADJ
iajs-3351	25	22	adipokine	adipokine	NOUN
iajs-3351	25	23	.	.	PUNCT
iajs-3351	26	1	pcos	pcos	PROPN
iajs-3351	26	2	is	be	AUX
iajs-3351	26	3	also	also	ADV
iajs-3351	26	4	linked	link	VERB
iajs-3351	26	5	with	with	ADP
iajs-3351	26	6	ir	ir	PROPN
iajs-3351	26	7	,	,	PUNCT
iajs-3351	26	8	weight	weight	NOUN
iajs-3351	26	9	gain	gain	NOUN
iajs-3351	26	10	,	,	PUNCT
iajs-3351	26	11	metabolic	metabolic	NOUN
iajs-3351	26	12	syndrome	syndrome	NOUN
iajs-3351	26	13	,	,	PUNCT
iajs-3351	26	14	and	and	CCONJ
iajs-3351	26	15	chronic	chronic	ADJ
iajs-3351	26	16	disease	disease	NOUN
iajs-3351	26	17	[	[	X
iajs-3351	26	18	4	4	NUM
iajs-3351	26	19	-	-	SYM
iajs-3351	26	20	11	11	NUM
iajs-3351	26	21	]	]	PUNCT
iajs-3351	26	22	.	.	PUNCT
iajs-3351	27	1	many	many	ADJ
iajs-3351	27	2	complications	complication	NOUN
iajs-3351	27	3	have	have	AUX
iajs-3351	27	4	been	be	AUX
iajs-3351	27	5	observed	observe	VERB
iajs-3351	27	6	after	after	ADP
iajs-3351	27	7	infection	infection	NOUN
iajs-3351	27	8	with	with	ADP
iajs-3351	27	9	the	the	DET
iajs-3351	27	10	coronavirus	coronavirus	NOUN
iajs-3351	27	11	,	,	PUNCT
iajs-3351	27	12	known	know	VERB
iajs-3351	27	13	as	as	ADP
iajs-3351	27	14	respiratory	respiratory	ADJ
iajs-3351	27	15	syndrome	syndrome	NOUN
iajs-3351	27	16	(	(	PUNCT
iajs-3351	27	17	covid-19	covid-19	PROPN
iajs-3351	27	18	)	)	PUNCT
iajs-3351	28	1	[	[	X
iajs-3351	28	2	12	12	NUM
iajs-3351	28	3	]	]	PUNCT
iajs-3351	28	4	.	.	PUNCT
iajs-3351	29	1	the	the	DET
iajs-3351	29	2	first	first	ADJ
iajs-3351	29	3	cases	case	NOUN
iajs-3351	29	4	were	be	AUX
iajs-3351	29	5	described	describe	VERB
iajs-3351	29	6	in	in	ADP
iajs-3351	29	7	december	december	PROPN
iajs-3351	29	8	2019	2019	NUM
iajs-3351	29	9	in	in	ADP
iajs-3351	29	10	the	the	DET
iajs-3351	29	11	chinese	chinese	ADJ
iajs-3351	29	12	city	city	NOUN
iajs-3351	29	13	of	of	ADP
iajs-3351	29	14	wuhan	wuhan	PROPN
iajs-3351	29	15	.	.	PUNCT
iajs-3351	30	1	since	since	SCONJ
iajs-3351	30	2	then	then	ADV
iajs-3351	30	3	,	,	PUNCT
iajs-3351	30	4	the	the	DET
iajs-3351	30	5	disease	disease	NOUN
iajs-3351	30	6	has	have	AUX
iajs-3351	30	7	rapidly	rapidly	ADV
iajs-3351	30	8	spread	spread	VERB
iajs-3351	30	9	over	over	ADP
iajs-3351	30	10	more	more	ADJ
iajs-3351	30	11	than	than	ADP
iajs-3351	30	12	200	200	NUM
iajs-3351	30	13	countries	country	NOUN
iajs-3351	30	14	and	and	CCONJ
iajs-3351	30	15	infected	infected	ADJ
iajs-3351	30	16	millions	million	NOUN
iajs-3351	30	17	of	of	ADP
iajs-3351	30	18	people	people	NOUN
iajs-3351	30	19	with	with	ADP
iajs-3351	30	20	high	high	ADJ
iajs-3351	30	21	mortality	mortality	NOUN
iajs-3351	30	22	rates	rate	NOUN
iajs-3351	30	23	.	.	PUNCT
iajs-3351	31	1	this	this	PRON
iajs-3351	31	2	forced	force	VERB
iajs-3351	31	3	the	the	DET
iajs-3351	31	4	world	world	NOUN
iajs-3351	31	5	health	health	NOUN
iajs-3351	31	6	organization	organization	NOUN
iajs-3351	31	7	(	(	PUNCT
iajs-3351	31	8	who	who	PRON
iajs-3351	31	9	)	)	PUNCT
iajs-3351	31	10	to	to	PART
iajs-3351	31	11	announce	announce	VERB
iajs-3351	31	12	covid-19	covid-19	PROPN
iajs-3351	31	13	as	as	ADP
iajs-3351	31	14	a	a	DET
iajs-3351	31	15	pandemic	pandemic	ADJ
iajs-3351	31	16	[	[	X
iajs-3351	31	17	13	13	NUM
iajs-3351	31	18	]	]	PUNCT
iajs-3351	31	19	.	.	PUNCT
iajs-3351	32	1	the	the	DET
iajs-3351	32	2	complications	complication	NOUN
iajs-3351	32	3	and	and	CCONJ
iajs-3351	32	4	symptoms	symptom	NOUN
iajs-3351	32	5	of	of	ADP
iajs-3351	32	6	patients	patient	NOUN
iajs-3351	32	7	with	with	ADP
iajs-3351	32	8	pcos	pcos	PROPN
iajs-3351	32	9	show	show	VERB
iajs-3351	32	10	a	a	DET
iajs-3351	32	11	significant	significant	ADJ
iajs-3351	32	12	overlap	overlap	NOUN
iajs-3351	32	13	with	with	ADP
iajs-3351	32	14	risk	risk	NOUN
iajs-3351	32	15	factors	factor	NOUN
iajs-3351	32	16	for	for	ADP
iajs-3351	32	17	severe	severe	ADJ
iajs-3351	32	18	covid-19	covid-19	PROPN
iajs-3351	32	19	infection	infection	NOUN
iajs-3351	32	20	[	[	X
iajs-3351	32	21	14	14	NUM
iajs-3351	32	22	]	]	PUNCT
iajs-3351	32	23	.	.	PUNCT
iajs-3351	33	1	obese	obese	ADJ
iajs-3351	33	2	people	people	NOUN
iajs-3351	33	3	and	and	CCONJ
iajs-3351	33	4	people	people	NOUN
iajs-3351	33	5	who	who	PRON
iajs-3351	33	6	are	be	AUX
iajs-3351	33	7	highly	highly	ADV
iajs-3351	33	8	overweight	overweight	ADJ
iajs-3351	33	9	suffer	suffer	NOUN
iajs-3351	33	10	from	from	ADP
iajs-3351	33	11	an	an	DET
iajs-3351	33	12	increased	increase	VERB
iajs-3351	33	13	risk	risk	NOUN
iajs-3351	33	14	of	of	ADP
iajs-3351	33	15	complications	complication	NOUN
iajs-3351	33	16	from	from	ADP
iajs-3351	33	17	the	the	DET
iajs-3351	33	18	coronavirus	coronavirus	NOUN
iajs-3351	33	19	,	,	PUNCT
iajs-3351	33	20	which	which	PRON
iajs-3351	33	21	leads	lead	VERB
iajs-3351	33	22	to	to	ADP
iajs-3351	33	23	their	their	PRON
iajs-3351	33	24	admission	admission	NOUN
iajs-3351	33	25	to	to	ADP
iajs-3351	33	26	the	the	DET
iajs-3351	33	27	intensive	intensive	ADJ
iajs-3351	33	28	care	care	NOUN
iajs-3351	33	29	unit	unit	NOUN
iajs-3351	33	30	or	or	CCONJ
iajs-3351	33	31	death	death	NOUN
iajs-3351	33	32	,	,	PUNCT
iajs-3351	33	33	unlike	unlike	ADP
iajs-3351	33	34	people	people	NOUN
iajs-3351	33	35	with	with	ADP
iajs-3351	33	36	a	a	DET
iajs-3351	33	37	healthy	healthy	ADJ
iajs-3351	33	38	or	or	CCONJ
iajs-3351	33	39	average	average	ADJ
iajs-3351	33	40	weight	weight	NOUN
iajs-3351	33	41	[	[	X
iajs-3351	33	42	15	15	NUM
iajs-3351	33	43	]	]	PUNCT
iajs-3351	33	44	.	.	PUNCT
iajs-3351	34	1	obesity	obesity	NOUN
iajs-3351	34	2	has	have	VERB
iajs-3351	34	3	numerous	numerous	ADJ
iajs-3351	34	4	,	,	PUNCT
iajs-3351	34	5	intricate	intricate	ADJ
iajs-3351	34	6	side	side	NOUN
iajs-3351	34	7	effects	effect	NOUN
iajs-3351	34	8	,	,	PUNCT
iajs-3351	34	9	in	in	ADP
iajs-3351	34	10	addition	addition	NOUN
iajs-3351	34	11	to	to	ADP
iajs-3351	34	12	the	the	DET
iajs-3351	34	13	presence	presence	NOUN
iajs-3351	34	14	of	of	ADP
iajs-3351	34	15	other	other	ADJ
iajs-3351	34	16	factors	factor	NOUN
iajs-3351	34	17	that	that	PRON
iajs-3351	34	18	affect	affect	VERB
iajs-3351	34	19	the	the	DET
iajs-3351	34	20	severity	severity	NOUN
iajs-3351	34	21	of	of	ADP
iajs-3351	34	22	covid-19	covid-19	PROPN
iajs-3351	34	23	.	.	PUNCT
iajs-3351	35	1	more	more	ADJ
iajs-3351	35	2	than	than	ADP
iajs-3351	35	3	five	five	NUM
iajs-3351	35	4	hundred	hundred	NUM
iajs-3351	35	5	million	million	NUM
iajs-3351	35	6	people	people	NOUN
iajs-3351	35	7	suffer	suffer	VERB
iajs-3351	35	8	from	from	ADP
iajs-3351	35	9	obesity	obesity	NOUN
iajs-3351	35	10	on	on	ADP
iajs-3351	35	11	a	a	DET
iajs-3351	35	12	global	global	ADJ
iajs-3351	35	13	level	level	NOUN
iajs-3351	35	14	,	,	PUNCT
iajs-3351	35	15	and	and	CCONJ
iajs-3351	35	16	therefore	therefore	ADV
iajs-3351	35	17	,	,	PUNCT
iajs-3351	35	18	knowing	know	VERB
iajs-3351	35	19	the	the	DET
iajs-3351	35	20	mechanisms	mechanism	NOUN
iajs-3351	35	21	through	through	ADP
iajs-3351	35	22	which	which	PRON
iajs-3351	35	23	obesity	obesity	NOUN
iajs-3351	35	24	increases	increase	VERB
iajs-3351	35	25	the	the	DET
iajs-3351	35	26	severity	severity	NOUN
iajs-3351	35	27	of	of	ADP
iajs-3351	35	28	infection	infection	NOUN
iajs-3351	35	29	with	with	ADP
iajs-3351	35	30	the	the	DET
iajs-3351	35	31	virus	virus	NOUN
iajs-3351	35	32	is	be	AUX
iajs-3351	35	33	essential	essential	ADJ
iajs-3351	35	34	to	to	ADP
iajs-3351	35	35	solving	solve	VERB
iajs-3351	35	36	the	the	DET
iajs-3351	35	37	global	global	ADJ
iajs-3351	35	38	threat	threat	NOUN
iajs-3351	35	39	to	to	ADP
iajs-3351	35	40	health	health	NOUN
iajs-3351	35	41	[	[	X
iajs-3351	35	42	16	16	NUM
iajs-3351	35	43	]	]	PUNCT
iajs-3351	35	44	.	.	PUNCT
iajs-3351	36	1	the	the	DET
iajs-3351	36	2	interference	interference	NOUN
iajs-3351	36	3	of	of	ADP
iajs-3351	36	4	pcos	pcos	NOUN
iajs-3351	36	5	complications	complication	NOUN
iajs-3351	36	6	,	,	PUNCT
iajs-3351	36	7	like	like	ADP
iajs-3351	36	8	metabolic	metabolic	NOUN
iajs-3351	36	9	disorders	disorder	NOUN
iajs-3351	36	10	and	and	CCONJ
iajs-3351	36	11	cardiac	cardiac	ADJ
iajs-3351	36	12	disease	disease	NOUN
iajs-3351	36	13	,	,	PUNCT
iajs-3351	36	14	with	with	ADP
iajs-3351	36	15	the	the	DET
iajs-3351	36	16	significant	significant	ADJ
iajs-3351	36	17	specific	specific	ADJ
iajs-3351	36	18	risk	risk	NOUN
iajs-3351	36	19	factors	factor	NOUN
iajs-3351	36	20	for	for	ADP
iajs-3351	36	21	clinical	clinical	ADJ
iajs-3351	36	22	results	result	NOUN
iajs-3351	36	23	of	of	ADP
iajs-3351	36	24	covid-19	covid-19	PROPN
iajs-3351	36	25	means	mean	VERB
iajs-3351	36	26	pcos	pcos	PROPN
iajs-3351	36	27	women	woman	NOUN
iajs-3351	36	28	are	be	AUX
iajs-3351	36	29	expected	expect	VERB
iajs-3351	36	30	to	to	PART
iajs-3351	36	31	be	be	AUX
iajs-3351	36	32	more	more	ADV
iajs-3351	36	33	at	at	ADP
iajs-3351	36	34	risk	risk	NOUN
iajs-3351	36	35	for	for	ADP
iajs-3351	36	36	coronavirus	coronavirus	NOUN
iajs-3351	36	37	infection	infection	NOUN
iajs-3351	36	38	[	[	X
iajs-3351	36	39	17	17	NUM
iajs-3351	36	40	-	-	SYM
iajs-3351	36	41	19	19	NUM
iajs-3351	36	42	]	]	PUNCT
iajs-3351	36	43	.	.	PUNCT
iajs-3351	37	1	angiotensin	angiotensin	NOUN
iajs-3351	37	2	-	-	PUNCT
iajs-3351	37	3	converting	convert	VERB
iajs-3351	37	4	enzyme	enzyme	NOUN
iajs-3351	37	5	(	(	PUNCT
iajs-3351	37	6	ace2	ace2	PROPN
iajs-3351	37	7	)	)	PUNCT
iajs-3351	37	8	eases	ease	VERB
iajs-3351	37	9	the	the	DET
iajs-3351	37	10	virus	virus	NOUN
iajs-3351	37	11	into	into	ADP
iajs-3351	37	12	the	the	DET
iajs-3351	37	13	cellular	cellular	NOUN
iajs-3351	37	14	.	.	PUNCT
iajs-3351	38	1	ace2	ace2	PROPN
iajs-3351	38	2	is	be	AUX
iajs-3351	38	3	a	a	DET
iajs-3351	38	4	type	type	NOUN
iajs-3351	38	5	1	1	NUM
iajs-3351	38	6	fundamental	fundamental	ADJ
iajs-3351	38	7	glycoprotein	glycoprotein	NOUN
iajs-3351	38	8	that	that	PRON
iajs-3351	38	9	is	be	AUX
iajs-3351	38	10	secreted	secrete	VERB
iajs-3351	38	11	in	in	ADP
iajs-3351	38	12	many	many	ADJ
iajs-3351	38	13	tissues	tissue	NOUN
iajs-3351	38	14	.	.	PUNCT
iajs-3351	39	1	the	the	DET
iajs-3351	39	2	most	most	ADV
iajs-3351	39	3	noteworthy	noteworthy	ADJ
iajs-3351	39	4	expression	expression	NOUN
iajs-3351	39	5	of	of	ADP
iajs-3351	39	6	ace2	ace2	PROPN
iajs-3351	39	7	is	be	AUX
iajs-3351	39	8	seen	see	VERB
iajs-3351	39	9	in	in	ADP
iajs-3351	39	10	the	the	DET
iajs-3351	39	11	kidney	kidney	NOUN
iajs-3351	39	12	,	,	PUNCT
iajs-3351	39	13	the	the	DET
iajs-3351	39	14	endothelium	endothelium	NOUN
iajs-3351	39	15	,	,	PUNCT
iajs-3351	39	16	the	the	DET
iajs-3351	39	17	lungs	lung	NOUN
iajs-3351	39	18	,	,	PUNCT
iajs-3351	39	19	and	and	CCONJ
iajs-3351	39	20	the	the	DET
iajs-3351	39	21	heart	heart	NOUN
iajs-3351	39	22	.	.	PUNCT
iajs-3351	40	1	this	this	DET
iajs-3351	40	2	virus	virus	NOUN
iajs-3351	40	3	also	also	ADV
iajs-3351	40	4	affects	affect	VERB
iajs-3351	40	5	heart	heart	NOUN
iajs-3351	40	6	disease	disease	NOUN
iajs-3351	40	7	,	,	PUNCT
iajs-3351	40	8	kidney	kidney	NOUN
iajs-3351	40	9	disease	disease	NOUN
iajs-3351	40	10	,	,	PUNCT
iajs-3351	40	11	and	and	CCONJ
iajs-3351	40	12	liver	liver	NOUN
iajs-3351	40	13	disease	disease	NOUN
iajs-3351	40	14	.	.	PUNCT
iajs-3351	41	1	in	in	ADP
iajs-3351	41	2	addition	addition	NOUN
iajs-3351	41	3	,	,	PUNCT
iajs-3351	41	4	the	the	DET
iajs-3351	41	5	effect	effect	NOUN
iajs-3351	41	6	of	of	ADP
iajs-3351	41	7	virus	virus	NOUN
iajs-3351	41	8	infection	infection	NOUN
iajs-3351	41	9	on	on	ADP
iajs-3351	41	10	adipose	adipose	PRON
iajs-3351	41	11	tissue	tissue	NOUN
iajs-3351	41	12	needs	need	VERB
iajs-3351	41	13	further	further	ADJ
iajs-3351	41	14	study	study	NOUN
iajs-3351	41	15	[	[	X
iajs-3351	41	16	20	20	NUM
iajs-3351	41	17	]	]	PUNCT
iajs-3351	41	18	.	.	PUNCT
iajs-3351	42	1	an	an	DET
iajs-3351	42	2	essential	essential	ADJ
iajs-3351	42	3	part	part	NOUN
iajs-3351	42	4	of	of	ADP
iajs-3351	42	5	the	the	DET
iajs-3351	42	6	renin	renin	ADJ
iajs-3351	42	7	-	-	PUNCT
iajs-3351	42	8	angiotensin	angiotensin	NOUN
iajs-3351	42	9	system	system	NOUN
iajs-3351	42	10	(	(	PUNCT
iajs-3351	42	11	ras	ras	NOUN
iajs-3351	42	12	)	)	PUNCT
iajs-3351	42	13	is	be	AUX
iajs-3351	42	14	ace2	ace2	PROPN
iajs-3351	42	15	.	.	PUNCT
iajs-3351	43	1	in	in	ADP
iajs-3351	43	2	the	the	DET
iajs-3351	43	3	ras	ras	PROPN
iajs-3351	43	4	system	system	NOUN
iajs-3351	43	5	,	,	PUNCT
iajs-3351	43	6	the	the	DET
iajs-3351	43	7	ace2ang(1–7)-mas	ace2ang(1–7)-ma	NOUN
iajs-3351	43	8	counter	counter	ADJ
iajs-3351	43	9	-	-	ADJ
iajs-3351	43	10	regulatory	regulatory	ADJ
iajs-3351	43	11	axis	axis	NOUN
iajs-3351	43	12	and	and	CCONJ
iajs-3351	43	13	the	the	DET
iajs-3351	43	14	classical	classical	ADJ
iajs-3351	43	15	-	-	PUNCT
iajs-3351	43	16	ace	ace	NOUN
iajs-3351	43	17	-	-	PUNCT
iajs-3351	43	18	angiotensin2	angiotensin2	NOUN
iajs-3351	43	19	)	)	PUNCT
iajs-3351	43	20	,	,	PUNCT
iajs-3351	43	21	and	and	CCONJ
iajs-3351	43	22	angiotensin	angiotensin	NOUN
iajs-3351	43	23	type	type	NOUN
iajs-3351	43	24	1	1	NUM
iajs-3351	43	25	receptor	receptor	NOUN
iajs-3351	43	26	(	(	PUNCT
iajs-3351	43	27	at1r	at1r	NOUN
iajs-3351	43	28	)	)	PUNCT
iajs-3351	43	29	axis	axis	NOUN
iajs-3351	43	30	are	be	AUX
iajs-3351	43	31	crucial	crucial	ADJ
iajs-3351	43	32	.	.	PUNCT
iajs-3351	44	1	lung	lung	NOUN
iajs-3351	44	2	damage	damage	NOUN
iajs-3351	44	3	is	be	AUX
iajs-3351	44	4	prevented	prevent	VERB
iajs-3351	44	5	by	by	ADP
iajs-3351	44	6	ace2	ace2	PROPN
iajs-3351	44	7	,	,	PUNCT
iajs-3351	44	8	which	which	PRON
iajs-3351	44	9	opposes	oppose	VERB
iajs-3351	44	10	the	the	DET
iajs-3351	44	11	activation	activation	NOUN
iajs-3351	44	12	of	of	ADP
iajs-3351	44	13	the	the	DET
iajs-3351	44	14	traditional	traditional	ADJ
iajs-3351	44	15	ras	ras	NOUN
iajs-3351	44	16	ace	ace	PROPN
iajs-3351	44	17	-	-	PUNCT
iajs-3351	44	18	ang	ang	PROPN
iajs-3351	44	19	ii	ii	PROPN
iajs-3351	44	20	-	-	PUNCT
iajs-3351	44	21	at1r	at1r	PROPN
iajs-3351	44	22	axis	axis	NOUN
iajs-3351	45	1	[	[	X
iajs-3351	45	2	21	21	NUM
iajs-3351	45	3	-	-	SYM
iajs-3351	45	4	24	24	NUM
iajs-3351	45	5	]	]	PUNCT
iajs-3351	45	6	.	.	PUNCT
iajs-3351	46	1	this	this	DET
iajs-3351	46	2	study	study	NOUN
iajs-3351	46	3	investigated	investigate	VERB
iajs-3351	46	4	the	the	DET
iajs-3351	46	5	relationship	relationship	NOUN
iajs-3351	46	6	between	between	ADP
iajs-3351	46	7	ace2	ace2	PROPN
iajs-3351	46	8	and	and	CCONJ
iajs-3351	46	9	ir	ir	PROPN
iajs-3351	46	10	and	and	CCONJ
iajs-3351	46	11	other	other	ADJ
iajs-3351	46	12	parameters	parameter	NOUN
iajs-3351	46	13	in	in	ADP
iajs-3351	46	14	patients	patient	NOUN
iajs-3351	46	15	suffering	suffer	VERB
iajs-3351	46	16	from	from	ADP
iajs-3351	46	17	pcos	pcos	PROPN
iajs-3351	46	18	with	with	ADP
iajs-3351	46	19	coronavirus	coronavirus	NOUN
iajs-3351	46	20	.	.	PUNCT
iajs-3351	47	1	2	2	X
iajs-3351	47	2	.	.	X
iajs-3351	47	3	materials	material	NOUN
iajs-3351	47	4	and	and	CCONJ
iajs-3351	47	5	methods	method	NOUN
iajs-3351	47	6	2.1	2.1	NUM
iajs-3351	47	7	sample	sample	NOUN
iajs-3351	47	8	collection	collection	NOUN
iajs-3351	47	9	subjects	subject	NOUN
iajs-3351	47	10	included	include	VERB
iajs-3351	47	11	pcos	pcos	ADJ
iajs-3351	47	12	women	woman	NOUN
iajs-3351	47	13	with	with	ADP
iajs-3351	47	14	infection	infection	NOUN
iajs-3351	47	15	or	or	CCONJ
iajs-3351	47	16	non	non	NOUN
iajs-3351	47	17	-	-	NOUN
iajs-3351	47	18	infection	infection	NOUN
iajs-3351	47	19	with	with	ADP
iajs-3351	47	20	covid-19	covid-19	PROPN
iajs-3351	47	21	,	,	PUNCT
iajs-3351	47	22	who	who	PRON
iajs-3351	47	23	were	be	AUX
iajs-3351	47	24	divided	divide	VERB
iajs-3351	47	25	into	into	ADP
iajs-3351	47	26	2	2	NUM
iajs-3351	47	27	groups	group	NOUN
iajs-3351	47	28	according	accord	VERB
iajs-3351	47	29	to	to	ADP
iajs-3351	47	30	their	their	PRON
iajs-3351	47	31	bmi	bmi	NOUN
iajs-3351	47	32	.	.	PUNCT
iajs-3351	48	1	the	the	DET
iajs-3351	48	2	first	first	ADJ
iajs-3351	48	3	group	group	NOUN
iajs-3351	48	4	was	be	AUX
iajs-3351	48	5	obese	obese	ADJ
iajs-3351	48	6	pcos	pcos	ADJ
iajs-3351	48	7	women	woman	NOUN
iajs-3351	48	8	infected	infect	VERB
iajs-3351	48	9	with	with	ADP
iajs-3351	48	10	covid-19	covid-19	PROPN
iajs-3351	48	11	(	(	PUNCT
iajs-3351	48	12	n=56	n=56	NOUN
iajs-3351	48	13	)	)	PUNCT
iajs-3351	48	14	;	;	PUNCT
iajs-3351	48	15	the	the	DET
iajs-3351	48	16	second	second	ADJ
iajs-3351	48	17	group	group	NOUN
iajs-3351	48	18	was	be	AUX
iajs-3351	48	19	lean	lean	ADJ
iajs-3351	48	20	pcos	pcos	ADJ
iajs-3351	48	21	patients	patient	NOUN
iajs-3351	48	22	non	non	ADJ
iajs-3351	48	23	-	-	ADJ
iajs-3351	48	24	infected	infected	ADJ
iajs-3351	48	25	with	with	ADP
iajs-3351	48	26	covid-19	covid-19	PROPN
iajs-3351	48	27	(	(	PUNCT
iajs-3351	48	28	n=24	n=24	PROPN
iajs-3351	48	29	)	)	PUNCT
iajs-3351	48	30	,	,	PUNCT
iajs-3351	48	31	and	and	CCONJ
iajs-3351	48	32	the	the	DET
iajs-3351	48	33	control	control	NOUN
iajs-3351	48	34	group	group	NOUN
iajs-3351	48	35	was	be	AUX
iajs-3351	48	36	(	(	PUNCT
iajs-3351	48	37	40	40	NUM
iajs-3351	48	38	)	)	PUNCT
iajs-3351	48	39	.	.	PUNCT
iajs-3351	49	1	in	in	ADP
iajs-3351	49	2	this	this	DET
iajs-3351	49	3	study	study	NOUN
iajs-3351	49	4	,	,	PUNCT
iajs-3351	49	5	ladies	lady	NOUN
iajs-3351	49	6	(	(	PUNCT
iajs-3351	49	7	patients	patient	NOUN
iajs-3351	49	8	and	and	CCONJ
iajs-3351	49	9	healthy	healthy	ADJ
iajs-3351	49	10	subjects	subject	NOUN
iajs-3351	49	11	)	)	PUNCT
iajs-3351	49	12	who	who	PRON
iajs-3351	49	13	had	have	VERB
iajs-3351	49	14	previous	previous	ADJ
iajs-3351	49	15	operations	operation	NOUN
iajs-3351	49	16	,	,	PUNCT
iajs-3351	49	17	such	such	ADJ
iajs-3351	49	18	as	as	ADP
iajs-3351	49	19	removal	removal	NOUN
iajs-3351	49	20	of	of	ADP
iajs-3351	49	21	the	the	DET
iajs-3351	49	22	ovaries	ovary	NOUN
iajs-3351	49	23	and	and	CCONJ
iajs-3351	49	24	removal	removal	NOUN
iajs-3351	49	25	of	of	ADP
iajs-3351	49	26	the	the	DET
iajs-3351	49	27	uterus	uterus	NOUN
iajs-3351	49	28	or	or	CCONJ
iajs-3351	49	29	fallopian	fallopian	NOUN
iajs-3351	49	30	tubes	tube	NOUN
iajs-3351	49	31	,	,	PUNCT
iajs-3351	49	32	were	be	AUX
iajs-3351	49	33	excluded	exclude	VERB
iajs-3351	49	34	.	.	PUNCT
iajs-3351	50	1	also	also	ADV
iajs-3351	50	2	,	,	PUNCT
iajs-3351	50	3	pregnant	pregnant	ADJ
iajs-3351	50	4	ladies	lady	NOUN
iajs-3351	50	5	or	or	CCONJ
iajs-3351	50	6	those	those	PRON
iajs-3351	50	7	with	with	ADP
iajs-3351	50	8	one	one	NUM
iajs-3351	50	9	of	of	ADP
iajs-3351	50	10	the	the	DET
iajs-3351	50	11	following	follow	VERB
iajs-3351	50	12	diseases	disease	NOUN
iajs-3351	50	13	were	be	AUX
iajs-3351	50	14	excluded	exclude	VERB
iajs-3351	50	15	:	:	PUNCT
iajs-3351	50	16	high	high	ADJ
iajs-3351	50	17	blood	blood	NOUN
iajs-3351	50	18	pressure	pressure	NOUN
iajs-3351	50	19	,	,	PUNCT
iajs-3351	50	20	cardiac	cardiac	ADJ
iajs-3351	50	21	issues	issue	NOUN
iajs-3351	50	22	,	,	PUNCT
iajs-3351	50	23	or	or	CCONJ
iajs-3351	50	24	t2	t2	PROPN
iajs-3351	50	25	dm	dm	PROPN
iajs-3351	50	26	.	.	PUNCT
iajs-3351	50	27	ihjpas	ihjpas	PROPN
iajs-3351	50	28	.	.	PUNCT
iajs-3351	51	1	37	37	NUM
iajs-3351	51	2	(	(	PUNCT
iajs-3351	51	3	3	3	NUM
iajs-3351	51	4	)	)	PUNCT
iajs-3351	51	5	2024	2024	NUM
iajs-3351	51	6	289	289	NUM
iajs-3351	51	7	about	about	ADV
iajs-3351	51	8	10	10	NUM
iajs-3351	51	9	ml	ml	NOUN
iajs-3351	51	10	of	of	ADP
iajs-3351	51	11	blood	blood	NOUN
iajs-3351	51	12	samples	sample	NOUN
iajs-3351	51	13	were	be	AUX
iajs-3351	51	14	collected	collect	VERB
iajs-3351	51	15	in	in	ADP
iajs-3351	51	16	a	a	DET
iajs-3351	51	17	gel	gel	NOUN
iajs-3351	51	18	tube	tube	NOUN
iajs-3351	51	19	from	from	ADP
iajs-3351	51	20	pcos	pcos	PROPN
iajs-3351	51	21	patients	patient	NOUN
iajs-3351	51	22	with	with	ADP
iajs-3351	51	23	or	or	CCONJ
iajs-3351	51	24	without	without	ADP
iajs-3351	51	25	coronavirus	coronavirus	NOUN
iajs-3351	51	26	infection	infection	NOUN
iajs-3351	51	27	and	and	CCONJ
iajs-3351	51	28	the	the	DET
iajs-3351	51	29	control	control	NOUN
iajs-3351	51	30	group	group	NOUN
iajs-3351	51	31	for	for	ADP
iajs-3351	51	32	ace2	ace2	PROPN
iajs-3351	51	33	,	,	PUNCT
iajs-3351	51	34	gst	gst	NOUN
iajs-3351	51	35	activity	activity	NOUN
iajs-3351	51	36	,	,	PUNCT
iajs-3351	51	37	d	d	NOUN
iajs-3351	51	38	-	-	PUNCT
iajs-3351	51	39	dimer	dimer	ADJ
iajs-3351	51	40	,	,	PUNCT
iajs-3351	51	41	lipid	lipid	NOUN
iajs-3351	51	42	profile	profile	NOUN
iajs-3351	51	43	,	,	PUNCT
iajs-3351	51	44	fsh	fsh	NOUN
iajs-3351	51	45	,	,	PUNCT
iajs-3351	51	46	lh	lh	NOUN
iajs-3351	51	47	,	,	PUNCT
iajs-3351	51	48	testosterone	testosterone	NOUN
iajs-3351	51	49	,	,	PUNCT
iajs-3351	51	50	and	and	CCONJ
iajs-3351	51	51	insulin	insulin	NOUN
iajs-3351	51	52	.	.	PUNCT
iajs-3351	52	1	the	the	DET
iajs-3351	52	2	waist	waist	NOUN
iajs-3351	52	3	circumference	circumference	NOUN
iajs-3351	52	4	to	to	ADP
iajs-3351	52	5	the	the	DET
iajs-3351	52	6	hip	hip	NOUN
iajs-3351	52	7	was	be	AUX
iajs-3351	52	8	measured	measure	VERB
iajs-3351	52	9	using	use	VERB
iajs-3351	52	10	a	a	DET
iajs-3351	52	11	measurement	measurement	NOUN
iajs-3351	52	12	tool	tool	NOUN
iajs-3351	52	13	,	,	PUNCT
iajs-3351	52	14	and	and	CCONJ
iajs-3351	52	15	the	the	DET
iajs-3351	52	16	body	body	NOUN
iajs-3351	52	17	mass	mass	NOUN
iajs-3351	52	18	index	index	NOUN
iajs-3351	52	19	was	be	AUX
iajs-3351	52	20	also	also	ADV
iajs-3351	52	21	measured	measure	VERB
iajs-3351	52	22	using	use	VERB
iajs-3351	52	23	the	the	DET
iajs-3351	52	24	formula	formula	NOUN
iajs-3351	52	25	(	(	PUNCT
iajs-3351	52	26	weight/(height	weight/(height	NOUN
iajs-3351	52	27	)	)	PUNCT
iajs-3351	52	28	2	2	NUM
iajs-3351	52	29	)	)	PUNCT
iajs-3351	52	30	.	.	PUNCT
iajs-3351	53	1	the	the	DET
iajs-3351	53	2	homeostasis	homeostasis	NOUN
iajs-3351	53	3	model	model	NOUN
iajs-3351	53	4	is	be	AUX
iajs-3351	53	5	called	call	VERB
iajs-3351	53	6	(	(	PUNCT
iajs-3351	53	7	homa	homa	PROPN
iajs-3351	53	8	)	)	PUNCT
iajs-3351	53	9	where	where	SCONJ
iajs-3351	53	10	ir	ir	PROPN
iajs-3351	53	11	is	be	AUX
iajs-3351	53	12	measured	measure	VERB
iajs-3351	53	13	by	by	ADP
iajs-3351	53	14	the	the	DET
iajs-3351	53	15	formula	formula	NOUN
iajs-3351	53	16	(	(	PUNCT
iajs-3351	53	17	[	[	PUNCT
iajs-3351	53	18	fasting	fast	VERB
iajs-3351	53	19	insulin	insulin	NOUN
iajs-3351	53	20	×	×	NOUN
iajs-3351	53	21	fasting	fast	VERB
iajs-3351	53	22	blood	blood	NOUN
iajs-3351	53	23	glucose]/	glucose]/	NOUN
iajs-3351	53	24	22.5	22.5	NUM
iajs-3351	53	25	)	)	PUNCT
iajs-3351	54	1	[	[	X
iajs-3351	54	2	10	10	NUM
iajs-3351	54	3	]	]	PUNCT
iajs-3351	54	4	.	.	PUNCT
iajs-3351	55	1	serum	serum	PROPN
iajs-3351	55	2	sample	sample	PROPN
iajs-3351	55	3	preparation	preparation	NOUN
iajs-3351	55	4	was	be	AUX
iajs-3351	55	5	done	do	VERB
iajs-3351	55	6	by	by	ADP
iajs-3351	55	7	letting	let	VERB
iajs-3351	55	8	the	the	DET
iajs-3351	55	9	blood	blood	NOUN
iajs-3351	55	10	tube	tube	NOUN
iajs-3351	55	11	sit	sit	VERB
iajs-3351	55	12	for	for	ADP
iajs-3351	55	13	20–25	20–25	NUM
iajs-3351	55	14	minutes	minute	NOUN
iajs-3351	55	15	at	at	ADP
iajs-3351	55	16	25	25	NUM
iajs-3351	55	17	°	°	NOUN
iajs-3351	55	18	c	c	NOUN
iajs-3351	55	19	,	,	PUNCT
iajs-3351	55	20	then	then	ADV
iajs-3351	55	21	centrifuged	centrifuge	VERB
iajs-3351	55	22	at	at	ADP
iajs-3351	55	23	2000–3000	2000–3000	NUM
iajs-3351	55	24	rpm	rpm	NOUN
iajs-3351	55	25	for	for	ADP
iajs-3351	55	26	10	10	NUM
iajs-3351	55	27	minutes	minute	NOUN
iajs-3351	55	28	.	.	PUNCT
iajs-3351	56	1	the	the	DET
iajs-3351	56	2	separated	separate	VERB
iajs-3351	56	3	serum	serum	NOUN
iajs-3351	56	4	was	be	AUX
iajs-3351	56	5	stored	store	VERB
iajs-3351	56	6	in	in	ADP
iajs-3351	56	7	a	a	DET
iajs-3351	56	8	deep	deep	ADJ
iajs-3351	56	9	freeze	freeze	NOUN
iajs-3351	56	10	at	at	ADP
iajs-3351	56	11	-20	-20	PROPN
iajs-3351	56	12	°	°	ADP
iajs-3351	56	13	c	c	NOUN
iajs-3351	56	14	in	in	ADP
iajs-3351	56	15	the	the	DET
iajs-3351	56	16	kamal	kamal	PROPN
iajs-3351	56	17	-	-	PUNCT
iajs-3351	56	18	al	al	PROPN
iajs-3351	56	19	samara	samara	PROPN
iajs-3351	56	20	hospital	hospital	PROPN
iajs-3351	56	21	/	/	SYM
iajs-3351	56	22	laboratories	laboratory	NOUN
iajs-3351	56	23	department	department	NOUN
iajs-3351	56	24	for	for	ADP
iajs-3351	56	25	the	the	DET
iajs-3351	56	26	subsequent	subsequent	ADJ
iajs-3351	56	27	biochemical	biochemical	ADJ
iajs-3351	56	28	tests	test	NOUN
iajs-3351	56	29	.	.	PUNCT
iajs-3351	57	1	the	the	DET
iajs-3351	57	2	serum	serum	NOUN
iajs-3351	57	3	was	be	AUX
iajs-3351	57	4	used	use	VERB
iajs-3351	57	5	to	to	PART
iajs-3351	57	6	check	check	VERB
iajs-3351	57	7	blood	blood	NOUN
iajs-3351	57	8	glucose	glucose	NOUN
iajs-3351	57	9	levels	level	NOUN
iajs-3351	57	10	and	and	CCONJ
iajs-3351	57	11	lipid	lipid	NOUN
iajs-3351	57	12	profile	profile	NOUN
iajs-3351	57	13	measurement	measurement	NOUN
iajs-3351	57	14	using	use	VERB
iajs-3351	57	15	manual	manual	ADJ
iajs-3351	57	16	methods	method	NOUN
iajs-3351	57	17	,	,	PUNCT
iajs-3351	57	18	a	a	DET
iajs-3351	57	19	vidas	vidas	PROPN
iajs-3351	57	20	instrument	instrument	NOUN
iajs-3351	57	21	analyzer	analyzer	NOUN
iajs-3351	57	22	was	be	AUX
iajs-3351	57	23	used	use	VERB
iajs-3351	57	24	to	to	PART
iajs-3351	57	25	measure	measure	VERB
iajs-3351	57	26	the	the	DET
iajs-3351	57	27	pituitary	pituitary	ADJ
iajs-3351	57	28	hormone	hormone	NOUN
iajs-3351	57	29	,	,	PUNCT
iajs-3351	57	30	and	and	CCONJ
iajs-3351	57	31	gst	gst	NOUN
iajs-3351	57	32	activity	activity	NOUN
iajs-3351	57	33	was	be	AUX
iajs-3351	57	34	measured	measure	VERB
iajs-3351	57	35	using	use	VERB
iajs-3351	57	36	a	a	DET
iajs-3351	57	37	spectrophotometer	spectrophotometer	NOUN
iajs-3351	57	38	instrument	instrument	NOUN
iajs-3351	57	39	.	.	PUNCT
iajs-3351	58	1	the	the	DET
iajs-3351	58	2	residual	residual	ADJ
iajs-3351	58	3	serum	serum	NOUN
iajs-3351	58	4	was	be	AUX
iajs-3351	58	5	frozen	freeze	VERB
iajs-3351	58	6	at	at	ADP
iajs-3351	58	7	-20	-20	NUM
iajs-3351	58	8	°	°	NOUN
iajs-3351	58	9	c	c	NOUN
iajs-3351	58	10	for	for	ADP
iajs-3351	58	11	the	the	DET
iajs-3351	58	12	assessment	assessment	NOUN
iajs-3351	58	13	of	of	ADP
iajs-3351	58	14	ace2	ace2	PROPN
iajs-3351	58	15	and	and	CCONJ
iajs-3351	58	16	d	d	NOUN
iajs-3351	58	17	-	-	PUNCT
iajs-3351	58	18	dimer	dimer	NOUN
iajs-3351	58	19	by	by	ADP
iajs-3351	58	20	elisa	elisa	PROPN
iajs-3351	58	21	(	(	PUNCT
iajs-3351	58	22	my	my	PRON
iajs-3351	58	23	biosource	biosource	NOUN
iajs-3351	58	24	,	,	PUNCT
iajs-3351	58	25	usa	usa	PROPN
iajs-3351	58	26	)	)	PUNCT
iajs-3351	58	27	.	.	PUNCT
iajs-3351	59	1	2.2	2.2	NUM
iajs-3351	59	2	statistical	statistical	ADJ
iajs-3351	59	3	analysis	analysis	NOUN
iajs-3351	59	4	all	all	DET
iajs-3351	59	5	statistical	statistical	ADJ
iajs-3351	59	6	analyses	analysis	NOUN
iajs-3351	59	7	were	be	AUX
iajs-3351	59	8	performed	perform	VERB
iajs-3351	59	9	using	use	VERB
iajs-3351	59	10	spss	spss	PROPN
iajs-3351	59	11	software	software	NOUN
iajs-3351	59	12	version	version	PROPN
iajs-3351	59	13	26.0	26.0	NUM
iajs-3351	59	14	.	.	PUNCT
iajs-3351	60	1	the	the	DET
iajs-3351	60	2	number	number	NOUN
iajs-3351	60	3	and	and	CCONJ
iajs-3351	60	4	percentage	percentage	NOUN
iajs-3351	60	5	of	of	ADP
iajs-3351	60	6	categorical	categorical	ADJ
iajs-3351	60	7	variables	variable	NOUN
iajs-3351	60	8	,	,	PUNCT
iajs-3351	60	9	as	as	ADV
iajs-3351	60	10	well	well	ADV
iajs-3351	60	11	as	as	ADP
iajs-3351	60	12	the	the	DET
iajs-3351	60	13	mean	mean	PROPN
iajs-3351	60	14	±	±	PROPN
iajs-3351	60	15	standard	standard	PROPN
iajs-3351	60	16	division	division	NOUN
iajs-3351	60	17	(	(	PUNCT
iajs-3351	60	18	sd	sd	NOUN
iajs-3351	60	19	)	)	PUNCT
iajs-3351	60	20	of	of	ADP
iajs-3351	60	21	continuous	continuous	ADJ
iajs-3351	60	22	variables	variable	NOUN
iajs-3351	60	23	,	,	PUNCT
iajs-3351	60	24	were	be	AUX
iajs-3351	60	25	used	use	VERB
iajs-3351	60	26	to	to	PART
iajs-3351	60	27	perform	perform	VERB
iajs-3351	60	28	descriptive	descriptive	ADJ
iajs-3351	60	29	statistics	statistic	NOUN
iajs-3351	60	30	;	;	PUNCT
iajs-3351	60	31	the	the	DET
iajs-3351	60	32	one	one	NUM
iajs-3351	60	33	-	-	PUNCT
iajs-3351	60	34	way	way	NOUN
iajs-3351	60	35	-	-	PUNCT
iajs-3351	60	36	anova	anova	PROPN
iajs-3351	60	37	is	be	AUX
iajs-3351	60	38	used	use	VERB
iajs-3351	60	39	to	to	PART
iajs-3351	60	40	assess	assess	VERB
iajs-3351	60	41	if	if	SCONJ
iajs-3351	60	42	there	there	PRON
iajs-3351	60	43	are	be	VERB
iajs-3351	60	44	statistically	statistically	ADV
iajs-3351	60	45	significant	significant	ADJ
iajs-3351	60	46	differences	difference	NOUN
iajs-3351	60	47	between	between	ADP
iajs-3351	60	48	the	the	DET
iajs-3351	60	49	means	mean	NOUN
iajs-3351	60	50	of	of	ADP
iajs-3351	60	51	the	the	DET
iajs-3351	60	52	studied	study	VERB
iajs-3351	60	53	groups	group	NOUN
iajs-3351	60	54	.	.	PUNCT
iajs-3351	61	1	also	also	ADV
iajs-3351	61	2	,	,	PUNCT
iajs-3351	61	3	the	the	DET
iajs-3351	61	4	roc	roc	PROPN
iajs-3351	61	5	curve	curve	NOUN
iajs-3351	61	6	was	be	AUX
iajs-3351	61	7	used	use	VERB
iajs-3351	61	8	.	.	PUNCT
iajs-3351	62	1	the	the	DET
iajs-3351	62	2	statistical	statistical	ADJ
iajs-3351	62	3	significance	significance	NOUN
iajs-3351	62	4	is	be	AUX
iajs-3351	62	5	set	set	VERB
iajs-3351	62	6	by	by	ADP
iajs-3351	62	7	probability	probability	NOUN
iajs-3351	62	8	value	value	NOUN
iajs-3351	62	9	,	,	PUNCT
iajs-3351	62	10	in	in	ADP
iajs-3351	62	11	which	which	PRON
iajs-3351	62	12	at	at	ADP
iajs-3351	62	13	(	(	PUNCT
iajs-3351	62	14	p	p	NOUN
iajs-3351	62	15	≤	≤	NOUN
iajs-3351	62	16	0.05	0.05	NUM
iajs-3351	62	17	)	)	PUNCT
iajs-3351	62	18	was	be	AUX
iajs-3351	62	19	accepted	accept	VERB
iajs-3351	62	20	as	as	ADP
iajs-3351	62	21	significant	significant	ADJ
iajs-3351	62	22	,	,	PUNCT
iajs-3351	62	23	whereas	whereas	SCONJ
iajs-3351	62	24	highly	highly	ADV
iajs-3351	62	25	significant	significant	ADJ
iajs-3351	62	26	,	,	PUNCT
iajs-3351	62	27	when	when	SCONJ
iajs-3351	62	28	(	(	PUNCT
iajs-3351	62	29	p	p	NOUN
iajs-3351	62	30	≤	≤	NUM
iajs-3351	62	31	0.001	0.001	NUM
iajs-3351	62	32	)	)	PUNCT
iajs-3351	62	33	,	,	PUNCT
iajs-3351	62	34	but	but	CCONJ
iajs-3351	62	35	at	at	ADP
iajs-3351	62	36	(	(	PUNCT
iajs-3351	62	37	p	p	PRON
iajs-3351	62	38	≥	≥	NOUN
iajs-3351	62	39	0.05	0.05	NUM
iajs-3351	62	40	)	)	PUNCT
iajs-3351	62	41	was	be	AUX
iajs-3351	62	42	accepted	accept	VERB
iajs-3351	62	43	as	as	ADP
iajs-3351	62	44	non	non	ADJ
iajs-3351	62	45	-	-	ADJ
iajs-3351	62	46	significant	significant	ADJ
iajs-3351	62	47	.	.	PUNCT
iajs-3351	63	1	3	3	X
iajs-3351	63	2	.	.	X
iajs-3351	63	3	results	result	VERB
iajs-3351	63	4	the	the	DET
iajs-3351	63	5	values	value	NOUN
iajs-3351	63	6	of	of	ADP
iajs-3351	63	7	(	(	PUNCT
iajs-3351	63	8	mean	mean	PROPN
iajs-3351	63	9	±	±	NUM
iajs-3351	63	10	se	se	NOUN
iajs-3351	63	11	)	)	PUNCT
iajs-3351	63	12	anthropometric	anthropometric	ADJ
iajs-3351	63	13	measurements	measurement	NOUN
iajs-3351	63	14	bmi	bmi	VERB
iajs-3351	63	15	and	and	CCONJ
iajs-3351	63	16	whr	whr	PROPN
iajs-3351	63	17	for	for	ADP
iajs-3351	63	18	patients	patient	NOUN
iajs-3351	63	19	and	and	CCONJ
iajs-3351	63	20	control	control	NOUN
iajs-3351	63	21	groups	group	NOUN
iajs-3351	63	22	shown	show	VERB
iajs-3351	63	23	in	in	ADP
iajs-3351	63	24	table	table	NOUN
iajs-3351	63	25	1	1	NUM
iajs-3351	63	26	are	be	AUX
iajs-3351	63	27	highly	highly	ADV
iajs-3351	63	28	significant	significant	ADJ
iajs-3351	63	29	(	(	PUNCT
iajs-3351	63	30	p	p	NOUN
iajs-3351	63	31	≤	≤	NUM
iajs-3351	63	32	0.001	0.001	NUM
iajs-3351	63	33	)	)	PUNCT
iajs-3351	63	34	in	in	ADP
iajs-3351	63	35	patients	patient	NOUN
iajs-3351	63	36	(	(	PUNCT
iajs-3351	63	37	lean	lean	ADJ
iajs-3351	63	38	pcos	pcos	ADJ
iajs-3351	63	39	women	woman	NOUN
iajs-3351	63	40	without	without	ADP
iajs-3351	63	41	covid-19	covid-19	PROPN
iajs-3351	63	42	infection	infection	NOUN
iajs-3351	63	43	(	(	PUNCT
iajs-3351	63	44	23.37±0.40	23.37±0.40	NOUN
iajs-3351	63	45	)	)	PUNCT
iajs-3351	63	46	,	,	PUNCT
iajs-3351	63	47	obese	obese	ADJ
iajs-3351	63	48	pcos	pcos	ADJ
iajs-3351	63	49	women	woman	NOUN
iajs-3351	63	50	with	with	ADP
iajs-3351	63	51	covid-19	covid-19	PROPN
iajs-3351	63	52	infection	infection	NOUN
iajs-3351	63	53	(	(	PUNCT
iajs-3351	63	54	34.17±0.66	34.17±0.66	NUM
iajs-3351	63	55	)	)	PUNCT
iajs-3351	63	56	,	,	PUNCT
iajs-3351	63	57	and	and	CCONJ
iajs-3351	63	58	healthy	healthy	ADJ
iajs-3351	63	59	women	woman	NOUN
iajs-3351	63	60	(	(	PUNCT
iajs-3351	63	61	22.10±0.38	22.10±0.38	NUM
iajs-3351	63	62	)	)	PUNCT
iajs-3351	63	63	where	where	SCONJ
iajs-3351	63	64	the	the	DET
iajs-3351	63	65	results	result	NOUN
iajs-3351	63	66	were	be	AUX
iajs-3351	63	67	higher	high	ADJ
iajs-3351	63	68	in	in	ADP
iajs-3351	63	69	stage	stage	NOUN
iajs-3351	63	70	(	(	PUNCT
iajs-3351	63	71	obese	obese	ADJ
iajs-3351	63	72	pcos	pco	NOUN
iajs-3351	63	73	than	than	ADP
iajs-3351	63	74	lean	lean	ADJ
iajs-3351	63	75	pcos	pco	NOUN
iajs-3351	63	76	than	than	ADP
iajs-3351	63	77	healthy	healthy	ADJ
iajs-3351	63	78	women	woman	NOUN
iajs-3351	63	79	)	)	PUNCT
iajs-3351	63	80	,	,	PUNCT
iajs-3351	63	81	respectively	respectively	ADV
iajs-3351	63	82	.	.	PUNCT
iajs-3351	63	83	table	table	NOUN
iajs-3351	63	84	1	1	NUM
iajs-3351	63	85	.	.	PUNCT
iajs-3351	63	86	comprehensive	comprehensive	ADJ
iajs-3351	63	87	distention	distention	NOUN
iajs-3351	63	88	for	for	ADP
iajs-3351	63	89	the	the	DET
iajs-3351	63	90	study	study	NOUN
iajs-3351	63	91	participants	participant	NOUN
iajs-3351	63	92	.	.	PUNCT
iajs-3351	64	1	fasting	fast	VERB
iajs-3351	64	2	blood	blood	NOUN
iajs-3351	64	3	sugar	sugar	NOUN
iajs-3351	64	4	and	and	CCONJ
iajs-3351	64	5	lipid	lipid	NOUN
iajs-3351	64	6	profiles	profile	NOUN
iajs-3351	64	7	were	be	AUX
iajs-3351	64	8	measured	measure	VERB
iajs-3351	64	9	for	for	ADP
iajs-3351	64	10	all	all	DET
iajs-3351	64	11	the	the	DET
iajs-3351	64	12	patient	patient	ADJ
iajs-3351	64	13	and	and	CCONJ
iajs-3351	64	14	control	control	NOUN
iajs-3351	64	15	groups	group	NOUN
iajs-3351	64	16	as	as	SCONJ
iajs-3351	64	17	shown	show	VERB
iajs-3351	64	18	in	in	ADP
iajs-3351	64	19	table	table	NOUN
iajs-3351	64	20	2	2	NUM
iajs-3351	64	21	.	.	PUNCT
iajs-3351	65	1	the	the	DET
iajs-3351	65	2	results	result	NOUN
iajs-3351	65	3	of	of	ADP
iajs-3351	65	4	high	high	ADJ
iajs-3351	65	5	significance	significance	NOUN
iajs-3351	65	6	for	for	ADP
iajs-3351	65	7	fbs	fbs	PROPN
iajs-3351	65	8	and	and	CCONJ
iajs-3351	65	9	lipid	lipid	NOUN
iajs-3351	65	10	profile	profile	NOUN
iajs-3351	65	11	(	(	PUNCT
iajs-3351	65	12	p	p	NOUN
iajs-3351	65	13	≤	≤	NUM
iajs-3351	65	14	0.05	0.05	NUM
iajs-3351	65	15	)	)	PUNCT
iajs-3351	65	16	for	for	ADP
iajs-3351	65	17	(	(	PUNCT
iajs-3351	65	18	fbs	fbs	PROPN
iajs-3351	65	19	,	,	PUNCT
iajs-3351	65	20	tc	tc	NOUN
iajs-3351	65	21	,	,	PUNCT
iajs-3351	65	22	ldl	ldl	NOUN
iajs-3351	65	23	,	,	PUNCT
iajs-3351	65	24	vldl	vldl	NOUN
iajs-3351	65	25	,	,	PUNCT
iajs-3351	65	26	and	and	CCONJ
iajs-3351	65	27	hdl	hdl	NOUN
iajs-3351	65	28	)	)	PUNCT
iajs-3351	65	29	mean	mean	VERB
iajs-3351	65	30	the	the	DET
iajs-3351	65	31	stage	stage	NOUN
iajs-3351	65	32	(	(	PUNCT
iajs-3351	65	33	obese	obese	PROPN
iajs-3351	65	34	pcos	pcos	PROPN
iajs-3351	65	35	then	then	ADV
iajs-3351	65	36	lean	lean	ADJ
iajs-3351	65	37	pcos	pco	NOUN
iajs-3351	65	38	,	,	PUNCT
iajs-3351	65	39	then	then	ADV
iajs-3351	65	40	healthy	healthy	ADJ
iajs-3351	65	41	women	woman	NOUN
iajs-3351	65	42	)	)	PUNCT
iajs-3351	65	43	,	,	PUNCT
iajs-3351	65	44	respectively	respectively	ADV
iajs-3351	65	45	.	.	PUNCT
iajs-3351	66	1	it	it	PRON
iajs-3351	66	2	was	be	AUX
iajs-3351	66	3	higher	high	ADJ
iajs-3351	66	4	than	than	ADP
iajs-3351	66	5	the	the	DET
iajs-3351	66	6	control	control	NOUN
iajs-3351	66	7	and	and	CCONJ
iajs-3351	66	8	found	find	VERB
iajs-3351	66	9	lower	low	ADJ
iajs-3351	66	10	in	in	ADP
iajs-3351	66	11	hdl	hdl	PROPN
iajs-3351	66	12	-	-	PUNCT
iajs-3351	66	13	c	c	NOUN
iajs-3351	66	14	values	value	NOUN
iajs-3351	66	15	and	and	CCONJ
iajs-3351	66	16	higher	high	ADJ
iajs-3351	66	17	in	in	ADP
iajs-3351	66	18	other	other	ADJ
iajs-3351	66	19	lipid	lipid	NOUN
iajs-3351	66	20	profile	profile	NOUN
iajs-3351	66	21	levels	level	NOUN
iajs-3351	66	22	in	in	ADP
iajs-3351	66	23	obese	obese	ADJ
iajs-3351	66	24	patient	patient	ADJ
iajs-3351	66	25	women	woman	NOUN
iajs-3351	66	26	infected	infect	VERB
iajs-3351	66	27	with	with	ADP
iajs-3351	66	28	the	the	DET
iajs-3351	66	29	virus	virus	NOUN
iajs-3351	66	30	(	(	PUNCT
iajs-3351	66	31	covid-19	covid-19	PROPN
iajs-3351	66	32	)	)	PUNCT
iajs-3351	66	33	as	as	SCONJ
iajs-3351	66	34	compared	compare	VERB
iajs-3351	66	35	to	to	ADP
iajs-3351	66	36	patient	patient	ADJ
iajs-3351	66	37	women	woman	NOUN
iajs-3351	66	38	infected	infect	VERB
iajs-3351	66	39	with	with	ADP
iajs-3351	66	40	the	the	DET
iajs-3351	66	41	virus	virus	NOUN
iajs-3351	66	42	.	.	PUNCT
iajs-3351	67	1	parameters	parameter	NOUN
iajs-3351	67	2	lean	lean	VERB
iajs-3351	67	3	pcos	pcos	ADJ
iajs-3351	67	4	women	woman	NOUN
iajs-3351	67	5	without	without	ADP
iajs-3351	67	6	covid-19	covid-19	PROPN
iajs-3351	67	7	infection	infection	NOUN
iajs-3351	67	8	(	(	PUNCT
iajs-3351	67	9	n=24	n=24	PROPN
iajs-3351	67	10	)	)	PUNCT
iajs-3351	67	11	obese	obese	ADJ
iajs-3351	67	12	pcos	pcos	ADJ
iajs-3351	67	13	women	woman	NOUN
iajs-3351	67	14	with	with	ADP
iajs-3351	67	15	covid-19	covid-19	PROPN
iajs-3351	67	16	infection	infection	NOUN
iajs-3351	67	17	(	(	PUNCT
iajs-3351	67	18	n=56	n=56	NOUN
iajs-3351	67	19	)	)	PUNCT
iajs-3351	67	20	healthy	healthy	ADJ
iajs-3351	67	21	women	woman	NOUN
iajs-3351	67	22	(	(	PUNCT
iajs-3351	67	23	n=40	n=40	ADJ
iajs-3351	67	24	)	)	PUNCT
iajs-3351	67	25	p	p	ADJ
iajs-3351	67	26	-	-	PUNCT
iajs-3351	67	27	value	value	NOUN
iajs-3351	67	28	bmi	bmi	NOUN
iajs-3351	67	29	(	(	PUNCT
iajs-3351	67	30	kg	kg	NOUN
iajs-3351	67	31	/	/	SYM
iajs-3351	67	32	m	m	VERB
iajs-3351	67	33	2	2	NUM
iajs-3351	67	34	)	)	PUNCT
iajs-3351	67	35	mean	mean	VERB
iajs-3351	67	36	23.37	23.37	NUM
iajs-3351	67	37	34.17	34.17	NUM
iajs-3351	67	38	22.10	22.10	NUM
iajs-3351	67	39	*	*	PUNCT
iajs-3351	67	40	*	*	PUNCT
iajs-3351	67	41	0.0001	0.0001	NUM
iajs-3351	67	42	std	std	NOUN
iajs-3351	67	43	.	.	PUNCT
iajs-3351	68	1	error	error	NOUN
iajs-3351	68	2	0.40	0.40	NUM
iajs-3351	68	3	0.66	0.66	NUM
iajs-3351	68	4	0.38	0.38	NUM
iajs-3351	69	1	whr	whr	NOUN
iajs-3351	69	2	mean	mean	VERB
iajs-3351	69	3	5.10	5.10	NUM
iajs-3351	69	4	5.12	5.12	NUM
iajs-3351	69	5	3.91	3.91	NUM
iajs-3351	69	6	*	*	PUNCT
iajs-3351	69	7	*	*	PUNCT
iajs-3351	69	8	0.0001	0.0001	NUM
iajs-3351	69	9	std	std	NOUN
iajs-3351	69	10	.	.	PUNCT
iajs-3351	70	1	error	error	NOUN
iajs-3351	70	2	0.11	0.11	NUM
iajs-3351	70	3	0.069	0.069	NUM
iajs-3351	70	4	0.12	0.12	NUM
iajs-3351	70	5	ihjpas	ihjpa	NOUN
iajs-3351	70	6	.	.	PUNCT
iajs-3351	71	1	37	37	NUM
iajs-3351	71	2	(	(	PUNCT
iajs-3351	71	3	3	3	NUM
iajs-3351	71	4	)	)	PUNCT
iajs-3351	71	5	2024	2024	NUM
iajs-3351	71	6	290	290	NUM
iajs-3351	71	7	table	table	NOUN
iajs-3351	71	8	2	2	NUM
iajs-3351	71	9	.	.	PUNCT
iajs-3351	71	10	levels	level	NOUN
iajs-3351	71	11	of	of	ADP
iajs-3351	71	12	lipid	lipid	ADJ
iajs-3351	71	13	profile	profile	NOUN
iajs-3351	71	14	of	of	ADP
iajs-3351	71	15	study	study	NOUN
iajs-3351	71	16	groups	group	NOUN
iajs-3351	71	17	.	.	PUNCT
iajs-3351	72	1	as	as	ADP
iajs-3351	72	2	for	for	ADP
iajs-3351	72	3	the	the	DET
iajs-3351	72	4	hormonal	hormonal	ADJ
iajs-3351	72	5	parameter	parameter	NOUN
iajs-3351	72	6	values	value	NOUN
iajs-3351	72	7	shown	show	VERB
iajs-3351	72	8	in	in	ADP
iajs-3351	72	9	table	table	NOUN
iajs-3351	72	10	3	3	NUM
iajs-3351	72	11	,	,	PUNCT
iajs-3351	72	12	follicle	follicle	NOUN
iajs-3351	72	13	-	-	PUNCT
iajs-3351	72	14	stimulated	stimulate	VERB
iajs-3351	72	15	hormone	hormone	NOUN
iajs-3351	72	16	(	(	PUNCT
iajs-3351	72	17	fsh	fsh	NOUN
iajs-3351	72	18	)	)	PUNCT
iajs-3351	72	19	values	value	NOUN
iajs-3351	72	20	were	be	AUX
iajs-3351	72	21	decreased	decrease	VERB
iajs-3351	72	22	in	in	ADP
iajs-3351	72	23	patients	patient	NOUN
iajs-3351	72	24	women	woman	NOUN
iajs-3351	72	25	compared	compare	VERB
iajs-3351	72	26	to	to	ADP
iajs-3351	72	27	healthy	healthy	ADJ
iajs-3351	72	28	women	woman	NOUN
iajs-3351	72	29	groups	group	NOUN
iajs-3351	72	30	at	at	ADP
iajs-3351	72	31	p	p	NOUN
iajs-3351	72	32	values	value	NOUN
iajs-3351	72	33	≤	≤	NOUN
iajs-3351	72	34	0.01	0.01	NUM
iajs-3351	72	35	,	,	PUNCT
iajs-3351	72	36	while	while	SCONJ
iajs-3351	72	37	leutilizing	leutilize	VERB
iajs-3351	72	38	hormone	hormone	NOUN
iajs-3351	72	39	(	(	PUNCT
iajs-3351	72	40	lh	lh	PROPN
iajs-3351	72	41	)	)	PUNCT
iajs-3351	72	42	,	,	PUNCT
iajs-3351	72	43	lh	lh	PROPN
iajs-3351	72	44	/	/	SYM
iajs-3351	72	45	fsh	fsh	PROPN
iajs-3351	72	46	ratio	ratio	NOUN
iajs-3351	72	47	,	,	PUNCT
iajs-3351	72	48	insulin	insulin	NOUN
iajs-3351	72	49	,	,	PUNCT
iajs-3351	72	50	homa	homa	PROPN
iajs-3351	72	51	ir	ir	PROPN
iajs-3351	72	52	,	,	PUNCT
iajs-3351	72	53	and	and	CCONJ
iajs-3351	72	54	testosterone	testosterone	NOUN
iajs-3351	72	55	levels	level	NOUN
iajs-3351	72	56	were	be	AUX
iajs-3351	72	57	significantly	significantly	ADV
iajs-3351	72	58	higher	high	ADJ
iajs-3351	72	59	in	in	ADP
iajs-3351	72	60	obese	obese	ADJ
iajs-3351	72	61	pcos	pco	NOUN
iajs-3351	72	62	with	with	ADP
iajs-3351	72	63	covid-19	covid-19	PROPN
iajs-3351	72	64	infection	infection	NOUN
iajs-3351	72	65	and	and	CCONJ
iajs-3351	72	66	lean	lean	ADJ
iajs-3351	72	67	pcos	pco	NOUN
iajs-3351	72	68	without	without	ADP
iajs-3351	72	69	covid-19	covid-19	PROPN
iajs-3351	72	70	infection	infection	NOUN
iajs-3351	72	71	than	than	ADP
iajs-3351	72	72	in	in	ADP
iajs-3351	72	73	the	the	DET
iajs-3351	72	74	healthy	healthy	ADJ
iajs-3351	72	75	group	group	NOUN
iajs-3351	72	76	.	.	PUNCT
iajs-3351	73	1	table	table	NOUN
iajs-3351	73	2	3	3	NUM
iajs-3351	73	3	.	.	PUNCT
iajs-3351	74	1	levels	level	NOUN
iajs-3351	74	2	of	of	ADP
iajs-3351	74	3	hormones	hormone	NOUN
iajs-3351	74	4	of	of	ADP
iajs-3351	74	5	women	woman	NOUN
iajs-3351	74	6	with	with	ADP
iajs-3351	74	7	pcos	pcos	PROPN
iajs-3351	74	8	and	and	CCONJ
iajs-3351	74	9	controls	control	NOUN
iajs-3351	74	10	.	.	PUNCT
iajs-3351	75	1	table	table	NOUN
iajs-3351	75	2	4	4	NUM
iajs-3351	75	3	.	.	PUNCT
iajs-3351	76	1	and	and	CCONJ
iajs-3351	76	2	figure	figure	VERB
iajs-3351	76	3	1	1	NUM
iajs-3351	76	4	.	.	PUNCT
iajs-3351	77	1	show	show	VERB
iajs-3351	77	2	the	the	DET
iajs-3351	77	3	mean	mean	NOUN
iajs-3351	77	4	±	±	PROPN
iajs-3351	77	5	se	se	PROPN
iajs-3351	77	6	values	value	NOUN
iajs-3351	77	7	of	of	ADP
iajs-3351	77	8	ace2	ace2	PROPN
iajs-3351	77	9	levels	level	NOUN
iajs-3351	77	10	in	in	ADP
iajs-3351	77	11	patents	patent	NOUN
iajs-3351	77	12	groups	group	NOUN
iajs-3351	77	13	(	(	PUNCT
iajs-3351	77	14	lean	lean	ADJ
iajs-3351	77	15	pcos	pco	NOUN
iajs-3351	77	16	without	without	ADP
iajs-3351	77	17	covid-19	covid-19	PROPN
iajs-3351	77	18	infected	infect	VERB
iajs-3351	77	19	then	then	ADV
iajs-3351	77	20	obese	obese	ADJ
iajs-3351	77	21	pcos	pcos	PROPN
iajs-3351	77	22	with	with	ADP
iajs-3351	77	23	covid-19	covid-19	PROPN
iajs-3351	77	24	infected	infect	VERB
iajs-3351	77	25	then	then	ADV
iajs-3351	77	26	healthy	healthy	ADJ
iajs-3351	77	27	women	woman	NOUN
iajs-3351	77	28	)	)	PUNCT
iajs-3351	77	29	and	and	CCONJ
iajs-3351	77	30	healthy	healthy	ADJ
iajs-3351	77	31	group	group	NOUN
iajs-3351	77	32	(	(	PUNCT
iajs-3351	77	33	(	(	PUNCT
iajs-3351	77	34	127.37±6.6	127.37±6.6	NUM
iajs-3351	77	35	)	)	PUNCT
iajs-3351	77	36	,	,	PUNCT
iajs-3351	77	37	(	(	PUNCT
iajs-3351	77	38	110.42±3.74	110.42±3.74	NUM
iajs-3351	77	39	)	)	PUNCT
iajs-3351	77	40	,	,	PUNCT
iajs-3351	77	41	and	and	CCONJ
iajs-3351	77	42	(	(	PUNCT
iajs-3351	77	43	175.07±5.02	175.07±5.02	NUM
iajs-3351	77	44	)	)	PUNCT
iajs-3351	77	45	)	)	PUNCT
iajs-3351	77	46	respectively	respectively	ADV
iajs-3351	77	47	.	.	PUNCT
iajs-3351	78	1	statistically	statistically	ADJ
iajs-3351	78	2	parameters	parameter	NOUN
iajs-3351	78	3	lean	lean	ADJ
iajs-3351	78	4	pcos	pcos	ADJ
iajs-3351	78	5	women	woman	NOUN
iajs-3351	78	6	without	without	ADP
iajs-3351	78	7	covid-19	covid-19	PROPN
iajs-3351	78	8	infection	infection	NOUN
iajs-3351	78	9	(	(	PUNCT
iajs-3351	78	10	n=24	n=24	PROPN
iajs-3351	78	11	)	)	PUNCT
iajs-3351	78	12	obese	obese	ADJ
iajs-3351	78	13	pcos	pcos	ADJ
iajs-3351	78	14	women	woman	NOUN
iajs-3351	78	15	with	with	ADP
iajs-3351	78	16	covid-19	covid-19	PROPN
iajs-3351	78	17	infection	infection	NOUN
iajs-3351	78	18	(	(	PUNCT
iajs-3351	78	19	n=56	n=56	NOUN
iajs-3351	78	20	)	)	PUNCT
iajs-3351	78	21	healthy	healthy	ADJ
iajs-3351	78	22	women	woman	NOUN
iajs-3351	78	23	(	(	PUNCT
iajs-3351	78	24	n=40	n=40	ADJ
iajs-3351	78	25	)	)	PUNCT
iajs-3351	78	26	p	p	X
iajs-3351	78	27	-	-	PUNCT
iajs-3351	78	28	value	value	NOUN
iajs-3351	78	29	fbs	fbs	NOUN
iajs-3351	78	30	(	(	PUNCT
iajs-3351	78	31	mmol	mmol	NOUN
iajs-3351	78	32	/	/	SYM
iajs-3351	78	33	l	l	NOUN
iajs-3351	78	34	)	)	PUNCT
iajs-3351	78	35	mean	mean	NOUN
iajs-3351	78	36	5.86	5.86	NUM
iajs-3351	78	37	8.88	8.88	NUM
iajs-3351	78	38	3.73	3.73	NUM
iajs-3351	78	39	*	*	PUNCT
iajs-3351	78	40	*	*	PUNCT
iajs-3351	78	41	0.0001	0.0001	NUM
iajs-3351	78	42	std	std	NOUN
iajs-3351	78	43	.	.	PUNCT
iajs-3351	79	1	error	error	NOUN
iajs-3351	79	2	0.011	0.011	NUM
iajs-3351	79	3	0.017	0.017	NUM
iajs-3351	79	4	0.01	0.01	NUM
iajs-3351	79	5	cholesterol	cholesterol	NOUN
iajs-3351	79	6	(	(	PUNCT
iajs-3351	79	7	mmol	mmol	NOUN
iajs-3351	79	8	/	/	SYM
iajs-3351	79	9	l	l	NOUN
iajs-3351	79	10	)	)	PUNCT
iajs-3351	79	11	mean	mean	NOUN
iajs-3351	79	12	5.15	5.15	NUM
iajs-3351	79	13	5.38	5.38	NUM
iajs-3351	79	14	2.01	2.01	NUM
iajs-3351	79	15	*	*	PUNCT
iajs-3351	79	16	*	*	PUNCT
iajs-3351	79	17	0.0001	0.0001	NUM
iajs-3351	79	18	std	std	NOUN
iajs-3351	79	19	.	.	PUNCT
iajs-3351	80	1	error	error	NOUN
iajs-3351	80	2	0.42	0.42	NUM
iajs-3351	80	3	0.21	0.21	NUM
iajs-3351	80	4	0.31	0.31	NUM
iajs-3351	80	5	triglycerides	triglyceride	NOUN
iajs-3351	80	6	(	(	PUNCT
iajs-3351	80	7	mmol	mmol	NOUN
iajs-3351	80	8	/	/	SYM
iajs-3351	80	9	l	l	NOUN
iajs-3351	80	10	)	)	PUNCT
iajs-3351	80	11	mean	mean	NOUN
iajs-3351	80	12	6.30	6.30	NUM
iajs-3351	80	13	6.90	6.90	NUM
iajs-3351	80	14	4.43	4.43	NUM
iajs-3351	80	15	*	*	PUNCT
iajs-3351	80	16	*	*	PUNCT
iajs-3351	80	17	0.0001	0.0001	NUM
iajs-3351	80	18	std	std	NOUN
iajs-3351	80	19	.	.	PUNCT
iajs-3351	81	1	error	error	NOUN
iajs-3351	81	2	0.30	0.30	NUM
iajs-3351	81	3	0.18	0.18	NUM
iajs-3351	81	4	0.28	0.28	NUM
iajs-3351	81	5	hdl	hdl	PROPN
iajs-3351	81	6	-	-	PUNCT
iajs-3351	81	7	c	c	PROPN
iajs-3351	81	8	(	(	PUNCT
iajs-3351	81	9	mmol	mmol	NOUN
iajs-3351	81	10	/	/	SYM
iajs-3351	81	11	l	l	NOUN
iajs-3351	81	12	)	)	PUNCT
iajs-3351	81	13	mean	mean	NOUN
iajs-3351	81	14	1.35	1.35	NUM
iajs-3351	82	1	1.24	1.24	NUM
iajs-3351	82	2	1.66	1.66	NUM
iajs-3351	82	3	0.056	0.056	NUM
iajs-3351	82	4	std	std	NOUN
iajs-3351	82	5	.	.	PUNCT
iajs-3351	82	6	error	error	NOUN
iajs-3351	82	7	0.093	0.093	NUM
iajs-3351	82	8	0.11	0.11	NUM
iajs-3351	82	9	0.10	0.10	NUM
iajs-3351	82	10	ldl	ldl	NOUN
iajs-3351	82	11	(	(	PUNCT
iajs-3351	82	12	mmol	mmol	NOUN
iajs-3351	82	13	/	/	SYM
iajs-3351	82	14	l	l	NOUN
iajs-3351	82	15	)	)	PUNCT
iajs-3351	82	16	mean	mean	NOUN
iajs-3351	82	17	2.93	2.93	NUM
iajs-3351	82	18	3.14	3.14	NUM
iajs-3351	83	1	2.28	2.28	NUM
iajs-3351	83	2	*	*	SYM
iajs-3351	83	3	0.024	0.024	NUM
iajs-3351	83	4	std	std	NOUN
iajs-3351	83	5	.	.	NOUN
iajs-3351	83	6	error	error	NOUN
iajs-3351	83	7	0.30	0.30	NUM
iajs-3351	83	8	0.19	0.19	NUM
iajs-3351	83	9	0.23	0.23	NUM
iajs-3351	83	10	vldl	vldl	NOUN
iajs-3351	83	11	(	(	PUNCT
iajs-3351	83	12	mmol	mmol	NOUN
iajs-3351	83	13	/	/	SYM
iajs-3351	83	14	l	l	NOUN
iajs-3351	83	15	)	)	PUNCT
iajs-3351	83	16	mean	mean	NOUN
iajs-3351	84	1	2.19	2.19	NUM
iajs-3351	84	2	2.39	2.39	NUM
iajs-3351	84	3	0.91	0.91	NUM
iajs-3351	84	4	*	*	PUNCT
iajs-3351	84	5	*	*	PUNCT
iajs-3351	84	6	0.0001	0.0001	NUM
iajs-3351	84	7	std	std	NOUN
iajs-3351	84	8	.	.	PUNCT
iajs-3351	85	1	error	error	NOUN
iajs-3351	85	2	0.14	0.14	NUM
iajs-3351	85	3	0.16	0.16	NUM
iajs-3351	85	4	0.12	0.12	NUM
iajs-3351	85	5	parameters	parameter	NOUN
iajs-3351	85	6	lean	lean	ADJ
iajs-3351	85	7	pcos	pcos	ADJ
iajs-3351	85	8	women	woman	NOUN
iajs-3351	85	9	without	without	ADP
iajs-3351	85	10	covid-19	covid-19	PROPN
iajs-3351	85	11	infection	infection	NOUN
iajs-3351	85	12	(	(	PUNCT
iajs-3351	85	13	n=24	n=24	PROPN
iajs-3351	85	14	)	)	PUNCT
iajs-3351	85	15	obese	obese	ADJ
iajs-3351	85	16	pcos	pcos	ADJ
iajs-3351	85	17	women	woman	NOUN
iajs-3351	85	18	with	with	ADP
iajs-3351	85	19	covid-19	covid-19	PROPN
iajs-3351	85	20	infection	infection	NOUN
iajs-3351	85	21	(	(	PUNCT
iajs-3351	85	22	n=56	n=56	NOUN
iajs-3351	85	23	)	)	PUNCT
iajs-3351	85	24	healthy	healthy	ADJ
iajs-3351	85	25	women	woman	NOUN
iajs-3351	85	26	(	(	PUNCT
iajs-3351	85	27	n=40	n=40	ADJ
iajs-3351	85	28	)	)	PUNCT
iajs-3351	85	29	p	p	ADJ
iajs-3351	85	30	-	-	PUNCT
iajs-3351	85	31	value	value	NOUN
iajs-3351	85	32	fsh	fsh	NOUN
iajs-3351	85	33	(	(	PUNCT
iajs-3351	85	34	miu/	miu/	PROPN
iajs-3351	85	35	ml	ml	NOUN
iajs-3351	85	36	)	)	PUNCT
iajs-3351	85	37	mean	mean	NOUN
iajs-3351	85	38	5.00	5.00	NUM
iajs-3351	85	39	5.78	5.78	NUM
iajs-3351	85	40	7.81	7.81	NUM
iajs-3351	85	41	*	*	PUNCT
iajs-3351	85	42	*	*	PUNCT
iajs-3351	85	43	0.0001	0.0001	NUM
iajs-3351	85	44	std	std	NOUN
iajs-3351	85	45	.	.	PUNCT
iajs-3351	86	1	error	error	NOUN
iajs-3351	86	2	0.30	0.30	NUM
iajs-3351	86	3	0.35	0.35	NUM
iajs-3351	86	4	0.46	0.46	NUM
iajs-3351	86	5	lh	lh	NOUN
iajs-3351	86	6	(	(	PUNCT
iajs-3351	86	7	mlu/	mlu/	ADJ
iajs-3351	86	8	ml	ml	NOUN
iajs-3351	86	9	)	)	PUNCT
iajs-3351	86	10	mean	mean	NOUN
iajs-3351	86	11	8.09	8.09	NUM
iajs-3351	86	12	9.30	9.30	NUM
iajs-3351	86	13	4.42	4.42	NUM
iajs-3351	86	14	*	*	PUNCT
iajs-3351	86	15	*	*	PUNCT
iajs-3351	86	16	0.0001	0.0001	NUM
iajs-3351	86	17	std	std	NOUN
iajs-3351	86	18	.	.	PUNCT
iajs-3351	87	1	error	error	NOUN
iajs-3351	87	2	0.49	0.49	NUM
iajs-3351	87	3	0.68	0.68	NUM
iajs-3351	87	4	0.31	0.31	NUM
iajs-3351	87	5	lh	lh	PROPN
iajs-3351	87	6	/	/	SYM
iajs-3351	87	7	fsh	fsh	PROPN
iajs-3351	87	8	ratio	ratio	NOUN
iajs-3351	87	9	mean	mean	NOUN
iajs-3351	87	10	1.73	1.73	NUM
iajs-3351	87	11	1.69	1.69	NUM
iajs-3351	87	12	0.67	0.67	NUM
iajs-3351	87	13	*	*	PUNCT
iajs-3351	88	1	*	*	PUNCT
iajs-3351	88	2	0.0001	0.0001	NUM
iajs-3351	88	3	std	std	NOUN
iajs-3351	88	4	.	.	PUNCT
iajs-3351	88	5	error	error	NOUN
iajs-3351	88	6	0.14	0.14	NUM
iajs-3351	88	7	0.10	0.10	NUM
iajs-3351	88	8	0.10	0.10	NUM
iajs-3351	88	9	testosterone	testosterone	NOUN
iajs-3351	88	10	(	(	PUNCT
iajs-3351	88	11	ng/	ng/	ADJ
iajs-3351	88	12	ml	ml	NOUN
iajs-3351	88	13	)	)	PUNCT
iajs-3351	88	14	mean	mean	NOUN
iajs-3351	88	15	0.70	0.70	NUM
iajs-3351	88	16	0.74	0.74	NUM
iajs-3351	88	17	0.34	0.34	NUM
iajs-3351	88	18	*	*	PUNCT
iajs-3351	89	1	*	*	PUNCT
iajs-3351	89	2	0.0001	0.0001	NUM
iajs-3351	89	3	std	std	NOUN
iajs-3351	89	4	.	.	PUNCT
iajs-3351	89	5	error	error	NOUN
iajs-3351	89	6	0.04	0.04	NUM
iajs-3351	89	7	0.03	0.03	NUM
iajs-3351	89	8	0.02	0.02	NUM
iajs-3351	89	9	insulin	insulin	NOUN
iajs-3351	89	10	(	(	PUNCT
iajs-3351	89	11	μiu	μiu	PROPN
iajs-3351	89	12	/	/	SYM
iajs-3351	89	13	ml	ml	NOUN
iajs-3351	89	14	)	)	PUNCT
iajs-3351	89	15	mean	mean	NOUN
iajs-3351	89	16	34.57	34.57	NUM
iajs-3351	89	17	37.72	37.72	NUM
iajs-3351	89	18	6.90	6.90	NUM
iajs-3351	89	19	*	*	PUNCT
iajs-3351	89	20	*	*	PUNCT
iajs-3351	89	21	0.0001	0.0001	NUM
iajs-3351	89	22	std	std	NOUN
iajs-3351	89	23	.	.	PUNCT
iajs-3351	89	24	error	error	NOUN
iajs-3351	89	25	2.22	2.22	NUM
iajs-3351	89	26	2.35	2.35	NUM
iajs-3351	89	27	0.45	0.45	NUM
iajs-3351	89	28	homa	homa	NOUN
iajs-3351	89	29	-	-	PUNCT
iajs-3351	89	30	ir	ir	NOUN
iajs-3351	89	31	mean	mean	NOUN
iajs-3351	89	32	7.85	7.85	NUM
iajs-3351	89	33	8.65	8.65	NUM
iajs-3351	89	34	1.25	1.25	NUM
iajs-3351	89	35	*	*	PUNCT
iajs-3351	89	36	*	*	PUNCT
iajs-3351	89	37	0.0001	0.0001	NUM
iajs-3351	89	38	std	std	NOUN
iajs-3351	89	39	.	.	PUNCT
iajs-3351	90	1	error	error	NOUN
iajs-3351	90	2	0.58	0.58	NUM
iajs-3351	90	3	0.58	0.58	NUM
iajs-3351	90	4	0.11	0.11	NUM
iajs-3351	90	5	ihjpas	ihjpa	NOUN
iajs-3351	90	6	.	.	PUNCT
iajs-3351	91	1	37	37	NUM
iajs-3351	91	2	(	(	PUNCT
iajs-3351	91	3	3	3	NUM
iajs-3351	91	4	)	)	PUNCT
iajs-3351	91	5	2024	2024	NUM
iajs-3351	91	6	291	291	NUM
iajs-3351	91	7	highly	highly	ADV
iajs-3351	91	8	significant	significant	ADJ
iajs-3351	91	9	(	(	PUNCT
iajs-3351	91	10	p	p	NOUN
iajs-3351	91	11	≤	≤	NUM
iajs-3351	91	12	0.05	0.05	NUM
iajs-3351	91	13	)	)	PUNCT
iajs-3351	91	14	differences	difference	NOUN
iajs-3351	91	15	were	be	AUX
iajs-3351	91	16	found	find	VERB
iajs-3351	91	17	between	between	ADP
iajs-3351	91	18	mean	mean	PROPN
iajs-3351	91	19	serum	serum	NOUN
iajs-3351	91	20	ace2	ace2	PROPN
iajs-3351	91	21	,	,	PUNCT
iajs-3351	91	22	d	d	NOUN
iajs-3351	91	23	-	-	PUNCT
iajs-3351	91	24	dimer	dimer	ADJ
iajs-3351	91	25	,	,	PUNCT
iajs-3351	91	26	and	and	CCONJ
iajs-3351	91	27	gst	gst	NOUN
iajs-3351	91	28	activity	activity	NOUN
iajs-3351	91	29	levels	level	NOUN
iajs-3351	91	30	of	of	ADP
iajs-3351	91	31	both	both	DET
iajs-3351	91	32	pcos	pcos	PROPN
iajs-3351	91	33	patients	patient	NOUN
iajs-3351	91	34	'	'	PART
iajs-3351	91	35	groups	group	NOUN
iajs-3351	91	36	and	and	CCONJ
iajs-3351	91	37	healthy	healthy	ADJ
iajs-3351	91	38	groups	group	NOUN
iajs-3351	91	39	.	.	PUNCT
iajs-3351	92	1	table	table	NOUN
iajs-3351	92	2	4	4	NUM
iajs-3351	92	3	.	.	PUNCT
iajs-3351	93	1	levels	level	NOUN
iajs-3351	93	2	of	of	ADP
iajs-3351	93	3	ace2	ace2	PROPN
iajs-3351	93	4	,	,	PUNCT
iajs-3351	93	5	d	d	NOUN
iajs-3351	93	6	-	-	PUNCT
iajs-3351	93	7	dimer	dimer	ADJ
iajs-3351	93	8	,	,	PUNCT
iajs-3351	93	9	and	and	CCONJ
iajs-3351	93	10	gst	gst	NOUN
iajs-3351	93	11	enzyme	enzyme	NOUN
iajs-3351	93	12	activity	activity	NOUN
iajs-3351	93	13	in	in	ADP
iajs-3351	93	14	pcos	pcos	NOUN
iajs-3351	93	15	groups	group	NOUN
iajs-3351	93	16	and	and	CCONJ
iajs-3351	93	17	control	control	NOUN
iajs-3351	93	18	.	.	PUNCT
iajs-3351	94	1	the	the	DET
iajs-3351	94	2	area	area	NOUN
iajs-3351	94	3	under	under	ADP
iajs-3351	94	4	the	the	DET
iajs-3351	94	5	curve	curve	NOUN
iajs-3351	94	6	(	(	PUNCT
iajs-3351	94	7	roc	roc	PROPN
iajs-3351	94	8	)	)	PUNCT
iajs-3351	94	9	for	for	ADP
iajs-3351	94	10	ace2	ace2	NOUN
iajs-3351	94	11	and	and	CCONJ
iajs-3351	94	12	ir	ir	PROPN
iajs-3351	94	13	in	in	ADP
iajs-3351	94	14	pcos	pcos	NOUN
iajs-3351	94	15	groups	group	NOUN
iajs-3351	94	16	is	be	AUX
iajs-3351	94	17	0.929	0.929	NUM
iajs-3351	94	18	and	and	CCONJ
iajs-3351	94	19	1.000	1.000	NUM
iajs-3351	94	20	,	,	PUNCT
iajs-3351	94	21	respectively	respectively	ADV
iajs-3351	94	22	.	.	PUNCT
iajs-3351	95	1	the	the	DET
iajs-3351	95	2	cutoff	cutoff	NOUN
iajs-3351	95	3	value	value	NOUN
iajs-3351	95	4	for	for	ADP
iajs-3351	95	5	ace2	ace2	NOUN
iajs-3351	95	6	is	be	AUX
iajs-3351	95	7	˃104.25	˃104.25	NOUN
iajs-3351	95	8	,	,	PUNCT
iajs-3351	95	9	and	and	CCONJ
iajs-3351	95	10	ir	ir	PROPN
iajs-3351	95	11	is	be	AUX
iajs-3351	95	12	˃152.46	˃152.46	NOUN
iajs-3351	95	13	.	.	PUNCT
iajs-3351	95	14	renin	renin	ADJ
iajs-3351	95	15	and	and	CCONJ
iajs-3351	95	16	ace2	ace2	NOUN
iajs-3351	95	17	in	in	ADP
iajs-3351	95	18	pcos	pcos	PROPN
iajs-3351	95	19	patients	patient	NOUN
iajs-3351	95	20	were	be	AUX
iajs-3351	95	21	found	find	VERB
iajs-3351	95	22	to	to	PART
iajs-3351	95	23	have	have	VERB
iajs-3351	95	24	greater	great	ADJ
iajs-3351	95	25	sensitivity	sensitivity	NOUN
iajs-3351	95	26	and	and	CCONJ
iajs-3351	95	27	specificity	specificity	NOUN
iajs-3351	95	28	,	,	PUNCT
iajs-3351	95	29	respectively	respectively	ADV
iajs-3351	95	30	,	,	PUNCT
iajs-3351	95	31	at	at	ADP
iajs-3351	95	32	99.8	99.8	NUM
iajs-3351	95	33	and	and	CCONJ
iajs-3351	95	34	100	100	NUM
iajs-3351	95	35	%	%	NOUN
iajs-3351	95	36	figures	figure	NOUN
iajs-3351	95	37	1	1	NUM
iajs-3351	95	38	,	,	PUNCT
iajs-3351	95	39	2	2	NUM
iajs-3351	95	40	and	and	CCONJ
iajs-3351	95	41	table	table	NOUN
iajs-3351	95	42	5	5	NUM
iajs-3351	95	43	.	.	PUNCT
iajs-3351	95	44	figure	figure	NOUN
iajs-3351	95	45	1	1	NUM
iajs-3351	95	46	.	.	PUNCT
iajs-3351	96	1	the	the	DET
iajs-3351	96	2	roc	roc	PROPN
iajs-3351	96	3	curve	curve	NOUN
iajs-3351	96	4	of	of	ADP
iajs-3351	96	5	ace2	ace2	PROPN
iajs-3351	96	6	for	for	ADP
iajs-3351	96	7	pcos	pcos	NOUN
iajs-3351	96	8	groups	group	NOUN
iajs-3351	96	9	.	.	PUNCT
iajs-3351	97	1	figure	figure	NOUN
iajs-3351	97	2	2	2	NUM
iajs-3351	97	3	.	.	PUNCT
iajs-3351	98	1	the	the	DET
iajs-3351	98	2	roc	roc	PROPN
iajs-3351	98	3	curve	curve	NOUN
iajs-3351	98	4	of	of	ADP
iajs-3351	98	5	ir	ir	PROPN
iajs-3351	98	6	for	for	ADP
iajs-3351	98	7	pcos	pcos	PROPN
iajs-3351	98	8	groups	group	NOUN
iajs-3351	98	9	.	.	PUNCT
iajs-3351	99	1	parameters	parameter	NOUN
iajs-3351	99	2	lean	lean	VERB
iajs-3351	99	3	pcos	pcos	ADJ
iajs-3351	99	4	women	woman	NOUN
iajs-3351	99	5	without	without	ADP
iajs-3351	99	6	covid-19	covid-19	PROPN
iajs-3351	99	7	infection	infection	NOUN
iajs-3351	99	8	(	(	PUNCT
iajs-3351	99	9	n=24	n=24	PROPN
iajs-3351	99	10	)	)	PUNCT
iajs-3351	99	11	obese	obese	ADJ
iajs-3351	99	12	pcos	pcos	ADJ
iajs-3351	99	13	women	woman	NOUN
iajs-3351	99	14	with	with	ADP
iajs-3351	99	15	covid-19	covid-19	PROPN
iajs-3351	99	16	infection	infection	NOUN
iajs-3351	99	17	(	(	PUNCT
iajs-3351	99	18	n=56	n=56	NOUN
iajs-3351	99	19	)	)	PUNCT
iajs-3351	99	20	healthy	healthy	ADJ
iajs-3351	99	21	women	woman	NOUN
iajs-3351	99	22	(	(	PUNCT
iajs-3351	99	23	n=40	n=40	ADJ
iajs-3351	99	24	)	)	PUNCT
iajs-3351	99	25	p	p	NOUN
iajs-3351	99	26	-	-	PUNCT
iajs-3351	99	27	value	value	NOUN
iajs-3351	99	28	d	d	NOUN
iajs-3351	99	29	-	-	PUNCT
iajs-3351	99	30	dimer	dimer	NOUN
iajs-3351	99	31	(	(	PUNCT
iajs-3351	99	32	ng	ng	NOUN
iajs-3351	99	33	/	/	SYM
iajs-3351	99	34	ml	ml	NOUN
iajs-3351	99	35	)	)	PUNCT
iajs-3351	99	36	mean	mean	NOUN
iajs-3351	99	37	248.20	248.20	NUM
iajs-3351	99	38	250.41	250.41	NUM
iajs-3351	99	39	100.56	100.56	NUM
iajs-3351	99	40	*	*	PUNCT
iajs-3351	99	41	*	*	PUNCT
iajs-3351	99	42	0.0001	0.0001	NUM
iajs-3351	99	43	std	std	NOUN
iajs-3351	99	44	.	.	PUNCT
iajs-3351	100	1	error	error	NOUN
iajs-3351	100	2	11.93	11.93	NUM
iajs-3351	100	3	18.68	18.68	NUM
iajs-3351	100	4	7.35	7.35	NUM
iajs-3351	100	5	ace2	ace2	NOUN
iajs-3351	100	6	(	(	PUNCT
iajs-3351	100	7	pg	pg	NOUN
iajs-3351	100	8	/	/	SYM
iajs-3351	100	9	ml	ml	NOUN
iajs-3351	100	10	)	)	PUNCT
iajs-3351	100	11	mean	mean	VERB
iajs-3351	100	12	127.37	127.37	NUM
iajs-3351	101	1	110.42	110.42	NUM
iajs-3351	101	2	175.07	175.07	NUM
iajs-3351	101	3	*	*	PUNCT
iajs-3351	101	4	*	*	PUNCT
iajs-3351	101	5	0.0001	0.0001	NUM
iajs-3351	101	6	std	std	NOUN
iajs-3351	101	7	.	.	NOUN
iajs-3351	101	8	error	error	NOUN
iajs-3351	101	9	6.66	6.66	NUM
iajs-3351	101	10	3.74	3.74	NUM
iajs-3351	101	11	5.02	5.02	NUM
iajs-3351	101	12	gst	gst	NOUN
iajs-3351	101	13	activity	activity	NOUN
iajs-3351	101	14	(	(	PUNCT
iajs-3351	101	15	iu	iu	NOUN
iajs-3351	101	16	/	/	SYM
iajs-3351	101	17	l	l	NOUN
iajs-3351	101	18	)	)	PUNCT
iajs-3351	101	19	mean	mean	NOUN
iajs-3351	101	20	4.78	4.78	NUM
iajs-3351	101	21	4.24	4.24	NUM
iajs-3351	101	22	10.43	10.43	NUM
iajs-3351	101	23	*	*	PUNCT
iajs-3351	101	24	*	*	PUNCT
iajs-3351	101	25	0.0001	0.0001	NUM
iajs-3351	101	26	std	std	NOUN
iajs-3351	101	27	.	.	NOUN
iajs-3351	101	28	error	error	NOUN
iajs-3351	101	29	0.84	0.84	NUM
iajs-3351	101	30	0.49	0.49	NUM
iajs-3351	101	31	1.35	1.35	NUM
iajs-3351	101	32	ihjpas	ihjpa	NOUN
iajs-3351	101	33	.	.	PUNCT
iajs-3351	102	1	37	37	NUM
iajs-3351	102	2	(	(	PUNCT
iajs-3351	102	3	3	3	NUM
iajs-3351	102	4	)	)	PUNCT
iajs-3351	102	5	2024	2024	NUM
iajs-3351	102	6	292	292	NUM
iajs-3351	102	7	table	table	NOUN
iajs-3351	102	8	5	5	NUM
iajs-3351	102	9	.	.	PUNCT
iajs-3351	102	10	area	area	NOUN
iajs-3351	102	11	under	under	ADP
iajs-3351	102	12	the	the	DET
iajs-3351	102	13	curve	curve	NOUN
iajs-3351	102	14	for	for	ADP
iajs-3351	102	15	homa	homa	NOUN
iajs-3351	102	16	-	-	PUNCT
iajs-3351	102	17	ir	ir	PROPN
iajs-3351	102	18	and	and	CCONJ
iajs-3351	102	19	ace2	ace2	PROPN
iajs-3351	102	20	for	for	ADP
iajs-3351	102	21	pcos	pcos	NOUN
iajs-3351	102	22	groups	group	NOUN
iajs-3351	102	23	.	.	PUNCT
iajs-3351	103	1	area	area	NOUN
iajs-3351	103	2	under	under	ADP
iajs-3351	103	3	the	the	DET
iajs-3351	103	4	curve	curve	NOUN
iajs-3351	103	5	test	test	NOUN
iajs-3351	103	6	result	result	NOUN
iajs-3351	103	7	variable(s	variable(s	PROPN
iajs-3351	103	8	)	)	PUNCT
iajs-3351	103	9	area	area	NOUN
iajs-3351	103	10	std	std	PROPN
iajs-3351	103	11	.	.	PUNCT
iajs-3351	103	12	error	error	NOUN
iajs-3351	103	13	asymptotic	asymptotic	ADJ
iajs-3351	103	14	sig	sig	NOUN
iajs-3351	103	15	.	.	PUNCT
iajs-3351	104	1	b	b	X
iajs-3351	104	2	asymptotic	asymptotic	ADJ
iajs-3351	104	3	95	95	NUM
iajs-3351	104	4	%	%	NOUN
iajs-3351	104	5	confidence	confidence	NOUN
iajs-3351	104	6	interval	interval	NOUN
iajs-3351	104	7	lower	lower	ADV
iajs-3351	104	8	bound	bind	VERB
iajs-3351	104	9	upper	upper	ADJ
iajs-3351	104	10	bound	bind	VERB
iajs-3351	104	11	homa	homa	PROPN
iajs-3351	104	12	ir	ir	PROPN
iajs-3351	104	13	ace2	ace2	PROPN
iajs-3351	104	14	1.000	1.000	NUM
iajs-3351	104	15	0.929	0.929	NUM
iajs-3351	104	16	0.001	0.001	NUM
iajs-3351	104	17	0.022	0.022	NUM
iajs-3351	104	18	0.000	0.000	NUM
iajs-3351	104	19	0.000	0.000	NUM
iajs-3351	104	20	0.998	0.998	NUM
iajs-3351	104	21	0.885	0.885	NUM
iajs-3351	104	22	1.000	1.000	NUM
iajs-3351	104	23	0.973	0.973	NUM
iajs-3351	104	24	a.	a.	NOUN
iajs-3351	104	25	under	under	ADP
iajs-3351	104	26	the	the	DET
iajs-3351	104	27	nonparametric	nonparametric	PROPN
iajs-3351	104	28	assumption	assumption	PROPN
iajs-3351	104	29	b.	b.	PROPN
iajs-3351	104	30	null	null	PROPN
iajs-3351	104	31	hypothesis	hypothesis	NOUN
iajs-3351	104	32	:	:	PUNCT
iajs-3351	104	33	true	true	ADJ
iajs-3351	104	34	area	area	NOUN
iajs-3351	104	35	=	=	NOUN
iajs-3351	104	36	0.5	0.5	NUM
iajs-3351	104	37	.	.	NOUN
iajs-3351	104	38	4	4	NUM
iajs-3351	104	39	.	.	X
iajs-3351	105	1	discussion	discussion	NOUN
iajs-3351	105	2	this	this	DET
iajs-3351	105	3	study	study	NOUN
iajs-3351	105	4	aimed	aim	VERB
iajs-3351	105	5	to	to	PART
iajs-3351	105	6	evaluate	evaluate	VERB
iajs-3351	105	7	the	the	DET
iajs-3351	105	8	relationship	relationship	NOUN
iajs-3351	105	9	between	between	ADP
iajs-3351	105	10	ace2	ace2	PROPN
iajs-3351	105	11	and	and	CCONJ
iajs-3351	105	12	ir	ir	PROPN
iajs-3351	105	13	in	in	ADP
iajs-3351	105	14	pcos	pcos	PROPN
iajs-3351	105	15	and	and	CCONJ
iajs-3351	105	16	whether	whether	SCONJ
iajs-3351	105	17	or	or	CCONJ
iajs-3351	105	18	not	not	PART
iajs-3351	105	19	they	they	PRON
iajs-3351	105	20	are	be	AUX
iajs-3351	105	21	infected	infect	VERB
iajs-3351	105	22	with	with	ADP
iajs-3351	105	23	coronaviruses	coronaviruse	NOUN
iajs-3351	105	24	.	.	PUNCT
iajs-3351	106	1	as	as	SCONJ
iajs-3351	106	2	it	it	PRON
iajs-3351	106	3	has	have	AUX
iajs-3351	106	4	been	be	AUX
iajs-3351	106	5	shown	show	VERB
iajs-3351	106	6	that	that	SCONJ
iajs-3351	106	7	both	both	CCONJ
iajs-3351	106	8	pcos	pco	NOUN
iajs-3351	106	9	and	and	CCONJ
iajs-3351	106	10	covid-19	covid-19	PROPN
iajs-3351	106	11	infection	infection	NOUN
iajs-3351	106	12	influence	influence	NOUN
iajs-3351	106	13	multiple	multiple	ADJ
iajs-3351	106	14	overlapping	overlap	VERB
iajs-3351	106	15	mechanisms	mechanism	NOUN
iajs-3351	106	16	in	in	ADP
iajs-3351	106	17	the	the	DET
iajs-3351	106	18	body	body	NOUN
iajs-3351	106	19	,	,	PUNCT
iajs-3351	106	20	we	we	PRON
iajs-3351	106	21	try	try	VERB
iajs-3351	106	22	to	to	PART
iajs-3351	106	23	highlight	highlight	VERB
iajs-3351	106	24	vital	vital	ADJ
iajs-3351	106	25	potential	potential	ADJ
iajs-3351	106	26	vulnerabilities	vulnerability	NOUN
iajs-3351	106	27	in	in	ADP
iajs-3351	106	28	this	this	DET
iajs-3351	106	29	woman	woman	NOUN
iajs-3351	106	30	.	.	PUNCT
iajs-3351	107	1	ace2	ace2	PROPN
iajs-3351	107	2	is	be	AUX
iajs-3351	107	3	known	know	VERB
iajs-3351	107	4	as	as	ADP
iajs-3351	107	5	a	a	DET
iajs-3351	107	6	functional	functional	ADJ
iajs-3351	107	7	receptor	receptor	NOUN
iajs-3351	107	8	for	for	ADP
iajs-3351	107	9	covid-19	covid-19	PROPN
iajs-3351	107	10	.	.	PUNCT
iajs-3351	108	1	the	the	DET
iajs-3351	108	2	ace2	ace2	PROPN
iajs-3351	108	3	secretion	secretion	NOUN
iajs-3351	108	4	is	be	AUX
iajs-3351	108	5	regulated	regulate	VERB
iajs-3351	108	6	in	in	ADP
iajs-3351	108	7	the	the	DET
iajs-3351	108	8	adipose	adipose	ADJ
iajs-3351	108	9	tissue	tissue	NOUN
iajs-3351	108	10	of	of	ADP
iajs-3351	108	11	obese	obese	ADJ
iajs-3351	108	12	pcos	pcos	NOUN
iajs-3351	108	13	patients	patient	NOUN
iajs-3351	108	14	,	,	PUNCT
iajs-3351	108	15	changing	change	VERB
iajs-3351	108	16	the	the	DET
iajs-3351	108	17	adipose	adipose	ADJ
iajs-3351	108	18	tissue	tissue	NOUN
iajs-3351	108	19	into	into	ADP
iajs-3351	108	20	a	a	DET
iajs-3351	108	21	potential	potential	ADJ
iajs-3351	108	22	target	target	NOUN
iajs-3351	108	23	for	for	ADP
iajs-3351	108	24	the	the	DET
iajs-3351	108	25	virus	virus	NOUN
iajs-3351	108	26	.	.	PUNCT
iajs-3351	109	1	this	this	PRON
iajs-3351	109	2	may	may	AUX
iajs-3351	109	3	explain	explain	VERB
iajs-3351	109	4	the	the	DET
iajs-3351	109	5	correlation	correlation	NOUN
iajs-3351	109	6	of	of	ADP
iajs-3351	109	7	obese	obese	ADJ
iajs-3351	109	8	pcos	pcos	ADJ
iajs-3351	109	9	women	woman	NOUN
iajs-3351	109	10	with	with	ADP
iajs-3351	109	11	covid-19	covid-19	PROPN
iajs-3351	109	12	due	due	ADP
iajs-3351	109	13	to	to	ADP
iajs-3351	109	14	the	the	DET
iajs-3351	109	15	comorbidity	comorbidity	NOUN
iajs-3351	109	16	of	of	ADP
iajs-3351	109	17	covid-19	covid-19	PROPN
iajs-3351	109	18	infection	infection	NOUN
iajs-3351	109	19	;	;	PUNCT
iajs-3351	109	20	the	the	DET
iajs-3351	109	21	healthy	healthy	ADJ
iajs-3351	109	22	state	state	NOUN
iajs-3351	109	23	of	of	ADP
iajs-3351	109	24	these	these	DET
iajs-3351	109	25	patients	patient	NOUN
iajs-3351	109	26	is	be	AUX
iajs-3351	109	27	complex	complex	ADJ
iajs-3351	109	28	.	.	PUNCT
iajs-3351	110	1	therefore	therefore	ADV
iajs-3351	110	2	,	,	PUNCT
iajs-3351	110	3	the	the	DET
iajs-3351	110	4	side	side	NOUN
iajs-3351	110	5	effects	effect	NOUN
iajs-3351	110	6	of	of	ADP
iajs-3351	110	7	the	the	DET
iajs-3351	110	8	medications	medication	NOUN
iajs-3351	110	9	required	require	VERB
iajs-3351	110	10	to	to	PART
iajs-3351	110	11	be	be	AUX
iajs-3351	110	12	taken	take	VERB
iajs-3351	110	13	during	during	ADP
iajs-3351	110	14	the	the	DET
iajs-3351	110	15	treatment	treatment	NOUN
iajs-3351	110	16	should	should	AUX
iajs-3351	110	17	be	be	AUX
iajs-3351	110	18	addressed	address	VERB
iajs-3351	110	19	[	[	X
iajs-3351	110	20	25	25	NUM
iajs-3351	110	21	]	]	PUNCT
iajs-3351	110	22	.	.	PUNCT
iajs-3351	111	1	in	in	ADP
iajs-3351	111	2	the	the	DET
iajs-3351	111	3	current	current	ADJ
iajs-3351	111	4	study	study	NOUN
iajs-3351	111	5	,	,	PUNCT
iajs-3351	111	6	the	the	DET
iajs-3351	111	7	levels	level	NOUN
iajs-3351	111	8	of	of	ADP
iajs-3351	111	9	ace2	ace2	PROPN
iajs-3351	111	10	were	be	AUX
iajs-3351	111	11	found	find	VERB
iajs-3351	111	12	to	to	PART
iajs-3351	111	13	decrease	decrease	VERB
iajs-3351	111	14	in	in	ADP
iajs-3351	111	15	pcos	pcos	NOUN
iajs-3351	111	16	patients	patient	NOUN
iajs-3351	111	17	when	when	SCONJ
iajs-3351	111	18	compared	compare	VERB
iajs-3351	111	19	with	with	ADP
iajs-3351	111	20	control	control	NOUN
iajs-3351	111	21	groups	group	NOUN
iajs-3351	111	22	.	.	PUNCT
iajs-3351	112	1	additionally	additionally	ADV
iajs-3351	112	2	,	,	PUNCT
iajs-3351	112	3	it	it	PRON
iajs-3351	112	4	has	have	AUX
iajs-3351	112	5	been	be	AUX
iajs-3351	112	6	observed	observe	VERB
iajs-3351	112	7	that	that	SCONJ
iajs-3351	112	8	the	the	DET
iajs-3351	112	9	ace2	ace2	PROPN
iajs-3351	112	10	concentration	concentration	NOUN
iajs-3351	112	11	was	be	AUX
iajs-3351	112	12	lower	low	ADJ
iajs-3351	112	13	in	in	ADP
iajs-3351	112	14	obese	obese	ADJ
iajs-3351	112	15	pcos	pcos	NOUN
iajs-3351	112	16	women	woman	NOUN
iajs-3351	112	17	tainted	taint	VERB
iajs-3351	112	18	with	with	ADP
iajs-3351	112	19	covid-19	covid-19	PROPN
iajs-3351	112	20	than	than	ADP
iajs-3351	112	21	in	in	ADP
iajs-3351	112	22	lean	lean	ADJ
iajs-3351	112	23	patient	patient	ADJ
iajs-3351	112	24	women	woman	NOUN
iajs-3351	112	25	noninfected	noninfecte	VERB
iajs-3351	112	26	with	with	ADP
iajs-3351	112	27	covid-19	covid-19	PROPN
iajs-3351	112	28	.	.	PUNCT
iajs-3351	113	1	the	the	DET
iajs-3351	113	2	result	result	NOUN
iajs-3351	113	3	was	be	AUX
iajs-3351	113	4	in	in	ADP
iajs-3351	113	5	agreement	agreement	NOUN
iajs-3351	113	6	with	with	ADP
iajs-3351	113	7	previous	previous	ADJ
iajs-3351	113	8	study	study	NOUN
iajs-3351	113	9	[	[	X
iajs-3351	113	10	26	26	NUM
iajs-3351	113	11	]	]	X
iajs-3351	113	12	,	,	PUNCT
iajs-3351	113	13	who	who	PRON
iajs-3351	113	14	reported	report	VERB
iajs-3351	113	15	that	that	SCONJ
iajs-3351	113	16	serum	serum	NOUN
iajs-3351	113	17	ace2	ace2	PROPN
iajs-3351	113	18	levels	level	NOUN
iajs-3351	113	19	were	be	AUX
iajs-3351	113	20	lower	low	ADJ
iajs-3351	113	21	in	in	ADP
iajs-3351	113	22	women	woman	NOUN
iajs-3351	113	23	with	with	ADP
iajs-3351	113	24	pcos	pco	NOUN
iajs-3351	113	25	compared	compare	VERB
iajs-3351	113	26	with	with	ADP
iajs-3351	113	27	control	control	NOUN
iajs-3351	113	28	groups	group	NOUN
iajs-3351	113	29	.	.	PUNCT
iajs-3351	114	1	the	the	DET
iajs-3351	114	2	over	over	ADV
iajs-3351	114	3	-	-	PUNCT
iajs-3351	114	4	activated	activate	VERB
iajs-3351	114	5	ras	ras	NOUN
iajs-3351	114	6	prompts	prompt	NOUN
iajs-3351	114	7	high	high	ADJ
iajs-3351	114	8	levels	level	NOUN
iajs-3351	114	9	of	of	ADP
iajs-3351	114	10	ang-2	ang-2	ADJ
iajs-3351	114	11	.	.	PUNCT
iajs-3351	115	1	the	the	DET
iajs-3351	115	2	abundance	abundance	NOUN
iajs-3351	115	3	of	of	ADP
iajs-3351	115	4	ang-2	ang-2	PUNCT
iajs-3351	115	5	levels	level	NOUN
iajs-3351	115	6	separates	separate	VERB
iajs-3351	115	7	ace2	ace2	NOUN
iajs-3351	115	8	from	from	ADP
iajs-3351	115	9	the	the	DET
iajs-3351	115	10	angiotensin	angiotensin	NOUN
iajs-3351	115	11	receptor-1	receptor-1	NUM
iajs-3351	115	12	(	(	PUNCT
iajs-3351	115	13	at1r	at1r	NOUN
iajs-3351	115	14	)	)	PUNCT
iajs-3351	115	15	.	.	PUNCT
iajs-3351	116	1	these	these	PRON
iajs-3351	116	2	led	lead	VERB
iajs-3351	116	3	to	to	PART
iajs-3351	116	4	decreased	decrease	VERB
iajs-3351	116	5	ace2	ace2	PROPN
iajs-3351	116	6	levels	level	NOUN
iajs-3351	116	7	,	,	PUNCT
iajs-3351	116	8	which	which	PRON
iajs-3351	116	9	suggests	suggest	VERB
iajs-3351	116	10	that	that	SCONJ
iajs-3351	116	11	pcos	pcos	PROPN
iajs-3351	116	12	women	woman	NOUN
iajs-3351	116	13	are	be	AUX
iajs-3351	116	14	at	at	ADP
iajs-3351	116	15	risk	risk	NOUN
iajs-3351	116	16	for	for	ADP
iajs-3351	116	17	the	the	DET
iajs-3351	116	18	development	development	NOUN
iajs-3351	116	19	of	of	ADP
iajs-3351	116	20	hypertension	hypertension	NOUN
iajs-3351	116	21	.	.	PUNCT
iajs-3351	117	1	in	in	ADP
iajs-3351	117	2	the	the	DET
iajs-3351	117	3	current	current	ADJ
iajs-3351	117	4	study	study	NOUN
iajs-3351	117	5	,	,	PUNCT
iajs-3351	117	6	it	it	PRON
iajs-3351	117	7	has	have	AUX
iajs-3351	117	8	been	be	AUX
iajs-3351	117	9	observed	observe	VERB
iajs-3351	117	10	that	that	SCONJ
iajs-3351	117	11	glutathione	glutathione	NOUN
iajs-3351	117	12	transferase	transferase	NOUN
iajs-3351	117	13	activity	activity	NOUN
iajs-3351	117	14	decreased	decrease	VERB
iajs-3351	117	15	in	in	ADP
iajs-3351	117	16	women	woman	NOUN
iajs-3351	117	17	suffering	suffer	VERB
iajs-3351	117	18	from	from	ADP
iajs-3351	117	19	the	the	DET
iajs-3351	117	20	syndrome	syndrome	NOUN
iajs-3351	117	21	compared	compare	VERB
iajs-3351	117	22	with	with	ADP
iajs-3351	117	23	control	control	NOUN
iajs-3351	117	24	groups	group	NOUN
iajs-3351	117	25	.	.	PUNCT
iajs-3351	118	1	these	these	DET
iajs-3351	118	2	results	result	NOUN
iajs-3351	118	3	agree	agree	VERB
iajs-3351	118	4	with	with	ADP
iajs-3351	118	5	sun	sun	PROPN
iajs-3351	118	6	et	et	PROPN
iajs-3351	118	7	al	al	PROPN
iajs-3351	118	8	.	.	PUNCT
iajs-3351	119	1	[	[	X
iajs-3351	119	2	27	27	NUM
iajs-3351	119	3	]	]	PUNCT
iajs-3351	119	4	.	.	PUNCT
iajs-3351	120	1	it	it	PRON
iajs-3351	120	2	has	have	AUX
iajs-3351	120	3	been	be	AUX
iajs-3351	120	4	observed	observe	VERB
iajs-3351	120	5	that	that	SCONJ
iajs-3351	120	6	the	the	DET
iajs-3351	120	7	action	action	NOUN
iajs-3351	120	8	of	of	ADP
iajs-3351	120	9	compound	compound	NOUN
iajs-3351	120	10	gst	gst	PROPN
iajs-3351	120	11	decreased	decrease	VERB
iajs-3351	120	12	in	in	ADP
iajs-3351	120	13	obese	obese	ADJ
iajs-3351	120	14	ladies	lady	NOUN
iajs-3351	120	15	with	with	ADP
iajs-3351	120	16	pcos	pcos	PROPN
iajs-3351	120	17	and	and	CCONJ
iajs-3351	120	18	infected	infect	VERB
iajs-3351	120	19	with	with	ADP
iajs-3351	120	20	covid-19	covid-19	PROPN
iajs-3351	120	21	more	more	ADJ
iajs-3351	120	22	than	than	ADP
iajs-3351	120	23	the	the	DET
iajs-3351	120	24	control	control	NOUN
iajs-3351	120	25	group	group	NOUN
iajs-3351	120	26	.	.	PUNCT
iajs-3351	121	1	the	the	DET
iajs-3351	121	2	reduced	reduce	VERB
iajs-3351	121	3	mobility	mobility	NOUN
iajs-3351	121	4	of	of	ADP
iajs-3351	121	5	this	this	DET
iajs-3351	121	6	chemical	chemical	ADJ
iajs-3351	121	7	reinforcement	reinforcement	NOUN
iajs-3351	121	8	in	in	ADP
iajs-3351	121	9	pcos	pcos	PROPN
iajs-3351	121	10	patients	patient	NOUN
iajs-3351	121	11	may	may	AUX
iajs-3351	121	12	be	be	AUX
iajs-3351	121	13	due	due	ADJ
iajs-3351	121	14	to	to	ADP
iajs-3351	121	15	the	the	DET
iajs-3351	121	16	increased	increase	VERB
iajs-3351	121	17	production	production	NOUN
iajs-3351	121	18	of	of	ADP
iajs-3351	121	19	oxidative	oxidative	ADJ
iajs-3351	121	20	stress	stress	NOUN
iajs-3351	121	21	in	in	ADP
iajs-3351	121	22	pcos	pcos	NOUN
iajs-3351	121	23	patients	patient	NOUN
iajs-3351	121	24	with	with	ADP
iajs-3351	121	25	covid-19	covid-19	PROPN
iajs-3351	121	26	due	due	ADP
iajs-3351	121	27	to	to	ADP
iajs-3351	121	28	the	the	DET
iajs-3351	121	29	increased	increase	VERB
iajs-3351	121	30	levels	level	NOUN
iajs-3351	121	31	of	of	ADP
iajs-3351	121	32	body	body	NOUN
iajs-3351	121	33	fat	fat	ADJ
iajs-3351	121	34	,	,	PUNCT
iajs-3351	121	35	increasing	increase	VERB
iajs-3351	121	36	the	the	DET
iajs-3351	121	37	risk	risk	NOUN
iajs-3351	121	38	of	of	ADP
iajs-3351	121	39	cardiovascular	cardiovascular	ADJ
iajs-3351	121	40	disease	disease	NOUN
iajs-3351	121	41	and	and	CCONJ
iajs-3351	121	42	heart	heart	NOUN
iajs-3351	121	43	failure	failure	NOUN
iajs-3351	121	44	.	.	PUNCT
iajs-3351	122	1	these	these	DET
iajs-3351	122	2	results	result	NOUN
iajs-3351	122	3	agree	agree	VERB
iajs-3351	122	4	with	with	ADP
iajs-3351	122	5	moti	moti	PROPN
iajs-3351	122	6	et	et	PROPN
iajs-3351	122	7	al	al	PROPN
iajs-3351	122	8	.	.	PUNCT
iajs-3351	123	1	[	[	X
iajs-3351	123	2	28	28	NUM
iajs-3351	123	3	]	]	PUNCT
iajs-3351	123	4	.	.	PUNCT
iajs-3351	124	1	who	who	PRON
iajs-3351	124	2	suggested	suggest	VERB
iajs-3351	124	3	the	the	DET
iajs-3351	124	4	increase	increase	NOUN
iajs-3351	124	5	in	in	ADP
iajs-3351	124	6	oxidized	oxidize	VERB
iajs-3351	124	7	stress	stress	NOUN
iajs-3351	124	8	and	and	CCONJ
iajs-3351	124	9	the	the	DET
iajs-3351	124	10	decrease	decrease	NOUN
iajs-3351	124	11	in	in	ADP
iajs-3351	124	12	the	the	DET
iajs-3351	124	13	degree	degree	NOUN
iajs-3351	124	14	of	of	ADP
iajs-3351	124	15	prevention	prevention	NOUN
iajs-3351	124	16	agents	agent	NOUN
iajs-3351	124	17	in	in	ADP
iajs-3351	124	18	patient	patient	ADJ
iajs-3351	124	19	ladies	lady	NOUN
iajs-3351	124	20	when	when	SCONJ
iajs-3351	124	21	compared	compare	VERB
iajs-3351	124	22	with	with	ADP
iajs-3351	124	23	control	control	NOUN
iajs-3351	124	24	groups	group	NOUN
iajs-3351	124	25	.	.	PUNCT
iajs-3351	125	1	the	the	DET
iajs-3351	125	2	current	current	ADJ
iajs-3351	125	3	study	study	NOUN
iajs-3351	125	4	has	have	AUX
iajs-3351	125	5	shown	show	VERB
iajs-3351	125	6	a	a	DET
iajs-3351	125	7	significant	significant	ADJ
iajs-3351	125	8	increase	increase	NOUN
iajs-3351	125	9	in	in	ADP
iajs-3351	125	10	the	the	DET
iajs-3351	125	11	d	d	ADJ
iajs-3351	125	12	-	-	PUNCT
iajs-3351	125	13	dimer	dimer	ADJ
iajs-3351	125	14	values	value	NOUN
iajs-3351	125	15	of	of	ADP
iajs-3351	125	16	patients	patient	NOUN
iajs-3351	125	17	compared	compare	VERB
iajs-3351	125	18	with	with	ADP
iajs-3351	125	19	control	control	NOUN
iajs-3351	125	20	groups	group	NOUN
iajs-3351	125	21	.	.	PUNCT
iajs-3351	126	1	the	the	DET
iajs-3351	126	2	result	result	NOUN
iajs-3351	126	3	is	be	AUX
iajs-3351	126	4	in	in	ADP
iajs-3351	126	5	agreement	agreement	NOUN
iajs-3351	126	6	with	with	ADP
iajs-3351	126	7	earlier	early	ADJ
iajs-3351	126	8	study	study	NOUN
iajs-3351	126	9	[	[	X
iajs-3351	126	10	29	29	NUM
iajs-3351	126	11	]	]	PUNCT
iajs-3351	126	12	.	.	PUNCT
iajs-3351	127	1	an	an	DET
iajs-3351	127	2	increase	increase	NOUN
iajs-3351	127	3	in	in	ADP
iajs-3351	127	4	the	the	DET
iajs-3351	127	5	levels	level	NOUN
iajs-3351	127	6	of	of	ADP
iajs-3351	127	7	d	d	NOUN
iajs-3351	127	8	-	-	NOUN
iajs-3351	127	9	dimer	dimer	NOUN
iajs-3351	127	10	in	in	ADP
iajs-3351	127	11	women	woman	NOUN
iajs-3351	127	12	who	who	PRON
iajs-3351	127	13	had	have	VERB
iajs-3351	127	14	strong	strong	ADJ
iajs-3351	127	15	coagulation	coagulation	NOUN
iajs-3351	127	16	formation	formation	NOUN
iajs-3351	127	17	is	be	AUX
iajs-3351	127	18	proof	proof	NOUN
iajs-3351	127	19	that	that	SCONJ
iajs-3351	127	20	an	an	DET
iajs-3351	127	21	increase	increase	NOUN
iajs-3351	127	22	in	in	ADP
iajs-3351	127	23	d	d	NOUN
iajs-3351	127	24	-	-	PUNCT
iajs-3351	127	25	dimer	dimer	NOUN
iajs-3351	127	26	can	can	AUX
iajs-3351	127	27	be	be	AUX
iajs-3351	127	28	utilized	utilize	VERB
iajs-3351	127	29	as	as	ADP
iajs-3351	127	30	an	an	DET
iajs-3351	127	31	indicator	indicator	NOUN
iajs-3351	127	32	factor	factor	NOUN
iajs-3351	127	33	for	for	ADP
iajs-3351	127	34	cardiac	cardiac	ADJ
iajs-3351	127	35	disease	disease	NOUN
iajs-3351	127	36	in	in	ADP
iajs-3351	127	37	patients	patient	NOUN
iajs-3351	127	38	suffering	suffer	VERB
iajs-3351	127	39	from	from	ADP
iajs-3351	127	40	pco	pco	NOUN
iajs-3351	127	41	syndrome	syndrome	NOUN
iajs-3351	127	42	.	.	PUNCT
iajs-3351	128	1	also	also	ADV
iajs-3351	128	2	,	,	PUNCT
iajs-3351	128	3	this	this	DET
iajs-3351	128	4	result	result	NOUN
iajs-3351	128	5	agrees	agree	VERB
iajs-3351	128	6	with	with	ADP
iajs-3351	128	7	lehmann	lehmann	PROPN
iajs-3351	128	8	et	et	PROPN
iajs-3351	128	9	al	al	PROPN
iajs-3351	128	10	.	.	PROPN
iajs-3351	128	11	,	,	PUNCT
iajs-3351	128	12	study	study	VERB
iajs-3351	128	13	[	[	X
iajs-3351	128	14	30	30	NUM
iajs-3351	128	15	]	]	PUNCT
iajs-3351	128	16	.	.	PUNCT
iajs-3351	129	1	a	a	DET
iajs-3351	129	2	current	current	ADJ
iajs-3351	129	3	study	study	NOUN
iajs-3351	129	4	found	find	VERB
iajs-3351	129	5	that	that	SCONJ
iajs-3351	129	6	insulin	insulin	NOUN
iajs-3351	129	7	and	and	CCONJ
iajs-3351	129	8	homa	homa	PROPN
iajs-3351	129	9	ir	ir	PROPN
iajs-3351	129	10	increased	increase	VERB
iajs-3351	129	11	in	in	ADP
iajs-3351	129	12	obese	obese	ADJ
iajs-3351	129	13	women	woman	NOUN
iajs-3351	129	14	infected	infect	VERB
iajs-3351	129	15	with	with	ADP
iajs-3351	129	16	covid-19	covid-19	PROPN
iajs-3351	129	17	when	when	SCONJ
iajs-3351	129	18	compared	compare	VERB
iajs-3351	129	19	with	with	ADP
iajs-3351	129	20	lean	lean	ADJ
iajs-3351	129	21	women	woman	NOUN
iajs-3351	129	22	without	without	ADP
iajs-3351	129	23	covid-19	covid-19	PROPN
iajs-3351	129	24	.	.	PUNCT
iajs-3351	130	1	the	the	DET
iajs-3351	130	2	result	result	NOUN
iajs-3351	130	3	agrees	agree	VERB
iajs-3351	130	4	with	with	ADP
iajs-3351	130	5	previous	previous	ADJ
iajs-3351	130	6	research	research	NOUN
iajs-3351	130	7	[	[	X
iajs-3351	130	8	31	31	NUM
iajs-3351	130	9	]	]	PUNCT
iajs-3351	130	10	,	,	PUNCT
iajs-3351	130	11	which	which	PRON
iajs-3351	130	12	found	find	VERB
iajs-3351	130	13	that	that	SCONJ
iajs-3351	130	14	both	both	PRON
iajs-3351	130	15	insulin	insulin	NOUN
iajs-3351	130	16	and	and	CCONJ
iajs-3351	130	17	homa	homa	PROPN
iajs-3351	130	18	ir	ir	PROPN
iajs-3351	130	19	levels	level	NOUN
iajs-3351	130	20	increase	increase	VERB
iajs-3351	130	21	in	in	ADP
iajs-3351	130	22	pcos	pcos	ADJ
iajs-3351	130	23	women	woman	NOUN
iajs-3351	130	24	with	with	ADP
iajs-3351	130	25	or	or	CCONJ
iajs-3351	130	26	without	without	ADP
iajs-3351	130	27	covid-19	covid-19	PROPN
iajs-3351	130	28	compared	compare	VERB
iajs-3351	130	29	with	with	ADP
iajs-3351	130	30	healthy	healthy	ADJ
iajs-3351	130	31	women	woman	NOUN
iajs-3351	130	32	and	and	CCONJ
iajs-3351	130	33	found	find	VERB
iajs-3351	130	34	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-3351	130	35	and	and	CCONJ
iajs-3351	130	36	ir	ir	PROPN
iajs-3351	130	37	are	be	AUX
iajs-3351	130	38	seen	see	VERB
iajs-3351	130	39	only	only	ADV
iajs-3351	130	40	in	in	ADP
iajs-3351	130	41	obese	obese	ADJ
iajs-3351	130	42	women	woman	NOUN
iajs-3351	130	43	with	with	ADP
iajs-3351	130	44	pcos	pco	NOUN
iajs-3351	130	45	infected	infect	VERB
iajs-3351	130	46	with	with	ADP
iajs-3351	130	47	covid-19	covid-19	PROPN
iajs-3351	130	48	.	.	PUNCT
iajs-3351	130	49	ihjpas	ihjpas	PROPN
iajs-3351	130	50	.	.	PUNCT
iajs-3351	131	1	37	37	NUM
iajs-3351	131	2	(	(	PUNCT
iajs-3351	131	3	3	3	NUM
iajs-3351	131	4	)	)	PUNCT
iajs-3351	131	5	2024	2024	NUM
iajs-3351	131	6	293	293	NUM
iajs-3351	131	7	5	5	NUM
iajs-3351	131	8	.	.	PUNCT
iajs-3351	131	9	conclusion	conclusion	NOUN
iajs-3351	131	10	in	in	ADP
iajs-3351	131	11	conclusion	conclusion	NOUN
iajs-3351	131	12	,	,	PUNCT
iajs-3351	131	13	this	this	DET
iajs-3351	131	14	study	study	NOUN
iajs-3351	131	15	presents	present	VERB
iajs-3351	131	16	various	various	ADJ
iajs-3351	131	17	mechanisms	mechanism	NOUN
iajs-3351	131	18	that	that	PRON
iajs-3351	131	19	may	may	AUX
iajs-3351	131	20	contribute	contribute	VERB
iajs-3351	131	21	to	to	PART
iajs-3351	131	22	explain	explain	VERB
iajs-3351	131	23	the	the	DET
iajs-3351	131	24	pathophysiology	pathophysiology	NOUN
iajs-3351	131	25	of	of	ADP
iajs-3351	131	26	obese	obese	ADJ
iajs-3351	131	27	women	woman	NOUN
iajs-3351	131	28	with	with	ADP
iajs-3351	131	29	pcos	pcos	PROPN
iajs-3351	131	30	and	and	CCONJ
iajs-3351	131	31	those	those	PRON
iajs-3351	131	32	infected	infect	VERB
iajs-3351	131	33	with	with	ADP
iajs-3351	131	34	covid-19	covid-19	PROPN
iajs-3351	131	35	,	,	PUNCT
iajs-3351	131	36	including	include	VERB
iajs-3351	131	37	ace	ace	NOUN
iajs-3351	131	38	2	2	NUM
iajs-3351	131	39	(	(	PUNCT
iajs-3351	131	40	viral	viral	ADJ
iajs-3351	131	41	portal	portal	NOUN
iajs-3351	131	42	)	)	PUNCT
iajs-3351	131	43	,	,	PUNCT
iajs-3351	131	44	endothelial	endothelial	ADJ
iajs-3351	131	45	dysfunction	dysfunction	NOUN
iajs-3351	131	46	,	,	PUNCT
iajs-3351	131	47	thrombophilia	thrombophilia	NOUN
iajs-3351	131	48	,	,	PUNCT
iajs-3351	131	49	and	and	CCONJ
iajs-3351	131	50	the	the	DET
iajs-3351	131	51	angiotensin	angiotensin	NOUN
iajs-3351	131	52	-	-	PUNCT
iajs-3351	131	53	aldosterone	aldosterone	NOUN
iajs-3351	131	54	renin	renin	ADJ
iajs-3351	131	55	system	system	NOUN
iajs-3351	131	56	.	.	PUNCT
iajs-3351	132	1	moreover	moreover	ADV
iajs-3351	132	2	,	,	PUNCT
iajs-3351	132	3	it	it	PRON
iajs-3351	132	4	appears	appear	VERB
iajs-3351	132	5	that	that	SCONJ
iajs-3351	132	6	the	the	DET
iajs-3351	132	7	coronavirus	coronavirus	NOUN
iajs-3351	132	8	works	work	VERB
iajs-3351	132	9	to	to	PART
iajs-3351	132	10	activate	activate	VERB
iajs-3351	132	11	d	d	ADJ
iajs-3351	132	12	-	-	ADJ
iajs-3351	132	13	dimer	dimer	ADJ
iajs-3351	132	14	formation	formation	NOUN
iajs-3351	132	15	and	and	CCONJ
iajs-3351	132	16	ir	ir	NOUN
iajs-3351	132	17	.	.	PROPN
iajs-3351	133	1	in	in	ADP
iajs-3351	133	2	parallel	parallel	NOUN
iajs-3351	133	3	,	,	PUNCT
iajs-3351	133	4	we	we	PRON
iajs-3351	133	5	associate	associate	VERB
iajs-3351	133	6	ir	ir	PROPN
iajs-3351	133	7	with	with	ADP
iajs-3351	133	8	covid-19	covid-19	PROPN
iajs-3351	133	9	infection	infection	NOUN
iajs-3351	133	10	in	in	ADP
iajs-3351	133	11	obese	obese	ADJ
iajs-3351	133	12	pcos	pcos	NOUN
iajs-3351	133	13	patients	patient	NOUN
iajs-3351	133	14	as	as	ADP
iajs-3351	133	15	the	the	DET
iajs-3351	133	16	severity	severity	NOUN
iajs-3351	133	17	of	of	ADP
iajs-3351	133	18	the	the	DET
iajs-3351	133	19	disease	disease	NOUN
iajs-3351	133	20	increases	increase	VERB
iajs-3351	133	21	.	.	PUNCT
iajs-3351	134	1	in	in	ADP
iajs-3351	134	2	the	the	DET
iajs-3351	134	3	end	end	NOUN
iajs-3351	134	4	,	,	PUNCT
iajs-3351	134	5	the	the	DET
iajs-3351	134	6	potential	potential	ADJ
iajs-3351	134	7	effect	effect	NOUN
iajs-3351	134	8	can	can	AUX
iajs-3351	134	9	be	be	AUX
iajs-3351	134	10	used	use	VERB
iajs-3351	134	11	to	to	PART
iajs-3351	134	12	treat	treat	VERB
iajs-3351	134	13	ir	ir	PROPN
iajs-3351	134	14	and	and	CCONJ
iajs-3351	134	15	obesity	obesity	NOUN
iajs-3351	134	16	in	in	ADP
iajs-3351	134	17	pcos	pcos	PROPN
iajs-3351	134	18	patients	patient	NOUN
iajs-3351	134	19	with	with	ADP
iajs-3351	134	20	corona	corona	NOUN
iajs-3351	134	21	infection	infection	NOUN
iajs-3351	134	22	.	.	PUNCT
iajs-3351	135	1	acknowledgment	acknowledgment	NOUN
iajs-3351	135	2	the	the	DET
iajs-3351	135	3	authors	author	NOUN
iajs-3351	135	4	express	express	VERB
iajs-3351	135	5	their	their	PRON
iajs-3351	135	6	gratitude	gratitude	NOUN
iajs-3351	135	7	to	to	ADP
iajs-3351	135	8	the	the	DET
iajs-3351	135	9	kamal	kamal	PROPN
iajs-3351	135	10	al	al	PROPN
iajs-3351	135	11	samarai	samarai	PROPN
iajs-3351	135	12	hospital	hospital	NOUN
iajs-3351	135	13	staff	staff	NOUN
iajs-3351	135	14	in	in	ADP
iajs-3351	135	15	bagdad	bagdad	PROPN
iajs-3351	135	16	for	for	ADP
iajs-3351	135	17	their	their	PRON
iajs-3351	135	18	help	help	NOUN
iajs-3351	135	19	in	in	ADP
iajs-3351	135	20	gathering	gather	VERB
iajs-3351	135	21	and	and	CCONJ
iajs-3351	135	22	evaluating	evaluate	VERB
iajs-3351	135	23	samples	sample	NOUN
iajs-3351	135	24	and	and	CCONJ
iajs-3351	135	25	for	for	ADP
iajs-3351	135	26	their	their	PRON
iajs-3351	135	27	facilities	facility	NOUN
iajs-3351	135	28	,	,	PUNCT
iajs-3351	135	29	which	which	PRON
iajs-3351	135	30	enabled	enable	VERB
iajs-3351	135	31	this	this	DET
iajs-3351	135	32	study	study	NOUN
iajs-3351	135	33	to	to	PART
iajs-3351	135	34	be	be	AUX
iajs-3351	135	35	accomplished	accomplish	VERB
iajs-3351	135	36	.	.	PUNCT
iajs-3351	136	1	conflict	conflict	NOUN
iajs-3351	136	2	of	of	ADP
iajs-3351	136	3	interest	interest	NOUN
iajs-3351	136	4	there	there	PRON
iajs-3351	136	5	are	be	VERB
iajs-3351	136	6	no	no	DET
iajs-3351	136	7	conflicts	conflict	NOUN
iajs-3351	136	8	of	of	ADP
iajs-3351	136	9	interest	interest	NOUN
iajs-3351	136	10	.	.	PUNCT
iajs-3351	137	1	funding	funding	NOUN
iajs-3351	137	2	there	there	PRON
iajs-3351	137	3	is	be	VERB
iajs-3351	137	4	no	no	DET
iajs-3351	137	5	funding	funding	NOUN
iajs-3351	137	6	for	for	ADP
iajs-3351	137	7	the	the	DET
iajs-3351	137	8	article	article	NOUN
iajs-3351	137	9	ethical	ethical	ADJ
iajs-3351	137	10	clearance	clearance	NOUN
iajs-3351	137	11	the	the	DET
iajs-3351	137	12	scientific	scientific	ADJ
iajs-3351	137	13	committee	committee	NOUN
iajs-3351	137	14	at	at	ADP
iajs-3351	137	15	the	the	DET
iajs-3351	137	16	al	al	PROPN
iajs-3351	137	17	-	-	PUNCT
iajs-3351	137	18	nahrain	nahrain	PROPN
iajs-3351	137	19	university/	university/	NUM
iajs-3351	137	20	college	college	NOUN
iajs-3351	137	21	of	of	ADP
iajs-3351	137	22	science	science	NOUN
iajs-3351	137	23	has	have	AUX
iajs-3351	137	24	approved	approve	VERB
iajs-3351	137	25	this	this	DET
iajs-3351	137	26	work	work	NOUN
iajs-3351	137	27	.	.	PUNCT
iajs-3351	138	1	references	reference	NOUN
iajs-3351	138	2	1	1	NUM
iajs-3351	138	3	.	.	X
iajs-3351	138	4	ali	ali	PROPN
iajs-3351	138	5	,	,	PUNCT
iajs-3351	138	6	s.e	s.e	PROPN
iajs-3351	138	7	.	.	PROPN
iajs-3351	138	8	;	;	PUNCT
iajs-3351	138	9	khaleel	khaleel	PROPN
iajs-3351	138	10	,	,	PUNCT
iajs-3351	138	11	f.m	f.m	PROPN
iajs-3351	138	12	.	.	PROPN
iajs-3351	138	13	;	;	PUNCT
iajs-3351	138	14	ali	ali	PROPN
iajs-3351	138	15	,	,	PUNCT
iajs-3351	138	16	f.e	f.e	PROPN
iajs-3351	138	17	.	.	PROPN
iajs-3351	139	1	a	a	DET
iajs-3351	139	2	study	study	NOUN
iajs-3351	139	3	of	of	ADP
iajs-3351	139	4	apelin-36	apelin-36	PROPN
iajs-3351	139	5	and	and	CCONJ
iajs-3351	139	6	gst	gst	NOUN
iajs-3351	139	7	levels	level	NOUN
iajs-3351	139	8	with	with	ADP
iajs-3351	139	9	their	their	PRON
iajs-3351	139	10	relationship	relationship	NOUN
iajs-3351	139	11	to	to	ADP
iajs-3351	139	12	lipid	lipid	NOUN
iajs-3351	139	13	and	and	CCONJ
iajs-3351	139	14	other	other	ADJ
iajs-3351	139	15	biochemical	biochemical	ADJ
iajs-3351	139	16	parameters	parameter	NOUN
iajs-3351	139	17	in	in	ADP
iajs-3351	139	18	the	the	DET
iajs-3351	139	19	prediction	prediction	NOUN
iajs-3351	139	20	of	of	ADP
iajs-3351	139	21	heart	heart	NOUN
iajs-3351	139	22	diseases	disease	NOUN
iajs-3351	139	23	in	in	ADP
iajs-3351	139	24	pcos	pcos	ADJ
iajs-3351	139	25	women	woman	NOUN
iajs-3351	139	26	patients	patient	NOUN
iajs-3351	139	27	.	.	PUNCT
iajs-3351	140	1	baghdad	baghdad	PROPN
iajs-3351	140	2	sci	sci	PROPN
iajs-3351	140	3	.	.	PUNCT
iajs-3351	141	1	j	j	PROPN
iajs-3351	141	2	2020	2020	NUM
iajs-3351	141	3	,	,	PUNCT
iajs-3351	141	4	17(3	17(3	NUM
iajs-3351	141	5	)	)	PUNCT
iajs-3351	141	6	,	,	PUNCT
iajs-3351	141	7	0924	0924	NUM
iajs-3351	141	8	.	.	PUNCT
iajs-3351	142	1	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).0924	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).0924	NOUN
iajs-3351	142	2	.	.	NOUN
iajs-3351	142	3	2	2	NUM
iajs-3351	142	4	.	.	X
iajs-3351	142	5	ali	ali	PROPN
iajs-3351	142	6	,	,	PUNCT
iajs-3351	142	7	l.	l.	PROPN
iajs-3351	142	8	;	;	PUNCT
iajs-3351	142	9	khaleel	khaleel	PROPN
iajs-3351	142	10	,	,	PUNCT
iajs-3351	142	11	f.m	f.m	PROPN
iajs-3351	142	12	.	.	PROPN
iajs-3351	142	13	;	;	PUNCT
iajs-3351	142	14	ali	ali	PROPN
iajs-3351	142	15	,	,	PUNCT
iajs-3351	142	16	f.e	f.e	PROPN
iajs-3351	142	17	.	.	PROPN
iajs-3351	142	18	role	role	NOUN
iajs-3351	142	19	of	of	ADP
iajs-3351	142	20	apelin-13	apelin-13	PROPN
iajs-3351	142	21	and	and	CCONJ
iajs-3351	142	22	its	its	PRON
iajs-3351	142	23	relationship	relationship	NOUN
iajs-3351	142	24	with	with	ADP
iajs-3351	142	25	hormones	hormone	NOUN
iajs-3351	142	26	levels	level	NOUN
iajs-3351	142	27	and	and	CCONJ
iajs-3351	142	28	other	other	ADJ
iajs-3351	142	29	parameters	parameter	NOUN
iajs-3351	142	30	in	in	ADP
iajs-3351	142	31	iraqi	iraqi	ADJ
iajs-3351	142	32	polycystic	polycystic	ADJ
iajs-3351	142	33	ovary	ovary	ADJ
iajs-3351	142	34	syndrome	syndrome	NOUN
iajs-3351	142	35	patients	patient	NOUN
iajs-3351	142	36	.	.	PUNCT
iajs-3351	143	1	ann	ann	PROPN
iajs-3351	143	2	.	.	PROPN
iajs-3351	143	3	rom	rom	PROPN
iajs-3351	143	4	.	.	PUNCT
iajs-3351	143	5	soc	soc	PROPN
iajs-3351	143	6	.	.	PUNCT
iajs-3351	144	1	cell	cell	NOUN
iajs-3351	144	2	biol	biol	PROPN
iajs-3351	144	3	2021	2021	NUM
iajs-3351	144	4	,	,	PUNCT
iajs-3351	144	5	25(6	25(6	NUM
iajs-3351	144	6	)	)	PUNCT
iajs-3351	144	7	,	,	PUNCT
iajs-3351	144	8	8018	8018	NUM
iajs-3351	144	9	-	-	SYM
iajs-3351	144	10	24	24	NUM
iajs-3351	144	11	.	.	PUNCT
iajs-3351	145	1	http://annalsofrscb.ro/index.php/journal/article/view/6994	http://annalsofrscb.ro/index.php/journal/article/view/6994	X
iajs-3351	145	2	.	.	PUNCT
iajs-3351	146	1	3	3	X
iajs-3351	146	2	.	.	X
iajs-3351	146	3	ali	ali	PROPN
iajs-3351	146	4	,	,	PUNCT
iajs-3351	146	5	s.e	s.e	PROPN
iajs-3351	146	6	.	.	PROPN
iajs-3351	146	7	;	;	PUNCT
iajs-3351	146	8	khaleel	khaleel	PROPN
iajs-3351	146	9	,	,	PUNCT
iajs-3351	146	10	f.m	f.m	PROPN
iajs-3351	146	11	.	.	PROPN
iajs-3351	146	12	;	;	PUNCT
iajs-3351	146	13	ali	ali	PROPN
iajs-3351	146	14	,	,	PUNCT
iajs-3351	146	15	f.e	f.e	PROPN
iajs-3351	146	16	.	.	PROPN
iajs-3351	146	17	estimation	estimation	NOUN
iajs-3351	146	18	of	of	ADP
iajs-3351	146	19	renin	renin	ADJ
iajs-3351	146	20	and	and	CCONJ
iajs-3351	146	21	d	d	NOUN
iajs-3351	146	22	-	-	PUNCT
iajs-3351	146	23	dimer	dimer	ADJ
iajs-3351	146	24	levels	level	NOUN
iajs-3351	146	25	in	in	ADP
iajs-3351	146	26	women	woman	NOUN
iajs-3351	146	27	with	with	ADP
iajs-3351	146	28	polycystic	polycystic	ADJ
iajs-3351	146	29	ovary	ovary	ADJ
iajs-3351	146	30	disease	disease	NOUN
iajs-3351	146	31	with	with	ADP
iajs-3351	146	32	or	or	CCONJ
iajs-3351	146	33	without	without	ADP
iajs-3351	146	34	coronavirus	coronavirus	NOUN
iajs-3351	146	35	infection	infection	NOUN
iajs-3351	146	36	.	.	PUNCT
iajs-3351	147	1	bj	bj	NOUN
iajs-3351	147	2	-	-	PUNCT
iajs-3351	147	3	babs	babs	NOUN
iajs-3351	147	4	2022	2022	NUM
iajs-3351	147	5	,	,	PUNCT
iajs-3351	147	6	3(4	3(4	NUM
iajs-3351	147	7	)	)	PUNCT
iajs-3351	147	8	,	,	PUNCT
iajs-3351	147	9	286	286	NUM
iajs-3351	147	10	-	-	SYM
iajs-3351	147	11	98	98	NUM
iajs-3351	147	12	.	.	PUNCT
iajs-3351	148	1	https://doi.org/10.47419/	https://doi.org/10.47419/	PROPN
iajs-3351	148	2	bjbabs.v3i04.151	bjbabs.v3i04.151	NOUN
iajs-3351	148	3	.	.	PROPN
iajs-3351	149	1	4	4	NUM
iajs-3351	149	2	.	.	X
iajs-3351	149	3	ali	ali	PROPN
iajs-3351	149	4	,	,	PUNCT
iajs-3351	149	5	s.e	s.e	PROPN
iajs-3351	149	6	.	.	PROPN
iajs-3351	149	7	;	;	PUNCT
iajs-3351	149	8	khaleel	khaleel	PROPN
iajs-3351	149	9	,	,	PUNCT
iajs-3351	149	10	f.m	f.m	PROPN
iajs-3351	149	11	.	.	PROPN
iajs-3351	149	12	;	;	PUNCT
iajs-3351	149	13	ali	ali	PROPN
iajs-3351	149	14	,	,	PUNCT
iajs-3351	149	15	f.e	f.e	PROPN
iajs-3351	149	16	.	.	PROPN
iajs-3351	149	17	effect	effect	NOUN
iajs-3351	149	18	of	of	ADP
iajs-3351	149	19	apelin-36	apelin-36	PROPN
iajs-3351	149	20	on	on	ADP
iajs-3351	149	21	cardiovascular	cardiovascular	ADJ
iajs-3351	149	22	disease	disease	NOUN
iajs-3351	149	23	and	and	CCONJ
iajs-3351	149	24	its	its	PRON
iajs-3351	149	25	relationship	relationship	NOUN
iajs-3351	149	26	with	with	ADP
iajs-3351	149	27	other	other	ADJ
iajs-3351	149	28	parameters	parameter	NOUN
iajs-3351	149	29	in	in	ADP
iajs-3351	149	30	patients	patient	NOUN
iajs-3351	149	31	with	with	ADP
iajs-3351	149	32	pcos	pco	NOUN
iajs-3351	149	33	.	.	PUNCT
iajs-3351	150	1	cbej	cbej	ADJ
iajs-3351	150	2	.	.	PUNCT
iajs-3351	151	1	2020	2020	NUM
iajs-3351	151	2	.	.	PUNCT
iajs-3351	152	1	5	5	X
iajs-3351	152	2	.	.	X
iajs-3351	152	3	christ	christ	PROPN
iajs-3351	152	4	,	,	PUNCT
iajs-3351	152	5	j.p	j.p	PROPN
iajs-3351	152	6	.	.	PROPN
iajs-3351	152	7	;	;	PUNCT
iajs-3351	152	8	cedars	cedars	PROPN
iajs-3351	152	9	,	,	PUNCT
iajs-3351	152	10	m.i	m.i	PROPN
iajs-3351	152	11	.	.	PROPN
iajs-3351	152	12	current	current	ADJ
iajs-3351	152	13	guidelines	guideline	NOUN
iajs-3351	152	14	for	for	ADP
iajs-3351	152	15	diagnosing	diagnose	VERB
iajs-3351	152	16	pcos	pco	NOUN
iajs-3351	152	17	.	.	PUNCT
iajs-3351	153	1	diagnostics	diagnostic	NOUN
iajs-3351	153	2	2023	2023	NUM
iajs-3351	153	3	,	,	PUNCT
iajs-3351	153	4	13(6	13(6	NUM
iajs-3351	153	5	)	)	PUNCT
iajs-3351	153	6	,	,	PUNCT
iajs-3351	153	7	1113	1113	NUM
iajs-3351	153	8	.	.	PUNCT
iajs-3351	154	1	https://doi.org/10.3390/diagnostics13061113	https://doi.org/10.3390/diagnostics13061113	PROPN
iajs-3351	154	2	.	.	PUNCT
iajs-3351	155	1	6	6	NUM
iajs-3351	155	2	.	.	X
iajs-3351	155	3	ollila	ollila	PROPN
iajs-3351	155	4	,	,	PUNCT
iajs-3351	155	5	m.m	m.m	PROPN
iajs-3351	155	6	.	.	PROPN
iajs-3351	155	7	;	;	PUNCT
iajs-3351	155	8	arffman	arffman	NOUN
iajs-3351	155	9	,	,	PUNCT
iajs-3351	155	10	r.k	r.k	PROPN
iajs-3351	155	11	;	;	PUNCT
iajs-3351	155	12	korhonen	korhonen	PROPN
iajs-3351	155	13	,	,	PUNCT
iajs-3351	155	14	e.	e.	PROPN
iajs-3351	155	15	;	;	PUNCT
iajs-3351	155	16	morin	morin	PROPN
iajs-3351	155	17	-	-	PUNCT
iajs-3351	155	18	papunen	papunen	NOUN
iajs-3351	155	19	,	,	PUNCT
iajs-3351	155	20	l.	l.	PROPN
iajs-3351	155	21	;	;	PUNCT
iajs-3351	155	22	franks	frank	NOUN
iajs-3351	155	23	,	,	PUNCT
iajs-3351	155	24	s.	s.	PROPN
iajs-3351	155	25	;	;	PUNCT
iajs-3351	155	26	junttila	junttila	PROPN
iajs-3351	155	27	,	,	PUNCT
iajs-3351	155	28	j.	j.	PROPN
iajs-3351	155	29	;	;	PUNCT
iajs-3351	155	30	piltonen	piltonen	PROPN
iajs-3351	155	31	,	,	PUNCT
iajs-3351	155	32	t.t	t.t	PROPN
iajs-3351	155	33	.	.	PROPN
iajs-3351	155	34	women	woman	NOUN
iajs-3351	155	35	with	with	ADP
iajs-3351	155	36	pcos	pcos	PROPN
iajs-3351	155	37	have	have	VERB
iajs-3351	155	38	an	an	DET
iajs-3351	155	39	increased	increase	VERB
iajs-3351	155	40	risk	risk	NOUN
iajs-3351	155	41	for	for	ADP
iajs-3351	155	42	cardiovascular	cardiovascular	ADJ
iajs-3351	155	43	disease	disease	NOUN
iajs-3351	155	44	regardless	regardless	ADV
iajs-3351	155	45	of	of	ADP
iajs-3351	155	46	diagnostic	diagnostic	ADJ
iajs-3351	155	47	criteria	criterion	NOUN
iajs-3351	155	48	a	a	DET
iajs-3351	155	49	prospective	prospective	ADJ
iajs-3351	155	50	population	population	NOUN
iajs-3351	155	51	-	-	PUNCT
iajs-3351	155	52	based	base	VERB
iajs-3351	155	53	cohort	cohort	NOUN
iajs-3351	155	54	study	study	NOUN
iajs-3351	155	55	.	.	PUNCT
iajs-3351	156	1	eur	eur	PROPN
iajs-3351	156	2	.	.	PUNCT
iajs-3351	157	1	j.	j.	PROPN
iajs-3351	157	2	endocrinol	endocrinol	PROPN
iajs-3351	157	3	2023	2023	NUM
iajs-3351	157	4	,	,	PUNCT
iajs-3351	157	5	189(1),96	189(1),96	NUM
iajs-3351	157	6	-	-	SYM
iajs-3351	157	7	105	105	NUM
iajs-3351	157	8	.	.	PUNCT
iajs-3351	158	1	https://doi.org/10.1093/ejendo/lvad077	https://doi.org/10.1093/ejendo/lvad077	PROPN
iajs-3351	158	2	.	.	PUNCT
iajs-3351	159	1	7	7	X
iajs-3351	159	2	.	.	X
iajs-3351	159	3	barrea	barrea	PROPN
iajs-3351	159	4	,	,	PUNCT
iajs-3351	159	5	l.	l.	PROPN
iajs-3351	159	6	;	;	PUNCT
iajs-3351	159	7	verde	verde	PROPN
iajs-3351	159	8	,	,	PUNCT
iajs-3351	159	9	l.	l.	PROPN
iajs-3351	159	10	;	;	PUNCT
iajs-3351	159	11	camajani	camajani	PROPN
iajs-3351	159	12	,	,	PUNCT
iajs-3351	159	13	e.	e.	PROPN
iajs-3351	159	14	;	;	PUNCT
iajs-3351	159	15	cernea	cernea	PROPN
iajs-3351	159	16	,	,	PUNCT
iajs-3351	159	17	s.	s.	PROPN
iajs-3351	159	18	;	;	PUNCT
iajs-3351	159	19	frias	frias	PROPN
iajs-3351	159	20	-	-	PUNCT
iajs-3351	159	21	toral	toral	ADJ
iajs-3351	159	22	,	,	PUNCT
iajs-3351	159	23	e.	e.	PROPN
iajs-3351	159	24	;	;	PUNCT
iajs-3351	159	25	lamabadusuriya	lamabadusuriya	PROPN
iajs-3351	159	26	,	,	PUNCT
iajs-3351	159	27	d.	d.	PROPN
iajs-3351	159	28	;	;	PUNCT
iajs-3351	159	29	ceriani	ceriani	PROPN
iajs-3351	159	30	,	,	PUNCT
iajs-3351	159	31	f.	f.	PROPN
iajs-3351	159	32	;	;	PUNCT
iajs-3351	159	33	savastano	savastano	PROPN
iajs-3351	159	34	,	,	PUNCT
iajs-3351	159	35	s.	s.	PROPN
iajs-3351	159	36	;	;	PUNCT
iajs-3351	159	37	colao	colao	PROPN
iajs-3351	159	38	,	,	PUNCT
iajs-3351	159	39	a.	a.	NOUN
iajs-3351	159	40	;	;	PUNCT
iajs-3351	159	41	muscogiuri	muscogiuri	PROPN
iajs-3351	159	42	,	,	PUNCT
iajs-3351	159	43	g.	g.	PROPN
iajs-3351	159	44	ketogenic	ketogenic	PROPN
iajs-3351	159	45	diet	diet	PROPN
iajs-3351	159	46	as	as	ADP
iajs-3351	159	47	medical	medical	ADJ
iajs-3351	159	48	prescription	prescription	NOUN
iajs-3351	159	49	in	in	ADP
iajs-3351	159	50	women	woman	NOUN
iajs-3351	159	51	with	with	ADP
iajs-3351	159	52	polycystic	polycystic	ADJ
iajs-3351	159	53	ovary	ovary	ADJ
iajs-3351	159	54	syndrome	syndrome	NOUN
iajs-3351	159	55	(	(	PUNCT
iajs-3351	159	56	pcos	pcos	PROPN
iajs-3351	159	57	)	)	PUNCT
iajs-3351	159	58	.	.	PUNCT
iajs-3351	160	1	curr	curr	PROPN
iajs-3351	160	2	.	.	PUNCT
iajs-3351	161	1	nutr	nutr	PROPN
iajs-3351	161	2	.	.	PROPN
iajs-3351	161	3	rep	rep	PROPN
iajs-3351	161	4	.	.	PROPN
iajs-3351	161	5	2023	2023	NUM
iajs-3351	161	6	,	,	PUNCT
iajs-3351	161	7	12(1	12(1	NUM
iajs-3351	161	8	)	)	PUNCT
iajs-3351	161	9	,	,	PUNCT
iajs-3351	161	10	56	56	NUM
iajs-3351	161	11	-	-	SYM
iajs-3351	161	12	64	64	NUM
iajs-3351	161	13	.	.	PUNCT
iajs-3351	162	1	https://doi.org/10.1007/s13668-023-00456-1	https://doi.org/10.1007/s13668-023-00456-1	NUM
iajs-3351	162	2	.	.	PUNCT
iajs-3351	163	1	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).0924	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).0924	NOUN
iajs-3351	163	2	ihjpas	ihjpa	VERB
iajs-3351	163	3	.	.	PUNCT
iajs-3351	164	1	37	37	NUM
iajs-3351	164	2	(	(	PUNCT
iajs-3351	164	3	3	3	NUM
iajs-3351	164	4	)	)	PUNCT
iajs-3351	164	5	2024	2024	NUM
iajs-3351	164	6	294	294	NUM
iajs-3351	164	7	8	8	NUM
iajs-3351	164	8	.	.	PUNCT
iajs-3351	165	1	eng	eng	PROPN
iajs-3351	165	2	,	,	PUNCT
iajs-3351	165	3	p.c	p.c	PROPN
iajs-3351	165	4	.	.	PROPN
iajs-3351	165	5	;	;	PUNCT
iajs-3351	165	6	phylactou	phylactou	NOUN
iajs-3351	165	7	,	,	PUNCT
iajs-3351	165	8	m.	m.	NOUN
iajs-3351	165	9	;	;	PUNCT
iajs-3351	165	10	qayum	qayum	NOUN
iajs-3351	165	11	,	,	PUNCT
iajs-3351	165	12	a.	a.	NOUN
iajs-3351	165	13	;	;	PUNCT
iajs-3351	165	14	woods	woods	PROPN
iajs-3351	165	15	,	,	PUNCT
iajs-3351	165	16	c.	c.	PROPN
iajs-3351	165	17	;	;	PUNCT
iajs-3351	165	18	lee	lee	PROPN
iajs-3351	165	19	,	,	PUNCT
iajs-3351	165	20	h.	h.	PROPN
iajs-3351	165	21	;	;	PUNCT
iajs-3351	165	22	aziz	aziz	PROPN
iajs-3351	165	23	,	,	PUNCT
iajs-3351	165	24	s.	s.	PROPN
iajs-3351	165	25	;	;	PUNCT
iajs-3351	165	26	moore	moore	PROPN
iajs-3351	165	27	,	,	PUNCT
iajs-3351	165	28	b.	b.	PROPN
iajs-3351	165	29	;	;	PUNCT
iajs-3351	165	30	miras	miras	PROPN
iajs-3351	165	31	,	,	PUNCT
iajs-3351	165	32	a.d	a.d	PROPN
iajs-3351	165	33	.	.	PROPN
iajs-3351	165	34	;	;	PUNCT
iajs-3351	165	35	comninos	comnino	NOUN
iajs-3351	165	36	,	,	PUNCT
iajs-3351	165	37	a.n	a.n	PROPN
iajs-3351	165	38	.	.	PROPN
iajs-3351	165	39	;	;	PUNCT
iajs-3351	165	40	tan	tan	PROPN
iajs-3351	165	41	,	,	PUNCT
iajs-3351	165	42	t.	t.	PROPN
iajs-3351	165	43	;	;	PUNCT
iajs-3351	165	44	franks	frank	NOUN
iajs-3351	165	45	,	,	PUNCT
iajs-3351	165	46	s.	s.	PROPN
iajs-3351	165	47	obesity	obesity	NOUN
iajs-3351	165	48	-	-	PUNCT
iajs-3351	165	49	related	relate	VERB
iajs-3351	165	50	hypogonadism	hypogonadism	NOUN
iajs-3351	165	51	in	in	ADP
iajs-3351	165	52	women	woman	NOUN
iajs-3351	165	53	.	.	PUNCT
iajs-3351	166	1	endocr	endocr	PROPN
iajs-3351	166	2	rev	rev	PROPN
iajs-3351	166	3	2024	2024	NUM
iajs-3351	166	4	,	,	PUNCT
iajs-3351	166	5	45(2	45(2	NOUN
iajs-3351	166	6	)	)	PUNCT
iajs-3351	166	7	,	,	PUNCT
iajs-3351	166	8	171	171	NUM
iajs-3351	166	9	-	-	SYM
iajs-3351	166	10	89	89	NUM
iajs-3351	166	11	.	.	PUNCT
iajs-3351	167	1	https://doi.org/10.1210/endrev/bnad027	https://doi.org/10.1210/endrev/bnad027	NOUN
iajs-3351	167	2	.	.	PUNCT
iajs-3351	168	1	9	9	X
iajs-3351	168	2	.	.	X
iajs-3351	168	3	ibáñez	ibáñez	NOUN
iajs-3351	168	4	l	l	NOUN
iajs-3351	168	5	,	,	PUNCT
iajs-3351	168	6	de	de	PROPN
iajs-3351	168	7	zegher	zegher	PROPN
iajs-3351	168	8	f.	f.	PROPN
iajs-3351	168	9	adolescent	adolescent	PROPN
iajs-3351	168	10	pcos	pcos	PROPN
iajs-3351	168	11	:	:	PUNCT
iajs-3351	168	12	a	a	DET
iajs-3351	168	13	postpubertal	postpubertal	ADJ
iajs-3351	168	14	central	central	ADJ
iajs-3351	168	15	obesity	obesity	NOUN
iajs-3351	168	16	syndrome	syndrome	NOUN
iajs-3351	168	17	.	.	PUNCT
iajs-3351	169	1	trends	trend	NOUN
iajs-3351	169	2	mol	mol	ADP
iajs-3351	169	3	med	med	ADJ
iajs-3351	169	4	2023	2023	NUM
iajs-3351	169	5	,	,	PUNCT
iajs-3351	169	6	29(5	29(5	NUM
iajs-3351	169	7	)	)	PUNCT
iajs-3351	169	8	,	,	PUNCT
iajs-3351	169	9	354	354	NUM
iajs-3351	169	10	-	-	SYM
iajs-3351	169	11	63	63	NUM
iajs-3351	169	12	.	.	PUNCT
iajs-3351	169	13	https://doi.org/10.1016/j.molmed.2023.02.006	https://doi.org/10.1016/j.molmed.2023.02.006	NOUN
iajs-3351	169	14	.	.	PUNCT
iajs-3351	170	1	10	10	NUM
iajs-3351	170	2	.	.	PUNCT
iajs-3351	171	1	barber	barber	PROPN
iajs-3351	171	2	,	,	PUNCT
iajs-3351	171	3	t.m	t.m	PROPN
iajs-3351	171	4	.	.	PROPN
iajs-3351	171	5	;	;	PUNCT
iajs-3351	171	6	franks	frank	NOUN
iajs-3351	171	7	,	,	PUNCT
iajs-3351	171	8	s.	s.	PROPN
iajs-3351	171	9	obesity	obesity	PROPN
iajs-3351	171	10	and	and	CCONJ
iajs-3351	171	11	polycystic	polycystic	ADJ
iajs-3351	171	12	ovary	ovary	ADJ
iajs-3351	171	13	syndrome	syndrome	NOUN
iajs-3351	171	14	.	.	PUNCT
iajs-3351	172	1	clin	clin	PROPN
iajs-3351	172	2	endocrinol	endocrinol	NOUN
iajs-3351	172	3	2021	2021	NUM
iajs-3351	172	4	,	,	PUNCT
iajs-3351	172	5	95(4	95(4	NOUN
iajs-3351	172	6	)	)	PUNCT
iajs-3351	172	7	,	,	PUNCT
iajs-3351	172	8	53141	53141	NUM
iajs-3351	172	9	.	.	PUNCT
iajs-3351	173	1	https://doi.org/10.1111/cen.14421	https://doi.org/10.1111/cen.14421	NOUN
iajs-3351	173	2	.	.	PUNCT
iajs-3351	174	1	11	11	NUM
iajs-3351	174	2	.	.	X
iajs-3351	175	1	saleh	saleh	PROPN
iajs-3351	175	2	,	,	PUNCT
iajs-3351	175	3	b.o	b.o	PROPN
iajs-3351	175	4	.	.	PROPN
iajs-3351	175	5	;	;	PUNCT
iajs-3351	176	1	al	al	PROPN
iajs-3351	176	2	-	-	PUNCT
iajs-3351	176	3	naddawi	naddawi	PROPN
iajs-3351	176	4	,	,	PUNCT
iajs-3351	176	5	a.m.	a.m.	PROPN
iajs-3351	176	6	association	association	PROPN
iajs-3351	176	7	between	between	ADP
iajs-3351	176	8	serum	serum	NOUN
iajs-3351	176	9	fructose	fructose	ADJ
iajs-3351	176	10	level	level	NOUN
iajs-3351	176	11	and	and	CCONJ
iajs-3351	176	12	insulin	insulin	NOUN
iajs-3351	176	13	resistance	resistance	NOUN
iajs-3351	176	14	in	in	ADP
iajs-3351	176	15	women	woman	NOUN
iajs-3351	176	16	with	with	ADP
iajs-3351	176	17	polycystic	polycystic	ADJ
iajs-3351	176	18	ovary	ovary	ADJ
iajs-3351	176	19	syndrome	syndrome	NOUN
iajs-3351	176	20	:	:	PUNCT
iajs-3351	176	21	the	the	DET
iajs-3351	176	22	effect	effect	NOUN
iajs-3351	176	23	of	of	ADP
iajs-3351	176	24	obesity	obesity	NOUN
iajs-3351	176	25	.	.	PUNCT
iajs-3351	177	1	j	j	PROPN
iajs-3351	177	2	int	int	PROPN
iajs-3351	177	3	med	me	VERB
iajs-3351	177	4	res	re	NOUN
iajs-3351	177	5	2022	2022	NUM
iajs-3351	177	6	,	,	PUNCT
iajs-3351	177	7	64(2	64(2	NUM
iajs-3351	177	8	)	)	PUNCT
iajs-3351	177	9	,	,	PUNCT
iajs-3351	177	10	91	91	NUM
iajs-3351	177	11	-	-	SYM
iajs-3351	177	12	5	5	NUM
iajs-3351	177	13	.	.	PUNCT
iajs-3351	177	14	https://doi.org/10.32007/jfacmedbagdad.6421926	https://doi.org/10.32007/jfacmedbagdad.6421926	NOUN
iajs-3351	177	15	.	.	PUNCT
iajs-3351	178	1	12	12	NUM
iajs-3351	178	2	.	.	X
iajs-3351	178	3	ali	ali	PROPN
iajs-3351	178	4	,	,	PUNCT
iajs-3351	178	5	s.e	s.e	PROPN
iajs-3351	178	6	.	.	PROPN
iajs-3351	178	7	;	;	PUNCT
iajs-3351	178	8	khaleel	khaleel	PROPN
iajs-3351	178	9	,	,	PUNCT
iajs-3351	178	10	f.m	f.m	PROPN
iajs-3351	178	11	.	.	PROPN
iajs-3351	178	12	effect	effect	NOUN
iajs-3351	178	13	of	of	ADP
iajs-3351	178	14	covid-19	covid-19	PROPN
iajs-3351	178	15	on	on	ADP
iajs-3351	178	16	the	the	DET
iajs-3351	178	17	role	role	NOUN
iajs-3351	178	18	of	of	ADP
iajs-3351	178	19	renin	renin	ADJ
iajs-3351	178	20	enzyme	enzyme	NOUN
iajs-3351	178	21	and	and	CCONJ
iajs-3351	178	22	ace2	ace2	NOUN
iajs-3351	178	23	and	and	CCONJ
iajs-3351	178	24	hormones	hormone	NOUN
iajs-3351	178	25	in	in	ADP
iajs-3351	178	26	pcos	pcos	PROPN
iajs-3351	178	27	females	female	NOUN
iajs-3351	178	28	.	.	PUNCT
iajs-3351	179	1	baghdad	baghdad	PROPN
iajs-3351	179	2	sci	sci	PROPN
iajs-3351	179	3	.	.	PUNCT
iajs-3351	180	1	j.	j.	PROPN
iajs-3351	180	2	2023	2023	NUM
iajs-3351	180	3	,	,	PUNCT
iajs-3351	180	4	20(6	20(6	NOUN
iajs-3351	180	5	)	)	PUNCT
iajs-3351	180	6	,	,	PUNCT
iajs-3351	180	7	2249	2249	NUM
iajs-3351	180	8	-	-	SYM
iajs-3351	180	9	2255	2255	NUM
iajs-3351	180	10	.	.	PUNCT
iajs-3351	181	1	https://dx.doi.org/10.21123/bsj.2023.7746	https://dx.doi.org/10.21123/bsj.2023.7746	NOUN
iajs-3351	181	2	.	.	NOUN
iajs-3351	181	3	13	13	NUM
iajs-3351	181	4	.	.	X
iajs-3351	181	5	ali	ali	PROPN
iajs-3351	181	6	,	,	PUNCT
iajs-3351	181	7	s.e	s.e	PROPN
iajs-3351	181	8	.	.	PROPN
iajs-3351	181	9	;	;	PUNCT
iajs-3351	181	10	khaleel	khaleel	PROPN
iajs-3351	181	11	,	,	PUNCT
iajs-3351	181	12	f.m	f.m	PROPN
iajs-3351	181	13	.	.	PROPN
iajs-3351	181	14	assessing	assess	VERB
iajs-3351	181	15	the	the	DET
iajs-3351	181	16	activity	activity	NOUN
iajs-3351	181	17	of	of	ADP
iajs-3351	181	18	renin	renin	NOUN
iajs-3351	181	19	and	and	CCONJ
iajs-3351	181	20	gst	gst	NOUN
iajs-3351	181	21	in	in	ADP
iajs-3351	181	22	the	the	DET
iajs-3351	181	23	serum	serum	NOUN
iajs-3351	181	24	of	of	ADP
iajs-3351	181	25	ladies	lady	NOUN
iajs-3351	181	26	suffering	suffer	VERB
iajs-3351	181	27	from	from	ADP
iajs-3351	181	28	polycystic	polycystic	ADJ
iajs-3351	181	29	ovary	ovary	ADJ
iajs-3351	181	30	syndrome	syndrome	NOUN
iajs-3351	181	31	and	and	CCONJ
iajs-3351	181	32	covid-19	covid-19	PROPN
iajs-3351	181	33	to	to	PART
iajs-3351	181	34	predict	predict	VERB
iajs-3351	181	35	the	the	DET
iajs-3351	181	36	danger	danger	NOUN
iajs-3351	181	37	of	of	ADP
iajs-3351	181	38	cardiac	cardiac	ADJ
iajs-3351	181	39	disease	disease	NOUN
iajs-3351	181	40	.	.	PUNCT
iajs-3351	182	1	baghdad	baghdad	PROPN
iajs-3351	182	2	sci	sci	PROPN
iajs-3351	182	3	.	.	PUNCT
iajs-3351	183	1	j.	j.	PROPN
iajs-3351	183	2	2023	2023	NUM
iajs-3351	183	3	,	,	PUNCT
iajs-3351	183	4	20(3	20(3	NOUN
iajs-3351	183	5	)	)	PUNCT
iajs-3351	183	6	,	,	PUNCT
iajs-3351	183	7	0986	0986	NUM
iajs-3351	183	8	.	.	PUNCT
iajs-3351	184	1	https://dx.doi.org/10.21123/bsj.2023.7879	https://dx.doi.org/10.21123/bsj.2023.7879	NOUN
iajs-3351	184	2	.	.	PUNCT
iajs-3351	185	1	14	14	NUM
iajs-3351	185	2	.	.	PUNCT
iajs-3351	185	3	basavaraju	basavaraju	NOUN
iajs-3351	185	4	,	,	PUNCT
iajs-3351	185	5	s.v	s.v	PROPN
iajs-3351	185	6	.	.	PROPN
iajs-3351	185	7	;	;	PUNCT
iajs-3351	185	8	patton	patton	PROPN
iajs-3351	185	9	,	,	PUNCT
iajs-3351	185	10	m.e	m.e	PROPN
iajs-3351	185	11	.	.	PROPN
iajs-3351	185	12	;	;	PUNCT
iajs-3351	186	1	grimm	grimm	NOUN
iajs-3351	186	2	,	,	PUNCT
iajs-3351	186	3	k.	k.	PROPN
iajs-3351	186	4	;	;	PUNCT
iajs-3351	186	5	rasheed	rasheed	PROPN
iajs-3351	186	6	,	,	PUNCT
iajs-3351	186	7	m.a	m.a	PROPN
iajs-3351	186	8	.	.	PROPN
iajs-3351	186	9	;	;	PUNCT
iajs-3351	186	10	lester	lester	PROPN
iajs-3351	186	11	,	,	PUNCT
iajs-3351	186	12	s.	s.	PROPN
iajs-3351	186	13	;	;	PUNCT
iajs-3351	186	14	mills	mill	NOUN
iajs-3351	186	15	,	,	PUNCT
iajs-3351	186	16	l.	l.	PROPN
iajs-3351	186	17	;	;	PUNCT
iajs-3351	186	18	stump	stump	NOUN
iajs-3351	186	19	,	,	PUNCT
iajs-3351	186	20	f.m	f.m	PROPN
iajs-3351	186	21	.	.	PROPN
iajs-3351	186	22	;	;	PUNCT
iajs-3351	186	23	freeman	freeman	PROPN
iajs-3351	186	24	,	,	PUNCT
iajs-3351	186	25	b.	b.	PROPN
iajs-3351	186	26	;	;	PUNCT
iajs-3351	186	27	tamin	tamin	PROPN
iajs-3351	186	28	,	,	PUNCT
iajs-3351	186	29	a.	a.	NOUN
iajs-3351	186	30	;	;	PUNCT
iajs-3351	186	31	harcourt	harcourt	PROPN
iajs-3351	186	32	,	,	PUNCT
iajs-3351	186	33	j.	j.	PROPN
iajs-3351	186	34	;	;	PUNCT
iajs-3351	186	35	schiffer	schiffer	PROPN
iajs-3351	186	36	,	,	PUNCT
iajs-3351	186	37	j.	j.	PROPN
iajs-3351	186	38	serologic	serologic	PROPN
iajs-3351	186	39	testing	testing	NOUN
iajs-3351	186	40	of	of	ADP
iajs-3351	186	41	us	us	PROPN
iajs-3351	186	42	blood	blood	NOUN
iajs-3351	186	43	donations	donation	NOUN
iajs-3351	186	44	to	to	PART
iajs-3351	186	45	identify	identify	VERB
iajs-3351	186	46	severe	severe	ADJ
iajs-3351	186	47	acute	acute	ADJ
iajs-3351	186	48	respiratory	respiratory	ADJ
iajs-3351	186	49	syndrome	syndrome	NOUN
iajs-3351	186	50	coronavirus	coronavirus	NOUN
iajs-3351	186	51	2	2	NUM
iajs-3351	186	52	(	(	PUNCT
iajs-3351	186	53	sars	sar	NOUN
iajs-3351	186	54	-	-	PUNCT
iajs-3351	186	55	cov-2)–reactive	cov-2)–reactive	PROPN
iajs-3351	186	56	antibodies	antibody	NOUN
iajs-3351	186	57	.	.	PUNCT
iajs-3351	187	1	cli	cli	NOUN
iajs-3351	187	2	.	.	PUNCT
iajs-3351	187	3	infect	infect	VERB
iajs-3351	187	4	dis	dis	PROPN
iajs-3351	187	5	2021	2021	NUM
iajs-3351	187	6	,	,	PUNCT
iajs-3351	187	7	72(12	72(12	NUM
iajs-3351	187	8	)	)	PUNCT
iajs-3351	187	9	,	,	PUNCT
iajs-3351	187	10	e1004	e1004	PROPN
iajs-3351	187	11	-	-	PUNCT
iajs-3351	187	12	1009	1009	NUM
iajs-3351	187	13	.	.	PUNCT
iajs-3351	188	1	https://doi.org/10.1093/cid/ciaa1785	https://doi.org/10.1093/cid/ciaa1785	NOUN
iajs-3351	188	2	.	.	PUNCT
iajs-3351	189	1	15	15	NUM
iajs-3351	189	2	.	.	PUNCT
iajs-3351	189	3	dilbaz	dilbaz	PROPN
iajs-3351	189	4	,	,	PUNCT
iajs-3351	189	5	b.	b.	PROPN
iajs-3351	189	6	are	be	AUX
iajs-3351	189	7	women	woman	NOUN
iajs-3351	189	8	with	with	ADP
iajs-3351	189	9	polycystic	polycystic	ADJ
iajs-3351	189	10	ovary	ovary	ADJ
iajs-3351	189	11	syndrome	syndrome	NOUN
iajs-3351	189	12	more	more	ADV
iajs-3351	189	13	vulnerable	vulnerable	ADJ
iajs-3351	189	14	to	to	ADP
iajs-3351	189	15	covid-19	covid-19	PROPN
iajs-3351	189	16	infection	infection	NOUN
iajs-3351	189	17	.	.	PUNCT
iajs-3351	190	1	turk	turk	PROPN
iajs-3351	190	2	j	j	PROPN
iajs-3351	190	3	obstet	obstet	PROPN
iajs-3351	190	4	gynecol	gynecol	PROPN
iajs-3351	190	5	.	.	PROPN
iajs-3351	190	6	2021	2021	NUM
iajs-3351	190	7	,	,	PUNCT
iajs-3351	190	8	18(3	18(3	NUM
iajs-3351	190	9	)	)	PUNCT
iajs-3351	190	10	,	,	PUNCT
iajs-3351	190	11	221	221	NUM
iajs-3351	190	12	.	.	PUNCT
iajs-3351	191	1	https://doi.org/10.4274/tjod.galenos.2021.05014	https://doi.org/10.4274/tjod.galenos.2021.05014	NOUN
iajs-3351	191	2	.	.	PUNCT
iajs-3351	192	1	16	16	NUM
iajs-3351	192	2	.	.	PUNCT
iajs-3351	192	3	de	de	PROPN
iajs-3351	192	4	medeiros	medeiros	PROPN
iajs-3351	192	5	,	,	PUNCT
iajs-3351	192	6	s.f	s.f	PROPN
iajs-3351	192	7	.	.	PROPN
iajs-3351	192	8	;	;	PUNCT
iajs-3351	192	9	yamamoto	yamamoto	PROPN
iajs-3351	192	10	,	,	PUNCT
iajs-3351	192	11	m.m	m.m	PROPN
iajs-3351	192	12	.	.	PROPN
iajs-3351	192	13	;	;	PUNCT
iajs-3351	192	14	de	de	PROPN
iajs-3351	192	15	medeiros	medeiros	PROPN
iajs-3351	192	16	,	,	PUNCT
iajs-3351	192	17	m.a	m.a	PROPN
iajs-3351	192	18	.	.	PROPN
iajs-3351	192	19	;	;	PUNCT
iajs-3351	192	20	yamamoto	yamamoto	PROPN
iajs-3351	192	21	,	,	PUNCT
iajs-3351	192	22	a.k	a.k	PROPN
iajs-3351	192	23	.	.	PROPN
iajs-3351	192	24	;	;	PUNCT
iajs-3351	192	25	barbosa	barbosa	PROPN
iajs-3351	192	26	,	,	PUNCT
iajs-3351	192	27	b.b	b.b	PROPN
iajs-3351	192	28	.	.	PROPN
iajs-3351	192	29	polycystic	polycystic	ADJ
iajs-3351	192	30	ovary	ovary	ADJ
iajs-3351	192	31	syndrome	syndrome	NOUN
iajs-3351	192	32	and	and	CCONJ
iajs-3351	192	33	risks	risk	NOUN
iajs-3351	192	34	for	for	ADP
iajs-3351	192	35	covid-19	covid-19	PROPN
iajs-3351	192	36	infection	infection	NOUN
iajs-3351	192	37	:	:	PUNCT
iajs-3351	192	38	a	a	DET
iajs-3351	192	39	comprehensive	comprehensive	ADJ
iajs-3351	192	40	review	review	NOUN
iajs-3351	192	41	:	:	PUNCT
iajs-3351	192	42	pcos	pcos	PROPN
iajs-3351	192	43	and	and	CCONJ
iajs-3351	192	44	covid19	covid19	NOUN
iajs-3351	192	45	relationship	relationship	NOUN
iajs-3351	192	46	.	.	PUNCT
iajs-3351	193	1	rev	rev	PROPN
iajs-3351	193	2	endocr	endocr	PROPN
iajs-3351	193	3	metab	metab	PROPN
iajs-3351	193	4	dis	dis	PROPN
iajs-3351	193	5	2022	2022	NUM
iajs-3351	193	6	,	,	PUNCT
iajs-3351	193	7	23(2	23(2	NUM
iajs-3351	193	8	)	)	PUNCT
iajs-3351	193	9	,	,	PUNCT
iajs-3351	193	10	251	251	NUM
iajs-3351	193	11	-	-	SYM
iajs-3351	193	12	64	64	NUM
iajs-3351	193	13	.	.	PUNCT
iajs-3351	194	1	https://doi.org/10.1007/s11154-022-09715-y	https://doi.org/10.1007/s11154-022-09715-y	X
iajs-3351	194	2	.	.	PUNCT
iajs-3351	194	3	17	17	NUM
iajs-3351	194	4	.	.	PUNCT
iajs-3351	195	1	subramanian	subramanian	PROPN
iajs-3351	195	2	,	,	PUNCT
iajs-3351	195	3	a.	a.	PROPN
iajs-3351	195	4	;	;	PUNCT
iajs-3351	195	5	anand	anand	PROPN
iajs-3351	195	6	,	,	PUNCT
iajs-3351	195	7	a.	a.	NOUN
iajs-3351	195	8	;	;	PUNCT
iajs-3351	195	9	adderley	adderley	PROPN
iajs-3351	195	10	,	,	PUNCT
iajs-3351	195	11	n.j	n.j	PROPN
iajs-3351	195	12	.	.	PROPN
iajs-3351	195	13	;	;	PUNCT
iajs-3351	195	14	okoth	okoth	PROPN
iajs-3351	195	15	,	,	PUNCT
iajs-3351	195	16	k.	k.	PROPN
iajs-3351	195	17	;	;	PUNCT
iajs-3351	195	18	toulis	toulis	PROPN
iajs-3351	195	19	,	,	PUNCT
iajs-3351	195	20	k.a	k.a	PROPN
iajs-3351	195	21	.	.	PROPN
iajs-3351	195	22	;	;	PUNCT
iajs-3351	195	23	gokhale	gokhale	NOUN
iajs-3351	195	24	,	,	PUNCT
iajs-3351	195	25	k.	k.	PROPN
iajs-3351	195	26	;	;	PUNCT
iajs-3351	195	27	sainsbury	sainsbury	PROPN
iajs-3351	195	28	,	,	PUNCT
iajs-3351	195	29	c.	c.	PROPN
iajs-3351	195	30	;	;	PUNCT
iajs-3351	195	31	o'reilly	o'reilly	PROPN
iajs-3351	195	32	,	,	PUNCT
iajs-3351	195	33	m.w	m.w	PROPN
iajs-3351	195	34	.	.	PUNCT
iajs-3351	195	35	;	;	PUNCT
iajs-3351	195	36	arlt	arlt	NOUN
iajs-3351	195	37	,	,	PUNCT
iajs-3351	195	38	w.	w.	PROPN
iajs-3351	195	39	;	;	PUNCT
iajs-3351	195	40	nirantharakumar	nirantharakumar	PROPN
iajs-3351	195	41	,	,	PUNCT
iajs-3351	195	42	k.	k.	PROPN
iajs-3351	195	43	increased	increase	VERB
iajs-3351	195	44	covid-19	covid-19	PROPN
iajs-3351	195	45	infections	infection	NOUN
iajs-3351	195	46	in	in	ADP
iajs-3351	195	47	women	woman	NOUN
iajs-3351	195	48	with	with	ADP
iajs-3351	195	49	polycystic	polycystic	ADJ
iajs-3351	195	50	ovary	ovary	ADJ
iajs-3351	195	51	syndrome	syndrome	NOUN
iajs-3351	195	52	:	:	PUNCT
iajs-3351	195	53	a	a	DET
iajs-3351	195	54	population	population	NOUN
iajs-3351	195	55	-	-	PUNCT
iajs-3351	195	56	based	base	VERB
iajs-3351	195	57	study	study	NOUN
iajs-3351	195	58	.	.	PUNCT
iajs-3351	196	1	eur	eur	PROPN
iajs-3351	196	2	j	j	PROPN
iajs-3351	196	3	endocrinol	endocrinol	NOUN
iajs-3351	196	4	2021	2021	NUM
iajs-3351	196	5	,	,	PUNCT
iajs-3351	196	6	184(5	184(5	NUM
iajs-3351	196	7	)	)	PUNCT
iajs-3351	196	8	,	,	PUNCT
iajs-3351	196	9	637	637	NUM
iajs-3351	196	10	-	-	SYM
iajs-3351	196	11	45	45	NUM
iajs-3351	196	12	.	.	PUNCT
iajs-3351	197	1	https://doi.org/10.1530/eje-20-1163	https://doi.org/10.1530/eje-20-1163	PROPN
iajs-3351	197	2	.	.	PROPN
iajs-3351	197	3	18	18	NUM
iajs-3351	198	1	.	.	PUNCT
iajs-3351	198	2	han	han	PROPN
iajs-3351	198	3	,	,	PUNCT
iajs-3351	198	4	h.	h.	PROPN
iajs-3351	198	5	;	;	PUNCT
iajs-3351	198	6	xu	xu	PROPN
iajs-3351	198	7	,	,	PUNCT
iajs-3351	198	8	z.	z.	PROPN
iajs-3351	198	9	;	;	PUNCT
iajs-3351	198	10	cheng	cheng	PROPN
iajs-3351	198	11	,	,	PUNCT
iajs-3351	198	12	x.	x.	PROPN
iajs-3351	198	13	;	;	PUNCT
iajs-3351	198	14	zhong	zhong	PROPN
iajs-3351	198	15	,	,	PUNCT
iajs-3351	198	16	y.;yuan	y.;yuan	PROPN
iajs-3351	198	17	,	,	PUNCT
iajs-3351	198	18	l.	l.	PROPN
iajs-3351	198	19	;	;	PUNCT
iajs-3351	198	20	wang	wang	PROPN
iajs-3351	198	21	,	,	PUNCT
iajs-3351	198	22	f.	f.	PROPN
iajs-3351	198	23	;	;	PUNCT
iajs-3351	198	24	li	li	PROPN
iajs-3351	198	25	,	,	PUNCT
iajs-3351	198	26	y.	y.	PROPN
iajs-3351	198	27	;	;	PUNCT
iajs-3351	198	28	liu	liu	PROPN
iajs-3351	198	29	,	,	PUNCT
iajs-3351	198	30	f.	f.	PROPN
iajs-3351	198	31	;	;	PUNCT
iajs-3351	198	32	jiang	jiang	PROPN
iajs-3351	198	33	,	,	PUNCT
iajs-3351	198	34	y.	y.	PROPN
iajs-3351	198	35	;	;	PUNCT
iajs-3351	198	36	zhu	zhu	PROPN
iajs-3351	198	37	,	,	PUNCT
iajs-3351	198	38	c.	c.	PROPN
iajs-3351	198	39	;	;	PUNCT
iajs-3351	198	40	xia	xia	PROPN
iajs-3351	198	41	,	,	PUNCT
iajs-3351	198	42	y.	y.	PROPN
iajs-3351	198	43	descriptive	descriptive	PROPN
iajs-3351	198	44	,	,	PUNCT
iajs-3351	198	45	retrospective	retrospective	ADJ
iajs-3351	198	46	study	study	NOUN
iajs-3351	198	47	of	of	ADP
iajs-3351	198	48	the	the	DET
iajs-3351	198	49	clinical	clinical	ADJ
iajs-3351	198	50	characteristics	characteristic	NOUN
iajs-3351	198	51	of	of	ADP
iajs-3351	198	52	asymptomatic	asymptomatic	ADJ
iajs-3351	198	53	covid-19	covid-19	PROPN
iajs-3351	198	54	patients	patient	NOUN
iajs-3351	198	55	.	.	PUNCT
iajs-3351	199	1	msphere	msphere	PROPN
iajs-3351	199	2	2020	2020	NUM
iajs-3351	199	3	,	,	PUNCT
iajs-3351	199	4	5(5	5(5	NUM
iajs-3351	199	5	)	)	PUNCT
iajs-3351	199	6	,	,	PUNCT
iajs-3351	199	7	e00922	e00922	NOUN
iajs-3351	199	8	-	-	SYM
iajs-3351	199	9	20	20	NUM
iajs-3351	199	10	.	.	PUNCT
iajs-3351	200	1	https://doi.org/10.1128/msphere.00922-20	https://doi.org/10.1128/msphere.00922-20	PROPN
iajs-3351	200	2	.	.	PUNCT
iajs-3351	201	1	19	19	NUM
iajs-3351	201	2	.	.	PUNCT
iajs-3351	202	1	goren	goren	PROPN
iajs-3351	202	2	,	,	PUNCT
iajs-3351	202	3	a.v	a.v	PROPN
iajs-3351	202	4	.	.	PROPN
iajs-3351	202	5	;	;	PUNCT
iajs-3351	202	6	vano	vano	PROPN
iajs-3351	202	7	-	-	NOUN
iajs-3351	202	8	galvan	galvan	NOUN
iajs-3351	202	9	,	,	PUNCT
iajs-3351	202	10	s.	s.	PROPN
iajs-3351	202	11	;	;	PUNCT
iajs-3351	202	12	wambier	wambi	ADJ
iajs-3351	202	13	,	,	PUNCT
iajs-3351	202	14	c.g	c.g	PROPN
iajs-3351	202	15	.	.	PROPN
iajs-3351	202	16	;	;	PUNCT
iajs-3351	202	17	mccoy	mccoy	PROPN
iajs-3351	202	18	,	,	PUNCT
iajs-3351	202	19	j.	j.	PROPN
iajs-3351	202	20	;	;	PUNCT
iajs-3351	202	21	gomez	gomez	PROPN
iajs-3351	202	22	-	-	PUNCT
iajs-3351	202	23	zubiaur	zubiaur	PROPN
iajs-3351	202	24	,	,	PUNCT
iajs-3351	202	25	a.	a.	NOUN
iajs-3351	202	26	;	;	PUNCT
iajs-3351	202	27	moreno	moreno	PROPN
iajs-3351	202	28	-	-	PUNCT
iajs-3351	202	29	arrones	arrones	PROPN
iajs-3351	202	30	,	,	PUNCT
iajs-3351	202	31	o.m	o.m	PROPN
iajs-3351	202	32	.	.	PROPN
iajs-3351	202	33	;	;	PUNCT
iajs-3351	202	34	shapiro	shapiro	PROPN
iajs-3351	202	35	,	,	PUNCT
iajs-3351	202	36	j.	j.	PROPN
iajs-3351	202	37	;	;	PUNCT
iajs-3351	202	38	sinclair	sinclair	PROPN
iajs-3351	202	39	,	,	PUNCT
iajs-3351	202	40	r.d	r.d	PROPN
iajs-3351	202	41	.	.	PROPN
iajs-3351	202	42	;	;	PUNCT
iajs-3351	202	43	gold	gold	NOUN
iajs-3351	202	44	,	,	PUNCT
iajs-3351	202	45	m.h	m.h	PROPN
iajs-3351	202	46	.	.	PROPN
iajs-3351	202	47	;	;	PUNCT
iajs-3351	202	48	kovacevic	kovacevic	ADJ
iajs-3351	202	49	,	,	PUNCT
iajs-3351	202	50	m.	m.	NOUN
iajs-3351	202	51	;	;	PUNCT
iajs-3351	202	52	mesinkovska	mesinkovska	PROPN
iajs-3351	202	53	,	,	PUNCT
iajs-3351	202	54	n.a	n.a	PROPN
iajs-3351	202	55	.	.	PROPN
iajs-3351	203	1	a	a	DET
iajs-3351	203	2	preliminary	preliminary	ADJ
iajs-3351	203	3	observation	observation	NOUN
iajs-3351	203	4	:	:	PUNCT
iajs-3351	203	5	male	male	ADJ
iajs-3351	203	6	pattern	pattern	NOUN
iajs-3351	203	7	hair	hair	NOUN
iajs-3351	203	8	loss	loss	NOUN
iajs-3351	203	9	among	among	ADP
iajs-3351	203	10	hospitalized	hospitalize	VERB
iajs-3351	203	11	covid-19	covid-19	PROPN
iajs-3351	203	12	patients	patient	NOUN
iajs-3351	203	13	in	in	ADP
iajs-3351	203	14	spain	spain	PROPN
iajs-3351	203	15	-	-	PUNCT
iajs-3351	203	16	a	a	DET
iajs-3351	203	17	potential	potential	ADJ
iajs-3351	203	18	clue	clue	NOUN
iajs-3351	203	19	to	to	ADP
iajs-3351	203	20	the	the	DET
iajs-3351	203	21	role	role	NOUN
iajs-3351	203	22	of	of	ADP
iajs-3351	203	23	androgens	androgen	NOUN
iajs-3351	203	24	in	in	ADP
iajs-3351	203	25	covid-19	covid-19	PROPN
iajs-3351	203	26	severity	severity	NOUN
iajs-3351	203	27	.	.	PUNCT
iajs-3351	204	1	j	j	PROPN
iajs-3351	204	2	cosmet	cosmet	PROPN
iajs-3351	204	3	dermatol	dermatol	NOUN
iajs-3351	204	4	.	.	PUNCT
iajs-3351	205	1	2020	2020	NUM
iajs-3351	205	2	,	,	PUNCT
iajs-3351	205	3	19(7	19(7	PROPN
iajs-3351	205	4	)	)	PUNCT
iajs-3351	205	5	,	,	PUNCT
iajs-3351	205	6	1545	1545	NUM
iajs-3351	205	7	-	-	SYM
iajs-3351	205	8	7	7	NUM
iajs-3351	205	9	.	.	PUNCT
iajs-3351	205	10	https://doi:10.1111	https://doi:10.1111	PROPN
iajs-3351	205	11	/	/	SYM
iajs-3351	205	12	jocd.13443	jocd.13443	NOUN
iajs-3351	205	13	.	.	NOUN
iajs-3351	206	1	20	20	NUM
iajs-3351	206	2	.	.	PUNCT
iajs-3351	206	3	tahapary	tahapary	ADJ
iajs-3351	206	4	,	,	PUNCT
iajs-3351	206	5	d.l	d.l	PROPN
iajs-3351	206	6	.	.	PROPN
iajs-3351	206	7	;	;	PUNCT
iajs-3351	207	1	pratisthita	pratisthita	PROPN
iajs-3351	207	2	,	,	PUNCT
iajs-3351	207	3	l.b	l.b	PROPN
iajs-3351	207	4	.	.	PROPN
iajs-3351	207	5	;	;	PUNCT
iajs-3351	207	6	fitri	fitri	PROPN
iajs-3351	207	7	,	,	PUNCT
iajs-3351	207	8	n.a	n.a	PROPN
iajs-3351	207	9	.	.	PROPN
iajs-3351	207	10	;	;	PUNCT
iajs-3351	207	11	marcella	marcella	PROPN
iajs-3351	207	12	,	,	PUNCT
iajs-3351	207	13	c.	c.	PROPN
iajs-3351	207	14	;	;	PUNCT
iajs-3351	207	15	wafa	wafa	PROPN
iajs-3351	207	16	,	,	PUNCT
iajs-3351	207	17	s.	s.	PROPN
iajs-3351	207	18	;	;	PUNCT
iajs-3351	207	19	kurniawan	kurniawan	PROPN
iajs-3351	207	20	,	,	PUNCT
iajs-3351	207	21	f.	f.	PROPN
iajs-3351	207	22	;	;	PUNCT
iajs-3351	207	23	rizka	rizka	PROPN
iajs-3351	207	24	,	,	PUNCT
iajs-3351	207	25	a.	a.	NOUN
iajs-3351	207	26	;	;	PUNCT
iajs-3351	207	27	tarigan	tarigan	VERB
iajs-3351	207	28	,	,	PUNCT
iajs-3351	207	29	t.j	t.j	PROPN
iajs-3351	207	30	.	.	PROPN
iajs-3351	207	31	;	;	PUNCT
iajs-3351	207	32	harbuwono	harbuwono	PROPN
iajs-3351	207	33	,	,	PUNCT
iajs-3351	207	34	d.s	d.s	PROPN
iajs-3351	207	35	.	.	PROPN
iajs-3351	207	36	;	;	PUNCT
iajs-3351	207	37	purnamasari	purnamasari	PROPN
iajs-3351	207	38	,	,	PUNCT
iajs-3351	207	39	d.	d.	PROPN
iajs-3351	207	40	;	;	PUNCT
iajs-3351	207	41	soewondo	soewondo	PROPN
iajs-3351	207	42	,	,	PUNCT
iajs-3351	207	43	p.	p.	NOUN
iajs-3351	207	44	challenges	challenge	NOUN
iajs-3351	207	45	in	in	ADP
iajs-3351	207	46	the	the	DET
iajs-3351	207	47	diagnosis	diagnosis	NOUN
iajs-3351	207	48	of	of	ADP
iajs-3351	207	49	insulin	insulin	NOUN
iajs-3351	207	50	resistance	resistance	NOUN
iajs-3351	207	51	:	:	PUNCT
iajs-3351	207	52	focusing	focus	VERB
iajs-3351	207	53	on	on	ADP
iajs-3351	207	54	the	the	DET
iajs-3351	207	55	role	role	NOUN
iajs-3351	207	56	of	of	ADP
iajs-3351	207	57	homa	homa	NOUN
iajs-3351	207	58	-	-	PUNCT
iajs-3351	207	59	ir	ir	PROPN
iajs-3351	207	60	and	and	CCONJ
iajs-3351	207	61	tryglyceride	tryglyceride	ADV
iajs-3351	207	62	/	/	SYM
iajs-3351	207	63	glucose	glucose	NOUN
iajs-3351	207	64	index	index	NOUN
iajs-3351	207	65	.	.	PUNCT
iajs-3351	208	1	diabetes	diabetes	NOUN
iajs-3351	208	2	&	&	CCONJ
iajs-3351	208	3	metabolic	metabolic	PROPN
iajs-3351	208	4	syndrome	syndrome	PROPN
iajs-3351	208	5	:	:	PUNCT
iajs-3351	208	6	clin	clin	PROPN
iajs-3351	208	7	.	.	PUNCT
iajs-3351	209	1	res	re	NOUN
iajs-3351	209	2	.	.	PROPN
iajs-3351	209	3	2022	2022	NUM
iajs-3351	209	4	,	,	PUNCT
iajs-3351	209	5	16(8	16(8	NUM
iajs-3351	209	6	)	)	PUNCT
iajs-3351	209	7	,	,	PUNCT
iajs-3351	209	8	102581	102581	NUM
iajs-3351	209	9	.	.	PUNCT
iajs-3351	210	1	https://doi.org/10.1016/j.dsx.2022.102581	https://doi.org/10.1016/j.dsx.2022.102581	PROPN
iajs-3351	210	2	.	.	PROPN
iajs-3351	211	1	21	21	NUM
iajs-3351	211	2	.	.	X
iajs-3351	212	1	zhang	zhang	PROPN
iajs-3351	212	2	,	,	PUNCT
iajs-3351	212	3	x.	x.	PROPN
iajs-3351	212	4	;	;	PUNCT
iajs-3351	212	5	li	li	PROPN
iajs-3351	212	6	,	,	PUNCT
iajs-3351	212	7	s.	s.	PROPN
iajs-3351	212	8	;	;	PUNCT
iajs-3351	212	9	niu	niu	PROPN
iajs-3351	212	10	,	,	PUNCT
iajs-3351	212	11	s.	s.	PROPN
iajs-3351	212	12	ace2	ace2	PROPN
iajs-3351	212	13	and	and	CCONJ
iajs-3351	212	14	covid-19	covid-19	PROPN
iajs-3351	212	15	and	and	CCONJ
iajs-3351	212	16	the	the	DET
iajs-3351	212	17	resulting	result	VERB
iajs-3351	212	18	ards	ard	NOUN
iajs-3351	212	19	.	.	PUNCT
iajs-3351	213	1	postgrad	postgrad	PROPN
iajs-3351	213	2	med	med	PROPN
iajs-3351	213	3	j	j	PROPN
iajs-3351	213	4	2020	2020	NUM
iajs-3351	213	5	,	,	PUNCT
iajs-3351	213	6	96(1137	96(1137	NUM
iajs-3351	213	7	)	)	PUNCT
iajs-3351	213	8	,	,	PUNCT
iajs-3351	213	9	403	403	NUM
iajs-3351	213	10	-	-	SYM
iajs-3351	213	11	7	7	NUM
iajs-3351	213	12	.	.	PUNCT
iajs-3351	214	1	https://doi.org/10.1136/postgradmedj-2020-137935	https://doi.org/10.1136/postgradmedj-2020-137935	PROPN
iajs-3351	214	2	.	.	PUNCT
iajs-3351	215	1	22	22	NUM
iajs-3351	215	2	.	.	PUNCT
iajs-3351	216	1	ni	ni	PROPN
iajs-3351	216	2	,	,	PUNCT
iajs-3351	216	3	w.	w.	PROPN
iajs-3351	216	4	;	;	PUNCT
iajs-3351	216	5	yang	yang	PROPN
iajs-3351	216	6	,	,	PUNCT
iajs-3351	216	7	x.	x.	PROPN
iajs-3351	216	8	;	;	PUNCT
iajs-3351	216	9	yang	yang	PROPN
iajs-3351	216	10	,	,	PUNCT
iajs-3351	216	11	d.	d.	PROPN
iajs-3351	216	12	;	;	PUNCT
iajs-3351	216	13	bao	bao	PROPN
iajs-3351	216	14	,	,	PUNCT
iajs-3351	216	15	j.	j.	PROPN
iajs-3351	216	16	;	;	PUNCT
iajs-3351	216	17	li	li	PROPN
iajs-3351	216	18	,	,	PUNCT
iajs-3351	216	19	r.	r.	PROPN
iajs-3351	216	20	;	;	PUNCT
iajs-3351	216	21	xiao	xiao	PROPN
iajs-3351	216	22	,	,	PUNCT
iajs-3351	216	23	y.	y.	PROPN
iajs-3351	216	24	;	;	PUNCT
iajs-3351	216	25	hou	hou	PROPN
iajs-3351	216	26	,	,	PUNCT
iajs-3351	216	27	c.	c.	PROPN
iajs-3351	216	28	;	;	PUNCT
iajs-3351	216	29	wang	wang	PROPN
iajs-3351	216	30	,	,	PUNCT
iajs-3351	216	31	h.	h.	PROPN
iajs-3351	216	32	;	;	PUNCT
iajs-3351	216	33	liu	liu	PROPN
iajs-3351	216	34	,	,	PUNCT
iajs-3351	216	35	j.	j.	PROPN
iajs-3351	216	36	;	;	PUNCT
iajs-3351	216	37	yang	yang	PROPN
iajs-3351	216	38	,	,	PUNCT
iajs-3351	216	39	d.	d.	PROPN
iajs-3351	216	40	;	;	PUNCT
iajs-3351	216	41	xu	xu	PROPN
iajs-3351	216	42	,	,	PUNCT
iajs-3351	216	43	y.	y.	NOUN
iajs-3351	216	44	role	role	NOUN
iajs-3351	216	45	of	of	ADP
iajs-3351	216	46	angiotensin	angiotensin	NOUN
iajs-3351	216	47	-	-	PUNCT
iajs-3351	216	48	converting	convert	VERB
iajs-3351	216	49	enzyme	enzyme	NOUN
iajs-3351	216	50	2	2	NUM
iajs-3351	216	51	(	(	PUNCT
iajs-3351	216	52	ace2	ace2	PROPN
iajs-3351	216	53	)	)	PUNCT
iajs-3351	216	54	in	in	ADP
iajs-3351	216	55	covid-19	covid-19	PROPN
iajs-3351	216	56	.	.	PUNCT
iajs-3351	217	1	critical	critical	ADJ
iajs-3351	217	2	care	care	NOUN
iajs-3351	217	3	2020	2020	NUM
iajs-3351	217	4	,	,	PUNCT
iajs-3351	217	5	24(12	24(12	NUM
iajs-3351	217	6	)	)	PUNCT
iajs-3351	217	7	,	,	PUNCT
iajs-3351	217	8	1	1	NUM
iajs-3351	217	9	-	-	SYM
iajs-3351	217	10	0	0	NUM
iajs-3351	217	11	.	.	PUNCT
iajs-3351	217	12	https://doi.org/10.1186/s13054-020-03120-0	https://doi.org/10.1186/s13054-020-03120-0	NUM
iajs-3351	217	13	.	.	PUNCT
iajs-3351	218	1	23	23	NUM
iajs-3351	218	2	.	.	PUNCT
iajs-3351	219	1	scialo	scialo	PROPN
iajs-3351	219	2	,	,	PUNCT
iajs-3351	219	3	f.	f.	PROPN
iajs-3351	219	4	;	;	PUNCT
iajs-3351	219	5	daniele	daniele	PROPN
iajs-3351	219	6	,	,	PUNCT
iajs-3351	219	7	a.	a.	NOUN
iajs-3351	219	8	;	;	PUNCT
iajs-3351	219	9	amato	amato	PROPN
iajs-3351	219	10	,	,	PUNCT
iajs-3351	219	11	f.	f.	PROPN
iajs-3351	219	12	;	;	PUNCT
iajs-3351	219	13	pastore	pastore	PROPN
iajs-3351	219	14	,	,	PUNCT
iajs-3351	219	15	l.	l.	PROPN
iajs-3351	219	16	;	;	PUNCT
iajs-3351	219	17	matera	matera	PROPN
iajs-3351	219	18	,	,	PUNCT
iajs-3351	219	19	m.g	m.g	PROPN
iajs-3351	219	20	.	.	PROPN
iajs-3351	219	21	;	;	PUNCT
iajs-3351	219	22	cazzola	cazzola	NUM
iajs-3351	219	23	,	,	PUNCT
iajs-3351	219	24	m.	m.	NOUN
iajs-3351	219	25	;	;	PUNCT
iajs-3351	219	26	castaldo	castaldo	PROPN
iajs-3351	219	27	,	,	PUNCT
iajs-3351	219	28	g.	g.	PROPN
iajs-3351	219	29	;	;	PUNCT
iajs-3351	219	30	bianco	bianco	PROPN
iajs-3351	219	31	,	,	PUNCT
iajs-3351	219	32	a.	a.	NOUN
iajs-3351	219	33	ace2	ace2	PROPN
iajs-3351	219	34	:	:	PUNCT
iajs-3351	219	35	the	the	DET
iajs-3351	219	36	major	major	ADJ
iajs-3351	219	37	cell	cell	NOUN
iajs-3351	219	38	entry	entry	NOUN
iajs-3351	219	39	receptor	receptor	NOUN
iajs-3351	219	40	for	for	ADP
iajs-3351	219	41	sars	sar	NOUN
iajs-3351	219	42	-	-	PUNCT
iajs-3351	219	43	cov-2	cov-2	NOUN
iajs-3351	219	44	.	.	PUNCT
iajs-3351	220	1	lung	lung	PROPN
iajs-3351	220	2	2020	2020	NUM
iajs-3351	220	3	,	,	PUNCT
iajs-3351	220	4	198:867	198:867	NUM
iajs-3351	220	5	-	-	SYM
iajs-3351	220	6	77	77	NUM
iajs-3351	220	7	.	.	PUNCT
iajs-3351	221	1	https://doi.org/10.1007/s00408-020-00408-4	https://doi.org/10.1007/s00408-020-00408-4	PROPN
iajs-3351	221	2	.	.	PUNCT
iajs-3351	222	1	ihjpas	ihjpas	PROPN
iajs-3351	222	2	.	.	PUNCT
iajs-3351	223	1	37	37	NUM
iajs-3351	223	2	(	(	PUNCT
iajs-3351	223	3	3	3	NUM
iajs-3351	223	4	)	)	PUNCT
iajs-3351	223	5	2024	2024	NUM
iajs-3351	223	6	295	295	NUM
iajs-3351	223	7	24	24	NUM
iajs-3351	223	8	.	.	PUNCT
iajs-3351	224	1	lan	lan	PROPN
iajs-3351	224	2	,	,	PUNCT
iajs-3351	224	3	j.	j.	PROPN
iajs-3351	224	4	;	;	PUNCT
iajs-3351	224	5	ge	ge	PROPN
iajs-3351	224	6	,	,	PUNCT
iajs-3351	224	7	j.	j.	PROPN
iajs-3351	224	8	;	;	PUNCT
iajs-3351	224	9	yu	yu	PROPN
iajs-3351	224	10	,	,	PUNCT
iajs-3351	224	11	j.	j.	PROPN
iajs-3351	224	12	;	;	PUNCT
iajs-3351	224	13	shan	shan	PROPN
iajs-3351	224	14	,	,	PUNCT
iajs-3351	224	15	s.	s.	PROPN
iajs-3351	224	16	;	;	PUNCT
iajs-3351	224	17	zhou	zhou	PROPN
iajs-3351	224	18	,	,	PUNCT
iajs-3351	224	19	h.	h.	PROPN
iajs-3351	224	20	;	;	PUNCT
iajs-3351	224	21	fan	fan	PROPN
iajs-3351	224	22	,	,	PUNCT
iajs-3351	224	23	s.	s.	PROPN
iajs-3351	224	24	;	;	PUNCT
iajs-3351	224	25	zhang	zhang	PROPN
iajs-3351	224	26	,	,	PUNCT
iajs-3351	224	27	q.	q.	PROPN
iajs-3351	224	28	;	;	PUNCT
iajs-3351	224	29	shi	shi	PROPN
iajs-3351	224	30	,	,	PUNCT
iajs-3351	224	31	x.	x.	PROPN
iajs-3351	224	32	;	;	PUNCT
iajs-3351	224	33	wang	wang	PROPN
iajs-3351	224	34	,	,	PUNCT
iajs-3351	224	35	q.	q.	PROPN
iajs-3351	224	36	;	;	PUNCT
iajs-3351	224	37	zhang	zhang	PROPN
iajs-3351	224	38	,	,	PUNCT
iajs-3351	224	39	l.	l.	PROPN
iajs-3351	224	40	;	;	PUNCT
iajs-3351	224	41	wang	wang	PROPN
iajs-3351	224	42	,	,	PUNCT
iajs-3351	224	43	x.	x.	NOUN
iajs-3351	224	44	structure	structure	NOUN
iajs-3351	224	45	of	of	ADP
iajs-3351	224	46	the	the	DET
iajs-3351	224	47	sars	sar	NOUN
iajs-3351	224	48	-	-	PUNCT
iajs-3351	224	49	cov-2	cov-2	NOUN
iajs-3351	224	50	spike	spike	ADJ
iajs-3351	224	51	receptor	receptor	NOUN
iajs-3351	224	52	-	-	PUNCT
iajs-3351	224	53	binding	bind	VERB
iajs-3351	224	54	domain	domain	NOUN
iajs-3351	224	55	bound	bind	VERB
iajs-3351	224	56	to	to	ADP
iajs-3351	224	57	the	the	DET
iajs-3351	224	58	ace2	ace2	NOUN
iajs-3351	224	59	receptor	receptor	NOUN
iajs-3351	224	60	.	.	PUNCT
iajs-3351	225	1	nature	nature	NOUN
iajs-3351	225	2	2020	2020	NUM
iajs-3351	225	3	,	,	PUNCT
iajs-3351	225	4	581(7807	581(7807	NUM
iajs-3351	225	5	)	)	PUNCT
iajs-3351	225	6	,	,	PUNCT
iajs-3351	225	7	215	215	NUM
iajs-3351	225	8	-	-	SYM
iajs-3351	225	9	20	20	NUM
iajs-3351	225	10	.	.	PUNCT
iajs-3351	226	1	https://doi.org/10.1038/s41586-020-2180-5	https://doi.org/10.1038/s41586-020-2180-5	PROPN
iajs-3351	226	2	.	.	PUNCT
iajs-3351	227	1	25	25	NUM
iajs-3351	227	2	.	.	PUNCT
iajs-3351	228	1	huffman	huffman	PROPN
iajs-3351	228	2	,	,	PUNCT
iajs-3351	228	3	a.m.	a.m.	PROPN
iajs-3351	228	4	;	;	PUNCT
iajs-3351	228	5	rezq	rezq	PROPN
iajs-3351	228	6	,	,	PUNCT
iajs-3351	228	7	s.	s.	PROPN
iajs-3351	228	8	;	;	PUNCT
iajs-3351	228	9	basnet	basnet	PROPN
iajs-3351	228	10	,	,	PUNCT
iajs-3351	228	11	j.	j.	PROPN
iajs-3351	228	12	;	;	PUNCT
iajs-3351	228	13	yanes	yanes	PROPN
iajs-3351	228	14	cardozo	cardozo	PROPN
iajs-3351	228	15	,	,	PUNCT
iajs-3351	228	16	l.l	l.l	PROPN
iajs-3351	228	17	.	.	PROPN
iajs-3351	228	18	;	;	PUNCT
iajs-3351	228	19	romero	romero	PROPN
iajs-3351	228	20	,	,	PUNCT
iajs-3351	228	21	d.g	d.g	PROPN
iajs-3351	228	22	.	.	PROPN
iajs-3351	228	23	sars	sars	PROPN
iajs-3351	228	24	-	-	PUNCT
iajs-3351	228	25	cov-2	cov-2	PART
iajs-3351	228	26	viral	viral	ADJ
iajs-3351	228	27	entry	entry	NOUN
iajs-3351	228	28	proteins	protein	NOUN
iajs-3351	228	29	in	in	ADP
iajs-3351	228	30	hyperandrogenemic	hyperandrogenemic	ADJ
iajs-3351	228	31	female	female	ADJ
iajs-3351	228	32	mice	mouse	NOUN
iajs-3351	228	33	:	:	PUNCT
iajs-3351	228	34	implications	implication	NOUN
iajs-3351	228	35	for	for	ADP
iajs-3351	228	36	women	woman	NOUN
iajs-3351	228	37	with	with	ADP
iajs-3351	228	38	pcos	pcos	PROPN
iajs-3351	228	39	and	and	CCONJ
iajs-3351	228	40	covid-19	covid-19	PROPN
iajs-3351	228	41	.	.	PUNCT
iajs-3351	229	1	int	int	PROPN
iajs-3351	229	2	j	j	PROPN
iajs-3351	229	3	mol	mol	ADP
iajs-3351	229	4	sci	sci	PROPN
iajs-3351	229	5	2021	2021	NUM
iajs-3351	229	6	,	,	PUNCT
iajs-3351	229	7	22(9),4472	22(9),4472	NUM
iajs-3351	229	8	.	.	PUNCT
iajs-3351	230	1	https://doi.org/10.3390/ijms22094472	https://doi.org/10.3390/ijms22094472	PROPN
iajs-3351	230	2	.	.	PUNCT
iajs-3351	231	1	26	26	NUM
iajs-3351	231	2	.	.	PUNCT
iajs-3351	231	3	moin	moin	PROPN
iajs-3351	231	4	,	,	PUNCT
iajs-3351	231	5	a.s	a.s	PROPN
iajs-3351	231	6	.	.	PROPN
iajs-3351	231	7	;	;	PUNCT
iajs-3351	231	8	sathyapalan	sathyapalan	PROPN
iajs-3351	231	9	,	,	PUNCT
iajs-3351	231	10	t.	t.	PROPN
iajs-3351	231	11	;	;	PUNCT
iajs-3351	231	12	atkin	atkin	PROPN
iajs-3351	231	13	,	,	PUNCT
iajs-3351	231	14	s.l	s.l	PROPN
iajs-3351	231	15	.	.	PROPN
iajs-3351	231	16	;	;	PUNCT
iajs-3351	231	17	butler	butler	PROPN
iajs-3351	231	18	,	,	PUNCT
iajs-3351	231	19	a.e	a.e	PROPN
iajs-3351	231	20	.	.	PROPN
iajs-3351	231	21	renin	renin	ADJ
iajs-3351	231	22	-	-	PUNCT
iajs-3351	231	23	angiotensin	angiotensin	NOUN
iajs-3351	231	24	system	system	NOUN
iajs-3351	231	25	overactivation	overactivation	NOUN
iajs-3351	231	26	in	in	ADP
iajs-3351	231	27	polycystic	polycystic	ADJ
iajs-3351	231	28	ovary	ovary	ADJ
iajs-3351	231	29	syndrome	syndrome	NOUN
iajs-3351	231	30	,	,	PUNCT
iajs-3351	231	31	a	a	DET
iajs-3351	231	32	risk	risk	NOUN
iajs-3351	231	33	for	for	ADP
iajs-3351	231	34	sars	sar	NOUN
iajs-3351	231	35	-	-	PUNCT
iajs-3351	231	36	cov-2	cov-2	NOUN
iajs-3351	231	37	infection	infection	NOUN
iajs-3351	231	38	.	.	PUNCT
iajs-3351	232	1	metabolism	metabolism	NOUN
iajs-3351	232	2	open	open	ADJ
iajs-3351	232	3	2020	2020	NUM
iajs-3351	232	4	,	,	PUNCT
iajs-3351	232	5	7(15),100052	7(15),100052	NUM
iajs-3351	232	6	.	.	PUNCT
iajs-3351	233	1	https://doi.org/10.1016/j.metop.2020.100052	https://doi.org/10.1016/j.metop.2020.100052	PROPN
iajs-3351	233	2	.	.	PUNCT
iajs-3351	234	1	27	27	NUM
iajs-3351	234	2	.	.	X
iajs-3351	235	1	sun	sun	NOUN
iajs-3351	235	2	,	,	PUNCT
iajs-3351	235	3	x.	x.	PROPN
iajs-3351	235	4	;	;	PUNCT
iajs-3351	235	5	wu	wu	PROPN
iajs-3351	235	6	,	,	PUNCT
iajs-3351	235	7	x.	x.	PROPN
iajs-3351	235	8	;	;	PUNCT
iajs-3351	235	9	zhou	zhou	PROPN
iajs-3351	235	10	,	,	PUNCT
iajs-3351	235	11	y.	y.	PROPN
iajs-3351	235	12	;	;	PUNCT
iajs-3351	235	13	yu	yu	PROPN
iajs-3351	235	14	,	,	PUNCT
iajs-3351	235	15	x.	x.	PROPN
iajs-3351	235	16	;	;	PUNCT
iajs-3351	235	17	zhang	zhang	PROPN
iajs-3351	235	18	,	,	PUNCT
iajs-3351	235	19	w.	w.	PROPN
iajs-3351	235	20	evaluation	evaluation	NOUN
iajs-3351	235	21	of	of	ADP
iajs-3351	235	22	apelin	apelin	PROPN
iajs-3351	235	23	and	and	CCONJ
iajs-3351	235	24	insulin	insulin	NOUN
iajs-3351	235	25	resistance	resistance	NOUN
iajs-3351	235	26	in	in	ADP
iajs-3351	235	27	patients	patient	NOUN
iajs-3351	235	28	with	with	ADP
iajs-3351	235	29	pcos	pcos	PROPN
iajs-3351	235	30	and	and	CCONJ
iajs-3351	235	31	therapeutic	therapeutic	ADJ
iajs-3351	235	32	effect	effect	NOUN
iajs-3351	235	33	of	of	ADP
iajs-3351	235	34	drospirenone	drospirenone	NOUN
iajs-3351	235	35	ethinyl	ethinyl	PROPN
iajs-3351	235	36	estradiol	estradiol	PROPN
iajs-3351	235	37	plus	plus	CCONJ
iajs-3351	235	38	metformin	metformin	PROPN
iajs-3351	235	39	.	.	PUNCT
iajs-3351	236	1	medical	medical	PROPN
iajs-3351	236	2	science	science	PROPN
iajs-3351	236	3	monitor	monitor	PROPN
iajs-3351	236	4	:	:	PUNCT
iajs-3351	236	5	int	int	PROPN
iajs-3351	236	6	j	j	PROPN
iajs-3351	236	7	clin	clin	PROPN
iajs-3351	236	8	exp	exp	PROPN
iajs-3351	236	9	med	med	PROPN
iajs-3351	236	10	2015	2015	NUM
iajs-3351	236	11	,	,	PUNCT
iajs-3351	236	12	21	21	NUM
iajs-3351	236	13	(	(	PUNCT
iajs-3351	236	14	14	14	NUM
iajs-3351	236	15	)	)	PUNCT
iajs-3351	236	16	,	,	PUNCT
iajs-3351	236	17	2547	2547	NUM
iajs-3351	236	18	.	.	PUNCT
iajs-3351	237	1	https://doi	https://doi	ADJ
iajs-3351	237	2	:	:	PUNCT
iajs-3351	237	3	10.12659	10.12659	NUM
iajs-3351	237	4	/	/	SYM
iajs-3351	237	5	msm.894926	msm.894926	NOUN
iajs-3351	237	6	.	.	NOUN
iajs-3351	237	7	28	28	NUM
iajs-3351	237	8	.	.	PUNCT
iajs-3351	238	1	moti	moti	PROPN
iajs-3351	238	2	,	,	PUNCT
iajs-3351	238	3	m.	m.	NOUN
iajs-3351	238	4	;	;	PUNCT
iajs-3351	238	5	amini	amini	PROPN
iajs-3351	238	6	,	,	PUNCT
iajs-3351	238	7	l.	l.	PROPN
iajs-3351	238	8	;	;	PUNCT
iajs-3351	238	9	ardakani	ardakani	PROPN
iajs-3351	238	10	,	,	PUNCT
iajs-3351	238	11	s.s	s.s	PROPN
iajs-3351	238	12	.	.	PROPN
iajs-3351	238	13	;	;	PUNCT
iajs-3351	238	14	kamalzadeh	kamalzadeh	PROPN
iajs-3351	238	15	,	,	PUNCT
iajs-3351	238	16	s.	s.	PROPN
iajs-3351	238	17	;	;	PUNCT
iajs-3351	238	18	masoomikarimi	masoomikarimi	PROPN
iajs-3351	238	19	,	,	PUNCT
iajs-3351	238	20	m.	m.	NOUN
iajs-3351	238	21	oxidative	oxidative	ADJ
iajs-3351	238	22	stress	stress	NOUN
iajs-3351	238	23	and	and	CCONJ
iajs-3351	238	24	antioxidant	antioxidant	ADJ
iajs-3351	238	25	defense	defense	NOUN
iajs-3351	238	26	system	system	NOUN
iajs-3351	238	27	in	in	ADP
iajs-3351	238	28	iranian	iranian	ADJ
iajs-3351	238	29	women	woman	NOUN
iajs-3351	238	30	with	with	ADP
iajs-3351	238	31	polycystic	polycystic	ADJ
iajs-3351	238	32	ovary	ovary	ADJ
iajs-3351	238	33	syndrome	syndrome	NOUN
iajs-3351	238	34	.	.	PUNCT
iajs-3351	239	1	ijpr	ijpr	PROPN
iajs-3351	239	2	2015	2015	NUM
iajs-3351	239	3	,	,	PUNCT
iajs-3351	239	4	13(6),373	13(6),373	NUM
iajs-3351	239	5	.	.	PUNCT
iajs-3351	240	1	pmcid	pmcid	ADJ
iajs-3351	240	2	:	:	PUNCT
iajs-3351	240	3	pmc4555058	pmc4555058	ADJ
iajs-3351	240	4	.	.	PUNCT
iajs-3351	241	1	29	29	NUM
iajs-3351	241	2	.	.	PUNCT
iajs-3351	242	1	kebapcilar	kebapcilar	ADJ
iajs-3351	242	2	,	,	PUNCT
iajs-3351	242	3	l.	l.	PROPN
iajs-3351	242	4	;	;	PUNCT
iajs-3351	242	5	taner	taner	PROPN
iajs-3351	242	6	,	,	PUNCT
iajs-3351	242	7	c.e	c.e	PROPN
iajs-3351	242	8	.	.	PROPN
iajs-3351	242	9	;	;	PUNCT
iajs-3351	242	10	kebapcilar	kebapcilar	PRON
iajs-3351	242	11	,	,	PUNCT
iajs-3351	242	12	a.g	a.g	PROPN
iajs-3351	242	13	.	.	PROPN
iajs-3351	242	14	;	;	PUNCT
iajs-3351	242	15	sari	sari	PROPN
iajs-3351	242	16	,	,	PUNCT
iajs-3351	242	17	i.	i.	PROPN
iajs-3351	242	18	high	high	ADJ
iajs-3351	242	19	mean	mean	VERB
iajs-3351	242	20	platelet	platelet	NOUN
iajs-3351	242	21	volume	volume	NOUN
iajs-3351	242	22	,	,	PUNCT
iajs-3351	242	23	low	low	ADJ
iajs-3351	242	24	-	-	PUNCT
iajs-3351	242	25	grade	grade	NOUN
iajs-3351	242	26	systemic	systemic	ADJ
iajs-3351	242	27	coagulation	coagulation	NOUN
iajs-3351	242	28	and	and	CCONJ
iajs-3351	242	29	fibrinolytic	fibrinolytic	ADJ
iajs-3351	242	30	activation	activation	NOUN
iajs-3351	242	31	are	be	AUX
iajs-3351	242	32	associated	associate	VERB
iajs-3351	242	33	with	with	ADP
iajs-3351	242	34	androgen	androgen	NOUN
iajs-3351	242	35	and	and	CCONJ
iajs-3351	242	36	insulin	insulin	NOUN
iajs-3351	242	37	levels	level	NOUN
iajs-3351	242	38	in	in	ADP
iajs-3351	242	39	polycystic	polycystic	ADJ
iajs-3351	242	40	ovary	ovary	ADJ
iajs-3351	242	41	syndrome	syndrome	NOUN
iajs-3351	242	42	.	.	PUNCT
iajs-3351	243	1	arch	arch	PROPN
iajs-3351	243	2	gynecol	gynecol	PROPN
iajs-3351	243	3	obstet	obstet	NOUN
iajs-3351	243	4	2009	2009	NUM
iajs-3351	243	5	,	,	PUNCT
iajs-3351	243	6	280(56),187	280(56),187	NUM
iajs-3351	243	7	-	-	SYM
iajs-3351	243	8	93	93	NUM
iajs-3351	243	9	.	.	PUNCT
iajs-3351	244	1	https://doi.org/10.1007/s00404-008-0884-0	https://doi.org/10.1007/s00404-008-0884-0	NUM
iajs-3351	244	2	.	.	PUNCT
iajs-3351	245	1	30	30	NUM
iajs-3351	245	2	.	.	PUNCT
iajs-3351	246	1	lehmann	lehmann	PROPN
iajs-3351	246	2	,	,	PUNCT
iajs-3351	246	3	a.	a.	PROPN
iajs-3351	246	4	;	;	PUNCT
iajs-3351	246	5	prosch	prosch	PROPN
iajs-3351	246	6	,	,	PUNCT
iajs-3351	246	7	h.	h.	PROPN
iajs-3351	246	8	;	;	PUNCT
iajs-3351	246	9	zehetmayer	zehetmayer	PROPN
iajs-3351	246	10	,	,	PUNCT
iajs-3351	246	11	s.	s.	PROPN
iajs-3351	246	12	;	;	PUNCT
iajs-3351	246	13	gysan	gysan	PROPN
iajs-3351	246	14	,	,	PUNCT
iajs-3351	246	15	m.r	m.r	PROPN
iajs-3351	246	16	.	.	PROPN
iajs-3351	246	17	;	;	PUNCT
iajs-3351	246	18	bernitzky	bernitzky	PROPN
iajs-3351	246	19	,	,	PUNCT
iajs-3351	246	20	d.	d.	PROPN
iajs-3351	246	21	;	;	PUNCT
iajs-3351	246	22	vonbank	vonbank	PROPN
iajs-3351	246	23	,	,	PUNCT
iajs-3351	246	24	k.	k.	PROPN
iajs-3351	246	25	;	;	PUNCT
iajs-3351	246	26	idzko	idzko	PROPN
iajs-3351	246	27	,	,	PUNCT
iajs-3351	246	28	m.	m.	NOUN
iajs-3351	246	29	;	;	PUNCT
iajs-3351	246	30	gompelmann	gompelmann	PROPN
iajs-3351	246	31	,	,	PUNCT
iajs-3351	246	32	d.	d.	PROPN
iajs-3351	246	33	impact	impact	NOUN
iajs-3351	246	34	of	of	ADP
iajs-3351	246	35	persistent	persistent	ADJ
iajs-3351	246	36	d	d	ADJ
iajs-3351	246	37	-	-	PUNCT
iajs-3351	246	38	dimer	dimer	ADJ
iajs-3351	246	39	elevation	elevation	NOUN
iajs-3351	246	40	following	follow	VERB
iajs-3351	246	41	recovery	recovery	NOUN
iajs-3351	246	42	from	from	ADP
iajs-3351	246	43	covid-19	covid-19	PROPN
iajs-3351	246	44	.	.	PUNCT
iajs-3351	247	1	plos	plos	PROPN
iajs-3351	247	2	one	one	NUM
iajs-3351	247	3	.	.	PUNCT
iajs-3351	247	4	2021	2021	NUM
iajs-3351	247	5	,	,	PUNCT
iajs-3351	247	6	16(10	16(10	NOUN
iajs-3351	247	7	)	)	PUNCT
iajs-3351	247	8	,	,	PUNCT
iajs-3351	247	9	e0258351.https://doi.org/10.1371/journal.pone.0258351	e0258351.https://doi.org/10.1371/journal.pone.0258351	NOUN
iajs-3351	247	10	.	.	PUNCT
iajs-3351	248	1	31	31	NUM
iajs-3351	248	2	.	.	X
iajs-3351	248	3	bannigida	bannigida	PROPN
iajs-3351	248	4	,	,	PUNCT
iajs-3351	248	5	d.m	d.m	PROPN
iajs-3351	248	6	.	.	PUNCT
iajs-3351	248	7	;	;	PUNCT
iajs-3351	249	1	nayak	nayak	PROPN
iajs-3351	249	2	,	,	PUNCT
iajs-3351	249	3	b.s	b.s	PROPN
iajs-3351	249	4	.	.	PROPN
iajs-3351	249	5	;	;	PUNCT
iajs-3351	249	6	vijayaraghavan	vijayaraghavan	NOUN
iajs-3351	249	7	,	,	PUNCT
iajs-3351	249	8	r.	r.	PROPN
iajs-3351	249	9	insulin	insulin	NOUN
iajs-3351	249	10	resistance	resistance	NOUN
iajs-3351	249	11	and	and	CCONJ
iajs-3351	249	12	oxidative	oxidative	ADJ
iajs-3351	249	13	marker	marker	NOUN
iajs-3351	249	14	in	in	ADP
iajs-3351	249	15	women	woman	NOUN
iajs-3351	249	16	with	with	ADP
iajs-3351	249	17	pcos	pcos	PROPN
iajs-3351	249	18	.	.	PUNCT
iajs-3351	250	1	arch	arch	PROPN
iajs-3351	250	2	physiol	physiol	PROPN
iajs-3351	250	3	biochem	biochem	PROPN
iajs-3351	250	4	2020	2020	NUM
iajs-3351	250	5	,	,	PUNCT
iajs-3351	250	6	126(2	126(2	NUM
iajs-3351	250	7	)	)	PUNCT
iajs-3351	250	8	,	,	PUNCT
iajs-3351	250	9	183	183	NUM
iajs-3351	250	10	.	.	PUNCT
iajs-3351	251	1	https://doi.org/10.1080/13813455.2018.1499120	https://doi.org/10.1080/13813455.2018.1499120	NOUN
iajs-3351	251	2	.	.	PUNCT